PepsiCo (PEP) 8-K 7 Oct 15 Other Events Financial data

Document And Entity Information

Document And Entity Information	12 Months Ended
	Dec. 27, 2014
Document And Entity Information [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Dec. 27, 2014
Trading Symbol	PEP
Entity Registrant Name	PEPSICO INC
Entity Central Index Key	77,476

Consolidated Statement of Incom

Consolidated Statement of Income - USD ($) shares in Millions, $ in Millions		12 Months Ended
		Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Income Statement [Abstract]
Net Revenue		$ 66,683	$ 66,415	$ 65,492
Cost of sales		30,884	31,243	31,291
Gross Profit		35,799	35,172	34,201
Selling, general and administrative expenses		26,126	25,357	24,970
Amortization of intangible assets		92	110	119
Operating Profit		9,581	9,705	9,112
Interest expense		(909)	(911)	(899)
Interest income and other		85	97	91
Income before income taxes		8,757	8,891	8,304
Provision for income taxes		2,199	2,104	2,090
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest		6,558	6,787	6,214
Less: Net income attributable to noncontrolling interests		45	47	36
Net Income Attributable to PepsiCo		$ 6,513	$ 6,740	$ 6,178
Net Income Attributable to PepsiCo per Common Share
Basic		$ 4.31	$ 4.37	$ 3.96
Diluted		$ 4.27	$ 4.32	$ 3.92
Weighted-average common shares outstanding
Basic	[1]	1,509	1,541	1,557
Diluted	[1]	1,527	1,560	1,575
Cash dividends declared per common share		$ 2.5325	$ 2.24	$ 2.1275
[1]	Weighted-average common shares outstanding (in millions).

Consolidated Statement of Compr

Consolidated Statement of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 6,558	$ 6,787	$ 6,214
Other Comprehensive Loss
Currency translation adjustment, pre-tax amount	(5,010)	(1,303)	737
Other Comprehensive Income (Loss), Foreign Currency Translation Gain (Loss) Arising During Period, Tax	0	0	0
Currency translation adjustment, after-tax amount	(5,010)	(1,303)	737
Cash flow hedges:
Reclassification of net losses to net income, pre-tax amount	249	45	90
Reclassification of net losses to net income, tax benefit/(expense)	(95)	(17)	(32)
Reclassification of net losses to net income, after-tax amount	154	28	58
Net derivative losses, pre-tax amount	(88)	(20)	(50)
Net derivative losses, tax benefit/(expense)	44	10	10
Net derivative losses, after-tax amount	(44)	(10)	(40)
Pension and retiree medical:
Reclassification of net losses to net income	369	353	508
Net prior service cost, tax benefit (expense)	(122)	(123)	(87)
Net prior service cost, after-tax	247	230	421
Remeasurement of net liabilities and translation	(1,323)	2,164	(581)
Net (losses)/gains, tax benefit/(expense)	437	(764)	88
Net (losses)/gains, after-tax amount	(886)	1,400	(493)
Unrealized (losses)/gains on securities, pre-tax amount	(11)	57	18
Unrealized (losses)/gains on securities, tax benefit/(expense)	5	(28)
Unrealized (losses)/gains on securities, net of tax	(6)	29	18
Other, pre-tax amount	1
Other, tax benefit/(expense)		(16)	36
Other Comprehensive Income, Other, Net of Tax	1	(16)	36
Total Other Comprehensive Income (Loss), pre-tax amount	(5,813)	1,296	722
Total Other Comprehensive Income/(Loss), tax benefit/(expense)	269	(938)	15
Other Comprehensive Income/(Loss), after-tax amount	(5,544)	358	737
Comprehensive income	1,014	7,145	6,951
Comprehensive income attributable to noncontrolling interests	(43)	(45)	(31)
Comprehensive Income Attributable to PepsiCo	$ 971	$ 7,100	$ 6,920

Consolidated Statement of Cash

Consolidated Statement of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Statement of Cash Flows [Abstract]
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 6,558	$ 6,787	$ 6,214
Operating Activities
Depreciation and amortization	2,625	2,663	2,689
Stock-based compensation expense	297	303	278
Merger and integration charges	0	10	16
Cash payments for merger and integration charges	0	(25)	(83)
Restructuring and impairment charges	418	163	279
Cash payments for restructuring charges	(266)	(133)	(343)
Payments for restructuring and other charges related to Tingyi	0		176
Cash payments for restructuring and other charges related to the transaction with Tingyi	0	(26)	(109)
Venezuela remeasurement charges	105	111	0
Excess tax benefits from share-based payment arrangements	(114)	(117)	(124)
Pension and retiree medical plan contributions	(655)	(262)	(1,865)
Pension and retiree medical plan expenses	667	663	796
Deferred income taxes and other tax charges and credits	(19)	(1,058)	321
Accounts and notes receivable	(343)	(88)	(250)
Inventories	(111)	4	144
Prepaid expenses and other current assets	80	(51)	89
Accounts payable and other current liabilities	1,162	1,007	548
Income taxes payable	371	86	(97)
Other, net	(269)	(349)	(200)
Net Cash Provided by Operating Activities	10,506	9,688	8,479
Investing Activities
Capital spending	(2,859)	(2,795)	(2,714)
Sales of property, plant and equipment	115	109	95
Cash payments related to the transaction with Tingyi	0	(3)	(306)
Acquisitions and investments in noncontrolled affiliates	(88)	(109)	(121)
Divestitures	203	133	(32)
Short-term investments, by original maturity
More than three months - purchases	(6,305)	0	0
Payments for (Proceeds from) Short-Term Investments - Maturities	3,891	0	0
Three months or less, net	116	61	61
Other investing, net	(10)	(21)	12
Net Cash Used for Investing Activities	(4,937)	(2,625)	(3,005)
Financing Activities
Proceeds from issuances of long-term debt	3,855	4,195	5,999
Payments of long-term debt	(2,189)	(3,894)	(2,449)
Short-term borrowings, by original maturity
More than three months - proceeds	50	23	549
More than three months - payments	(10)	(492)	(248)
Three months or less, net	(2,037)	1,634	(1,762)
Cash dividends paid	(3,730)	(3,434)	(3,305)
Share repurchases - common	(5,012)	(3,001)	(3,219)
Share repurchases - preferred	(10)	(7)	(7)
Proceeds from exercises of stock options	755	1,123	1,122
Excess tax benefits from share-based payment arrangements	114	117	124
Acquisition of noncontrolling interests	0	(20)	(68)
Other financing	(50)	(33)	(42)
Net Cash Used for Financing Activities	(8,264)	(3,789)	(3,306)
Effect of exchange rate changes on cash and cash equivalents	(546)	(196)	62
Net (Decrease)/Increase in Cash and Cash Equivalents	(3,241)	3,078	2,230
Cash and Cash Equivalents, Beginning of Year	9,375	6,297	4,067
Cash and Cash Equivalents, End of Year	$ 6,134	$ 9,375	$ 6,297

Consolidated Balance Sheet

Consolidated Balance Sheet - USD ($) $ in Millions		Dec. 27, 2014	Dec. 28, 2013
ASSETS
Cash and cash equivalents		$ 6,134	$ 9,375
Short-term Investments		2,592	303
Accounts and notes receivable, net		6,651	6,954
Inventories	[1]	3,143	3,409
Prepaid expenses and other current assets		2,143	2,162
Assets, Current		20,663	22,203
Property, Plant and Equipment, net		17,244	18,575
Amortizable Intangible Assets, net		1,449	1,638
Goodwill		14,965	16,613
Indefinite-Lived Intangible Assets (Excluding Goodwill)		12,639	14,401
Nonamortizable Intangible Assets		27,604	31,014
Equity Method Investments		2,689	2,623
Other Assets		860	1,425
Total Assets		70,509	77,478
LIABILITIES AND EQUITY
Short-term obligations		5,076	5,306
Accounts payable and other current liabilities		13,016	12,533
Liabilities, Current		18,092	17,839
Long-Term Debt Obligations		23,821	24,333
Other Liabilities, Noncurrent		5,744	4,931
Deferred Income Taxes		5,304	5,986
Liabilities		$ 52,961	$ 53,089
Commitments and contingencies
Preferred Stock, no par value		$ 41	$ 41
PepsiCo Common Shareholders’ Equity
Common Stock, Value, Issued		25	25
Additional Paid in Capital, Common Stock		4,115	4,095
Retained Earnings (Accumulated Deficit)		49,092	46,420
Accumulated other comprehensive loss		(10,669)	(5,127)
Stockholders' Equity Attributable to Parent		17,578	24,409
Stockholders' Equity Attributable to Noncontrolling Interest		110	110
Total Equity		17,548	24,389
Liabilities and Equity		70,509	77,478
Preferred Stock
LIABILITIES AND EQUITY
Treasury Stock, Value		(181)	(171)
Common Stock
LIABILITIES AND EQUITY
Treasury Stock, Value		$ (24,985)	$ (21,004)
[1]	Approximately 3% of the inventory cost in both 2014 and 2013 was computed using the LIFO method. The differences between LIFO and FIFO methods of valuing these inventories were not material.

Consolidated Balance Sheet (Par

Consolidated Balance Sheet (Parenthetical) - $ / shares shares in Millions	Dec. 27, 2014	Dec. 28, 2013
Statement of Financial Position [Abstract]
Common stock, par value	$ 0.0167	$ 0.0167
Common stock, authorized	3,600	3,600
Common stock, issued	1,488	1,529
Repurchased common stock, shares	378	337

Consolidated Statement of Equit

Consolidated Statement of Equity - USD ($) shares in Thousands, $ in Millions		Total		Preferred Stock	Repurchased Preferred Stock	Common Stock	Capital In Excess Of Par Value	Retained Earnings	Accumulated Other Comprehensive Loss	Repurchased Common Stock	Total Common Shareholders' Equity	Noncontrolling Interests
Stock Repurchased During Period, Shares						(21,000)				(47,000)
Stock Repurchased During Period, Value										$ (3,219)
Stock option exercises/RSUs converted, tax benefit		$ 84
Preferred Stock, Shares Issued, Beginning of year at Dec. 31, 2011					(600)
Balance, beginning of year at Dec. 31, 2011					$ (157)	$ 26	$ 4,461	$ 40,316	$ (6,229)	$ (17,870)		$ 311
Balance, beginning of year (in shares) at Dec. 31, 2011										(301,000)
Balance, outstanding, beginning of year (in shares) at Dec. 31, 2011						1,565,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Redemptions					(7)
Stock-based compensation expense							278
Stock Options Exercises RSUs and Performance Stock Units Converted	[1]						(431)
Adjustments Related to Tax Withholding for Share-based Compensation							(70)
Other							(60)
Stock option exercises (in shares)										24,000
Stock option exercises										$ 1,488
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest		6,214						6,178				36
Cash dividends declared – common								(3,312)
Cash dividends declared – preferred								(1)
Cash dividends declared – RSUs and PSUs								(23)
Distributions to noncontrolling interests												(37)
Currency translation adjustment									742			(5)
Acquisitions and divestitures												(200)
Cash flow hedges:
Reclassification of net losses to net income		(40)							58
Net derivative losses		(58)							(40)
Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, Net of Tax									421
Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, before Reclassification Adjustments, Net of Tax									(493)
Pension and retiree medical:
Unrealized (losses)/gains on securities, net of tax		18							18
Other (in shares)										2,000
Other									36	$ (143)
Balance, end of year at Dec. 29, 2012		22,399			$ (164)	$ 26	4,178	43,158	(5,487)	$ (19,458)	$ 22,417	105
Balance, end of year (in shares) at Dec. 29, 2012										(322,000)
Balance, outstanding, end of year (in shares) at Dec. 29, 2012						1,544,000
Preferred Stock, Shares Issued, End of year at Dec. 29, 2012				800	600
Preferred Stock, Value, Outstanding				$ 41
Stock Repurchased During Period, Shares						(15,000)				(37,000)
Stock Repurchased During Period, Value										$ (3,000)
Stock option exercises/RSUs converted, tax benefit		45
Balance, beginning of year (in shares) at Dec. 29, 2012										(322,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Redemptions					$ (7)
Share repurchases						$ (1)
Stock-based compensation expense							303
Stock Options Exercises RSUs and Performance Stock Units Converted	[1]						(287)
Adjustments Related to Tax Withholding for Share-based Compensation							(87)
Other							(12)
Stock option exercises (in shares)										20,000
Stock option exercises										$ 1,301
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest		6,787						6,740				47
Cash dividends declared – common								(3,451)
Cash dividends declared – preferred								(1)
Cash dividends declared – RSUs and PSUs								(26)
Distributions to noncontrolling interests												(34)
Currency translation adjustment									(1,301)			(2)
Acquisitions and divestitures												(6)
Cash flow hedges:
Reclassification of net losses to net income		(10)							28
Net derivative losses		(28)							(10)
Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, Net of Tax									230
Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, before Reclassification Adjustments, Net of Tax									1,400
Pension and retiree medical:
Unrealized (losses)/gains on securities, net of tax		29							29
Other (in shares)										2,000
Other									(16)	$ (153)
Balance, end of year at Dec. 28, 2013		24,389			$ (171)	$ 25	4,095	46,420	(5,127)	$ (21,004)	24,409	110
Balance, end of year (in shares) at Dec. 28, 2013										(337,000)
Balance, outstanding, end of year (in shares) at Dec. 28, 2013						1,529,000
Preferred Stock, Shares Issued, End of year at Dec. 28, 2013				800	(600)
Preferred Stock, Value, Outstanding		41		$ 41
Stock Repurchased During Period, Shares						(41,000)				(57,000)
Stock Repurchased During Period, Value										$ (5,012)
Stock option exercises/RSUs converted, tax benefit		$ 74
Balance, beginning of year (in shares) at Dec. 28, 2013										(337,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Redemptions (in shares)					(100)
Redemptions					$ (10)
Stock-based compensation expense							297
Stock Options Exercises RSUs and Performance Stock Units Converted	[1]						(200)
Adjustments Related to Tax Withholding for Share-based Compensation							(91)
Other							14
Stock option exercises (in shares)		12,898	[2]							13,000
Stock option exercises										$ 866
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest		$ 6,558						6,513				45
Cash dividends declared – common								(3,814)
Cash dividends declared – preferred								(1)
Cash dividends declared – RSUs and PSUs								(26)
Distributions to noncontrolling interests												(41)
Currency translation adjustment									(5,008)			(2)
Cash flow hedges:
Reclassification of net losses to net income		(44)							154
Net derivative losses		(154)							(44)
Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, Net of Tax									247
Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, before Reclassification Adjustments, Net of Tax									(886)
Pension and retiree medical:
Unrealized (losses)/gains on securities, net of tax		(6)							(6)
Other (in shares)										3,000
Other									1	$ (165)		2
Balance, end of year at Dec. 27, 2014		17,548			$ (181)	$ 25	$ 4,115	$ 49,092	$ (10,669)	$ (24,985)	$ 17,578	$ 110
Balance, end of year (in shares) at Dec. 27, 2014										(378,000)
Balance, outstanding, end of year (in shares) at Dec. 27, 2014						1,488,000
Preferred Stock, Shares Issued, End of year at Dec. 27, 2014				800	(700)
Preferred Stock, Value, Outstanding		$ 41		$ 41
[1]	Includes total tax benefits of $74 million in 2014, $45 million in 2013 and $84 million in 2012.
[2]	Options are in thousands and include options previously granted under The Pepsi Bottling Group, Inc. (PBG) and PepsiAmericas, Inc. (PAS) plans. No additional options or shares were granted under the PBG and PAS plans after 2009.

Basis of Presentation and Our D

Basis of Presentation and Our Divisions	12 Months Ended
	Dec. 27, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis Of Presentation and Our Divisions	Note 1 — Basis of Presentation and Our Divisions Basis of Presentation The accompanying financial statements have been prepared in accordance with U.S. GAAP and include the consolidated accounts of PepsiCo, Inc. and the affiliates that we control. In addition, we include our share of the results of certain other affiliates using the equity method based on our economic ownership interest, our ability to exercise significant influence over the operating or financial decisions of these affiliates or our ability to direct their economic resources. We do not control these other affiliates, as our ownership in these other affiliates is generally 50% or less. Intercompany balances and transactions are eliminated. Our fiscal year ends on the last Saturday of each December, resulting in an additional week of results every five or six years. The results of our Venezuelan businesses have been reported under highly inflationary accounting since the beginning of 2010. See further unaudited information in “Our Business Risks,” “Items Affecting Comparability” and “Our Liquidity and Capital Resources” in Management’s Discussion and Analysis of Financial Condition and Results of Operations. Raw materials, direct labor and plant overhead, as well as purchasing and receiving costs, costs directly related to production planning, inspection costs and raw material handling facilities, are included in cost of sales. The costs of moving, storing and delivering finished product are included in selling, general and administrative expenses. The preparation of our consolidated financial statements requires us to make estimates and assumptions that affect reported amounts of assets, liabilities, revenues, expenses and disclosure of contingent assets and liabilities. Estimates are used in determining, among other items, sales incentives accruals, tax reserves, stock-based compensation, pension and retiree medical accruals, amounts and useful lives for intangible assets, and future cash flows associated with impairment testing for perpetual brands, goodwill and other long-lived assets. We evaluate our estimates on an ongoing basis using our historical experience, as well as other factors we believe appropriate under the circumstances, such as current economic conditions, and adjust or revise our estimates as circumstances change. As future events and their effect cannot be determined with precision, actual results could differ significantly from these estimates. While our United States and Canada (North America) results are reported on a weekly calendar basis, most of our international operations report on a monthly calendar basis. The following chart details our quarterly reporting schedule for all reporting periods presented: Quarter U.S. and Canada International First Quarter 12 weeks January, February Second Quarter 12 weeks March, April and May Third Quarter 12 weeks June, July and August Fourth Quarter 16 weeks September, October, November and December See “Our Divisions” below, and for additional unaudited information on items affecting the comparability of our consolidated results, see further unaudited information in “Items Affecting Comparability” in Management’s Discussion and Analysis of Financial Condition and Results of Operations. Tabular dollars are in millions, except per share amounts. All per share amounts reflect common per share amounts, assume dilution unless noted, and are based on unrounded amounts. Certain reclassifications were made to prior years’ amounts to conform to the current year presentation. Our Divisions Through our operations, authorized bottlers, contract manufacturers and other third parties, we make, market, sell and distribute a wide variety of convenient and enjoyable foods and beverages, serving customers and consumers in more than 200 countries and territories with our largest operations in North America, Russia, Mexico, the United Kingdom and Brazil. Division results are based on how our Chief Executive Officer assesses the performance of and allocates resources to our divisions and are considered our reportable segments. For additional unaudited information on our divisions, see “Our Operations” contained in “Item 1. Business.” The accounting policies for the divisions are the same as those described in Note 2, except for the following allocation methodologies: • stock-based compensation expense; • pension and retiree medical expense; and • derivatives. Stock-Based Compensation Expense Our divisions are held accountable for stock-based compensation expense and, therefore, this expense is allocated to our divisions as an incremental employee compensation cost. The allocation of stock-based compensation expense in 2014 was approximately 15% to FLNA, 2% to QFNA, 23% to NAB, 7% to Latin America, 13% to ESSA, 10% to AMENA and 30% to corporate unallocated expenses. We had similar allocations of stock-based compensation expense to our divisions in 2013 and 2012 . The expense allocated to our divisions excludes any impact of changes in our assumptions during the year which reflect market conditions over which division management has no control. Therefore, any variances between allocated expense and our actual expense are recognized in corporate unallocated expenses. Pension and Retiree Medical Expense Pension and retiree medical service costs measured at a fixed discount rate, as well as amortization of costs related to certain pension plan amendments and gains and losses due to demographics (including mortality assumptions and salary experience) are reflected in division results for North American employees. Division results also include interest costs, measured at a fixed discount rate, for retiree medical plans. Interest costs for the pension plans, pension asset returns and the impact of pension funding, and gains and losses other than those due to demographics, are all reflected in corporate unallocated expenses. In addition, corporate unallocated expenses include the difference between the service costs measured at a fixed discount rate (included in division results as noted above) and the total service costs determined using the plans’ discount rates as disclosed in Note 7 to our consolidated financial statements. Derivatives We centrally manage commodity derivatives on behalf of our divisions. These commodity derivatives include agricultural products, energy and metals. Commodity derivatives that do not qualify for hedge accounting treatment are marked to market each period with the resulting gains and losses recorded in corporate unallocated expenses, as either cost of sales or selling, general and administrative expenses, depending on the underlying commodity. These gains and losses are subsequently reflected in division results when the divisions recognize the cost of the underlying commodity in operating profit. Therefore, the divisions realize the economic effects of the derivative without experiencing any resulting mark-to-market volatility, which remains in corporate unallocated expenses. These derivatives hedge underlying commodity price risk and were not entered into for trading or speculative purposes. Net revenue and operating profit of each division are as follows: Net Revenue Operating Profit (a) 2014 2013 2012 2014 2013 2012 FLNA $ 14,502 $ 14,126 $ 13,574 $ 4,054 $ 3,877 $ 3,646 QFNA 2,568 2,612 2,636 621 617 695 NAB 20,171 20,083 20,428 2,421 2,580 2,569 Latin America 9,425 9,335 8,761 1,636 1,617 1,427 ESSA 13,399 13,828 13,506 1,389 1,327 1,361 AMENA 6,618 6,431 6,587 985 1,140 716 Total division 66,683 66,415 65,492 11,106 11,158 10,414 Corporate Unallocated Mark-to-market net (losses)/gains (68 ) (72 ) 65 Restructuring and impairment charges (41 ) (11 ) (10 ) Pension lump sum settlement charges (141 ) — (195 ) Venezuela remeasurement charges (126 ) (124 ) — Other (1,149 ) (1,246 ) (1,162 ) $ 66,683 $ 66,415 $ 65,492 $ 9,581 $ 9,705 $ 9,112 (a) For information on the impact of restructuring and impairment charges on our divisions, see Note 3 to our consolidated financial statements. See also Note 15 to our consolidated financial statements for more information on our transaction with Tingyi and refranchising of our beverage business in Vietnam in our AMENA segment. Corporate Corporate unallocated includes costs of our corporate headquarters, centrally managed initiatives such as research and development projects, unallocated insurance and benefit programs, foreign exchange transaction gains and losses, commodity derivative gains and losses, our ongoing business transformation initiatives and certain other items. Other Division Information Total assets and capital spending of each division are as follows: Total Assets Capital Spending 2014 2013 2014 2013 2012 FLNA $ 5,307 $ 5,308 $ 519 $ 423 $ 365 QFNA 982 983 58 38 37 NAB 28,665 29,176 708 705 681 Latin America 6,283 6,003 379 395 457 ESSA (a) 13,934 18,725 502 551 576 AMENA 5,855 5,731 517 530 509 Total division 61,026 65,926 2,683 2,642 2,625 Corporate (b) 9,483 11,552 176 153 89 $ 70,509 $ 77,478 $ 2,859 $ 2,795 $ 2,714 (a) The change in total assets in 2014 primarily reflects the depreciation of the Russian ruble. (b) Corporate assets consist principally of cash and cash equivalents, short-term investments, derivative instruments, property, plant and equipment and certain pension and tax assets. In 2014, the change in total Corporate assets was primarily due to the decrease in cash and cash equivalents and certain pension assets, partially offset by an increase in short-term investments. Amortization of intangible assets and depreciation and other amortization of each division are as follows: Amortization of Intangible Depreciation and 2014 2013 2012 2014 2013 2012 FLNA $ 7 $ 7 $ 7 $ 424 $ 430 $ 445 QFNA — — — 51 51 53 NAB 43 55 55 837 843 842 Latin America 10 11 14 273 273 261 ESSA 28 32 36 471 525 522 AMENA 4 5 7 313 283 305 Total division 92 110 119 2,369 2,405 2,428 Corporate — — — 164 148 142 $ 92 $ 110 $ 119 $ 2,533 $ 2,553 $ 2,570 Net revenue and long-lived assets by country are as follows: Net Revenue Long-Lived Assets (a) 2014 2013 2012 2014 2013 U.S. $ 34,219 $ 33,626 $ 33,348 $ 27,964 $ 28,157 Russia (b) 4,414 4,908 4,861 4,520 7,922 Mexico 4,113 4,347 3,955 1,126 1,233 Canada 3,022 3,195 3,290 2,815 3,067 United Kingdom 2,174 2,115 2,102 1,155 1,219 Brazil 1,790 1,835 1,866 928 1,005 All other countries 16,951 16,389 16,070 10,478 11,247 $ 66,683 $ 66,415 $ 65,492 $ 48,986 $ 53,850 (a) Long-lived assets represent property, plant and equipment, nonamortizable intangible assets, amortizable intangible assets and investments in noncontrolled affiliates. These assets are reported in the country where they are primarily used. (b) Change in long-lived assets in 2014 primarily reflects the depreciation of the Russian ruble.

Our Significant Accounting Poli

Our Significant Accounting Policies	12 Months Ended
	Dec. 27, 2014
Accounting Policies [Abstract]
Our Significant Accounting Policies	Our Significant Accounting Policies Revenue Recognition We recognize revenue upon shipment or delivery to our customers based on written sales terms that do not allow for a right of return. However, our policy for DSD and certain chilled products is to remove and replace damaged and out-of-date products from store shelves to ensure that consumers receive the product quality and freshness they expect. Similarly, our policy for certain warehouse-distributed products is to replace damaged and out-of-date products. Based on our experience with this practice, we have reserved for anticipated damaged and out-of-date products. For additional unaudited information on our revenue recognition and related policies, including our policy on bad debts, see “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations. We are exposed to concentration of credit risk from our customers, including Wal-Mart. In 2014 , sales to Wal-Mart (including Sam’s) represented approximately 12% of our total net revenue, including concentrate sales to our independent bottlers, which are used in finished goods sold by them to Wal-Mart. We have not experienced credit issues with these customers. Total Marketplace Spending We offer sales incentives and discounts through various programs to customers and consumers. Total marketplace spending includes sales incentives, discounts, advertising and other marketing activities. Sales incentives and discounts are primarily accounted for as a reduction of revenue and totaled $35.8 billion in 2014 and $34.7 billion in both 2013 and 2012 . Sales incentives and discounts include payments to customers for performing merchandising activities on our behalf, such as payments for in-store displays, payments to gain distribution of new products, payments for shelf space and discounts to promote lower retail prices. It also includes support provided to our independent bottlers through funding of advertising and other marketing activities. While most of these incentive arrangements have terms of no more than one year, certain arrangements, such as fountain pouring rights, may extend beyond one year. Costs incurred to obtain these arrangements are recognized over the shorter of the economic or contractual life, primarily as a reduction of revenue, and the remaining balances of $355 million as of December 27, 2014 and $410 million as of December 28, 2013 are included in prepaid expenses and other current assets and other assets on our balance sheet. For additional unaudited information on our sales incentives, see “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations. Advertising and other marketing activities, reported as selling, general and administrative expenses, totaled $3.9 billion in 2014 and 2013 and $3.7 billion in 2012 , including advertising expenses of $2.3 billion in 2014 , $2.4 billion in 2013 and $ 2.2 billion in 2012 . Deferred advertising costs are not expensed until the year first used and consist of: • media and personal service prepayments; • promotional materials in inventory; and • production costs of future media advertising. Deferred advertising costs of $42 million and $68 million as of December 27, 2014 and December 28, 2013 , respectively, are classified as prepaid expenses on our balance sheet. Distribution Costs Distribution costs, including the costs of shipping and handling activities, are reported as selling, general and administrative expenses. Shipping and handling expenses were $9.7 billion in 2014 , $9.4 billion in 2013 and $9.1 billion in 2012 . Cash Equivalents Cash equivalents are highly liquid investments with original maturities of three months or less. Software Costs We capitalize certain computer software and software development costs incurred in connection with developing or obtaining computer software for internal use when both the preliminary project stage is completed and it is probable that the software will be used as intended. Capitalized software costs include only (i) external direct costs of materials and services utilized in developing or obtaining computer software, (ii) compensation and related benefits for employees who are directly associated with the software project and (iii) interest costs incurred while developing internal-use computer software. Capitalized software costs are included in property, plant and equipment on our balance sheet and amortized on a straight-line basis when placed into service over the estimated useful lives of the software, which approximate 5 to 10 years. Software amortization totaled $208 million in 2014 , $197 million in 2013 and $196 million in 2012 . Net capitalized software and development costs were $0.9 billion and $1.1 billion as of December 27, 2014 and December 28, 2013 , respectively. Commitments and Contingencies We are subject to various claims and contingencies related to lawsuits, certain taxes and environmental matters, as well as commitments under contractual and other commercial obligations. We recognize liabilities for contingencies and commitments when a loss is probable and estimable. For additional information on our commitments, see Note 9 to our consolidated financial statements. Research and Development We engage in a variety of research and development activities and continue to invest to accelerate growth to drive innovation globally. These activities principally involve production, processing and packaging and include: development of new ingredients and products; reformulation and improvement in the quality of existing products; improvement and modernization of manufacturing processes; improvements in product quality, safety and integrity; development of, and improvements in, packaging technology and dispensing equipment; and efforts focused on identifying opportunities to transform, grow and broaden our product portfolio, including the development of sweetener alternatives and flavor modifiers to reduce added sugar, and recipes that allow us to reduce sodium levels in certain of our products. We also made investments to minimize our impact on the environment, including innovation in our packaging to make it increasingly sustainable, and developed and implemented new technologies to enhance the quality and value of our current and future products, as well as made investments to incorporate into our operations best practices and technology to support sustainable agriculture and to minimize our impact on the environment. We continue to make investments to conserve energy and raw materials, reduce waste in our facilities, recycle containers, use renewable resources and optimize package design to use fewer materials. Consumer research is excluded from research and development costs and included in other marketing costs. Research and development costs were $718 million , $665 million and $552 million in 2014 , 2013 and 2012 , respectively, and are reported within selling, general and administrative expenses. Goodwill and Other Intangible Assets Indefinite-lived intangible assets and goodwill are not amortized and are assessed for impairment at least annually, using either a qualitative or quantitative approach. We perform this annual assessment during our third quarter. Where we use the qualitative assessment, first we determine if, based on qualitative factors, it is more likely than not that an impairment exists. Factors considered include macroeconomic, industry and competitive conditions, legal and regulatory environment, historical financial performance and significant changes in the brand or reporting unit. If the qualitative assessment indicates that it is more likely than not that an impairment exists, then a quantitative assessment is performed. The quantitative assessment requires an analysis of several estimates including future cash flows or income consistent with management’s strategic business plans, annual sales growth rates and the selection of assumptions underlying a discount rate (weighted average cost of capital) based on market data available at the time. In the quantitative assessment of indefinite-lived intangible assets, if the carrying amount of the indefinite-lived intangible asset exceeds its estimated fair value, as determined by its discounted cash flows or another income-based approach, an impairment loss is recognized in an amount equal to that excess. Quantitative assessment of goodwill is performed using a two-step impairment test at the reporting unit level. A reporting unit can be a division or business within a division. The first step compares the carrying value of a reporting unit, including goodwill, with its estimated fair value, as determined by its discounted cash flows. If the carrying value of a reporting unit exceeds its estimated fair value, we complete the second step to determine the amount of goodwill impairment loss that we should record, if any. In the second step, we determine an implied fair value of the reporting unit’s goodwill by allocating the estimated fair value of the reporting unit to all of the assets and liabilities other than goodwill (including any unrecognized intangible assets). The amount of impairment loss is equal to the excess of the carrying value of the goodwill over the implied fair value of that goodwill. Quantitative assessments described above are primarily based on expected future levels of sales and operating profit which are inputs from our annual long-range planning process that are used to estimate future cash flows. Additionally, they are also impacted by estimates of discount rates, perpetuity growth assumptions and other factors. Significant management judgment is necessary to estimate the impact of competitive operating, macroeconomic and other factors to estimate future levels of sales, operating profit or cash flows. All assumptions used in our impairment evaluations for nonamortizable intangible assets, such as forecasted growth rates and weighted average cost of capital, are based on the best available market information and are consistent with our internal forecasts and operating plans. Amortizable intangible assets are only evaluated for impairment upon a significant change in the operating or macroeconomic environment. If an evaluation of the undiscounted future cash flows indicates impairment, the asset is written down to its estimated fair value, which is based on its discounted future cash flows or another income-based approach. For additional unaudited information on goodwill and other intangible assets see “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations. Other Significant Accounting Policies Our other significant accounting policies are disclosed as follows: • Property, Plant and Equipment and Intangible Assets – Note 4. • Income Taxes – Note 5, and for additional unaudited information see “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations. • Stock-Based Compensation – Note 6. • Pension, Retiree Medical and Savings Plans – Note 7, and for additional unaudited information see “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations. • Financial Instruments – Note 10, and for additional unaudited information, see “Our Business Risks” in Management’s Discussion and Analysis of Financial Condition and Results of Operations. • Inventories – Note 14. Inventories are valued at the lower of cost or market. Cost is determined using the average; first-in, first-out (FIFO) or last-in, first-out (LIFO) methods. • Translation of Financial Statements of Foreign Subsidiaries – Financial statements of foreign subsidiaries are translated into U.S. dollars using period-end exchange rates for assets and liabilities and weighted-average exchange rates for revenues and expenses. Adjustments resulting from translating net assets are reported as a separate component of accumulated other comprehensive loss within common shareholders’ equity as currency translation adjustment. Recent Accounting Pronouncements In June 2014, the Financial Accounting Standards Board (FASB) issued accounting guidance for share-based payments when the terms of an award provide that a performance target could be achieved after the requisite service period. The guidance requires that a performance target that could be achieved after the requisite service period is treated as a performance condition that affects the vesting of the award rather than factored into the grant date fair value. The guidance is effective as of the beginning of our 2016 fiscal year and can be applied prospectively to all share-based payments granted or modified on or after the effective date with early adoption permissible. This guidance is not expected to have any impact on our financial statements. In May 2014, the FASB issued accounting guidance on revenue recognition, which provides for a single five-step model to be applied to all revenue contracts with customers. The standard also requires additional financial statement disclosures that will enable users to understand the nature, amount, timing and uncertainty of revenue and cash flows relating to customer contracts. Companies have an option to use either a retrospective approach or cumulative effect adjustment approach to implement the standard. There is no option for early adoption. The provisions of this guidance will be effective as of the beginning of our 2017 fiscal year. We are currently evaluating the impact of the guidance on our financial statements and have not yet selected a transition approach to implement the standard. In July 2013, the FASB issued accounting guidance that requires an entity to net its liability for unrecognized tax positions against a net operating loss carryforward, a similar tax loss or a tax credit carryforward when settlement in this manner is available under the tax law. The provisions of this guidance were effective as of the beginning of our 2014 fiscal year and did not have a material impact on our financial statements. In February 2013, the FASB issued guidance that requires an entity to disclose information showing the effect of the items reclassified from accumulated other comprehensive income on the line items of net income. The provisions of this guidance were effective prospectively as of the beginning of our 2013 fiscal year. Accordingly, we included enhanced footnote disclosure for the years ended December 27, 2014 and December 28, 2013 in Note 13. In July 2012, the FASB issued accounting guidance that permits an entity to first assess qualitative factors to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired as a basis for determining whether it is necessary to perform a quantitative impairment test. An entity would continue to calculate the fair value of an indefinite-lived intangible asset if the asset fails the qualitative assessment, while no further analysis would be required if it passes. The provisions of this guidance were effective for 2013 and have had no impact on our annual indefinite-lived intangible asset impairment test results. In December 2011, the FASB issued disclosure requirements that were intended to enhance current disclosures on offsetting financial assets and liabilities. The disclosures required an entity to disclose both gross and net information about derivative instruments accounted for in accordance with the guidance on derivatives and hedging that are eligible for offset on the balance sheet and instruments and transactions subject to an agreement similar to a master netting arrangement. The provisions of these disclosure requirements were effective as of the beginning of our 2014 fiscal year. Accordingly, we included enhanced footnote disclosure in Note 10.

Restructuring, Impairment and I

Restructuring, Impairment and Integration Charges	12 Months Ended
	Dec. 27, 2014
Restructuring and Related Activities [Abstract]
Restructuring, Impairment And Integration Charges	Restructuring, Impairment and Integration Charges 2014 Multi-Year Productivity Plan The 2014 Productivity Plan includes the next generation of productivity initiatives that we believe will strengthen our food, snack and beverage businesses by: accelerating our investment in manufacturing automation; further optimizing our global manufacturing footprint, including closing certain manufacturing facilities; re-engineering our go-to-market systems in developed markets; expanding shared services; and implementing simplified organization structures to drive efficiency. The 2014 Productivity Plan is in addition to the 2012 Productivity Plan and is expected to continue the benefits of that plan. In 2014 and 2013 , we incurred restructuring charges of $357 million ($ 262 million after-tax or $ 0.17 per share) and $53 million ($ 39 million after-tax or $ 0.02 per share), respectively, in conjunction with our 2014 Productivity Plan. All of these charges were recorded in selling, general and administrative expenses and primarily relate to severance and other employee-related costs, asset impairments (all non-cash), and contract termination costs. Substantially all of the restructuring accrual at December 27, 2014 is expected to be paid by the end of 2015 . A summary of our 2014 Productivity Plan charges is as follows: 2014 2013 Severance and Other Asset Impairments Other Costs Total Severance and Other Other Costs Total FLNA $ 25 $ 10 $ 11 $ 46 $ 11 $ — $ 11 QFNA 12 — 2 14 3 — 3 NAB 60 56 56 172 9 — 9 Latin America 15 3 10 28 6 — 6 ESSA 24 4 14 42 10 — 10 AMENA 14 — 8 22 1 — 1 Corporate (a) (2 ) — 35 33 12 1 13 $ 148 $ 73 $ 136 $ 357 $ 52 $ 1 $ 53 (a) Income amount represents adjustments of previously recorded amounts. A summary of our 2014 Productivity Plan activity is as follows: Severance and Other Asset Impairments Other Costs Total 2013 restructuring charges $ 52 $ — $ 1 $ 53 Non-cash charges (22 ) — — (22 ) Liability as of December 28, 2013 30 — 1 31 2014 restructuring charges 148 73 136 357 Cash payments (56 ) — (109 ) (165 ) Non-cash charges (33 ) (73 ) (4 ) (110 ) Liability as of December 27, 2014 $ 89 $ — $ 24 $ 113 2012 Multi-Year Productivity Plan The 2012 Productivity Plan includes actions in every aspect of our business that we believe will strengthen our complementary food, snack and beverage businesses by: leveraging new technologies and processes across PepsiCo’s operations, go-to-market and information systems; heightening the focus on best practice sharing across the globe; consolidating manufacturing, warehouse and sales facilities; and implementing simplified organization structures, with wider spans of control and fewer layers of management. The 2012 Productivity Plan continues to enhance PepsiCo’s cost-competitiveness and provide a source of funding for future brand-building and innovation initiatives. In 2014 , 2013 and 2012 , we incurred restructuring charges of $61 million ($ 54 million after-tax or $ 0.04 per share), $110 million ( $90 million after-tax or $ 0.06 per share) and $279 million ($ 215 million after-tax or $ 0.14 per share), respectively, in conjunction with our 2012 Productivity Plan. All of these charges were recorded in selling, general and administrative expenses and primarily relate to severance and other employee-related costs, asset impairments (all non-cash), and contract termination costs. All of the restructuring accrual at December 27, 2014 is expected to be paid by the end of 2015 . A summary of our 2012 Productivity Plan charges is as follows: 2014 2013 2012 Severance and Other Asset Impairments Other Costs Total Severance and Other Asset Impairments Other Costs Total Severance and Other Asset Impairments Other Costs Total FLNA (a) $ (1 ) $ — $ 3 $ 2 $ 4 $ — $ 4 $ 8 $ 14 $ 8 $ 16 $ 38 QFNA — — — — — — 1 1 — — 9 9 NAB (3 ) 1 9 7 8 — 13 21 27 43 18 88 Latin America (a) 19 — (19 ) — 5 2 — 7 22 8 34 64 ESSA 6 5 18 29 36 2 12 50 14 16 12 42 AMENA 12 — 3 15 21 2 2 25 18 — 10 28 Corporate (a) (2 ) — 10 8 — — (2 ) (2 ) (6 ) — 16 10 $ 31 $ 6 $ 24 $ 61 $ 74 $ 6 $ 30 $ 110 $ 89 $ 75 $ 115 $ 279 (a) Income amounts represent adjustments of previously recorded amounts. A summary of our 2012 Productivity Plan activity is as follows: Severance and Other Asset Impairments Other Costs Total Liability as of December 31, 2011 $ 249 $ — $ 27 $ 276 2012 restructuring charges 89 75 115 279 Cash payments (239 ) — (104 ) (343 ) Non-cash charges (8 ) (75 ) (2 ) (85 ) Liability as of December 29, 2012 91 — 36 127 2013 restructuring charges 74 6 30 110 Cash payments (89 ) — (44 ) (133 ) Non-cash charges (8 ) (6 ) (5 ) (19 ) Liability as of December 28, 2013 68 — 17 85 2014 restructuring charges 31 6 24 61 Cash payments (65 ) — (36 ) (101 ) Non-cash charges (6 ) (6 ) — (12 ) Liability as of December 27, 2014 $ 28 $ — $ 5 $ 33 Other Productivity Initiatives In 2014, the Company incurred pre-tax charges of $67 million ( $54 million after-tax or $0.04 per share) related to productivity and efficiency initiatives outside the scope of the 2014 and 2012 Productivity Plans discussed above, including $11 million in Latin America, $26 million in ESSA and $30 million in AMENA. These charges were primarily recorded in selling, general and administrative expenses and reflect severance and other employee-related costs. These initiatives were excluded from Items Affecting Comparability. See additional unaudited information in “Results of Operations – Division Review” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Property, Plant and Equipment a

Property, Plant and Equipment and Intangible Assets	12 Months Ended
	Dec. 27, 2014
Property, Plant And Equipment And Intangible Assets [Abstract]
Property, Plant and Equipment and Intangible Assets	Property, Plant and Equipment and Intangible Assets A summary of our property, plant and equipment is as follows: Average 2014 2013 2012 Property, plant and equipment, net Land $ 1,288 $ 1,340 Buildings and improvements 15 – 44 8,114 8,375 Machinery and equipment, including fleet and software 5 – 15 25,146 25,415 Construction in progress 1,752 1,831 36,300 36,961 Accumulated depreciation (19,056 ) (18,386 ) $ 17,244 $ 18,575 Depreciation expense $ 2,441 $ 2,472 $ 2,489 Property, plant and equipment is recorded at historical cost. Depreciation and amortization are recognized on a straight-line basis over an asset’s estimated useful life. Land is not depreciated and construction in progress is not depreciated until ready for service. A summary of our amortizable intangible assets is as follows: 2014 2013 2012 Amortizable intangible assets, net Average Gross Accumulated Net Gross Accumulated Net Acquired franchise rights 56 – 60 $ 879 $ (89 ) $ 790 $ 910 $ (83 ) $ 827 Reacquired franchise rights 5 – 14 107 (95 ) 12 108 (86 ) 22 Brands 20 – 40 1,361 (1,004 ) 357 1,400 (996 ) 404 Other identifiable intangibles 10 – 24 595 (305 ) 290 686 (301 ) 385 $ 2,942 $ (1,493 ) $ 1,449 $ 3,104 $ (1,466 ) $ 1,638 Amortization expense $ 92 $ 110 $ 119 Amortization of intangible assets for each of the next five years, based on existing intangible assets as of December 27, 2014 and using average 2014 foreign exchange rates, is expected to be as follows: 2015 2016 2017 2018 2019 Five-year projected amortization $ 82 $ 74 $ 68 $ 66 $ 63 Depreciable and amortizable assets are only evaluated for impairment upon a significant change in the operating or macroeconomic environment. In these circumstances, if an evaluation of the undiscounted cash flows indicates impairment, the asset is written down to its estimated fair value, which is based on discounted future cash flows. Useful lives are periodically evaluated to determine whether events or circumstances have occurred which indicate the need for revision. For additional unaudited information on our policies for amortizable brands, see “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations. Nonamortizable Intangible Assets We did not recognize any impairment charges for goodwill in each of the fiscal years ended December 27, 2014, December 28, 2013 and December 29, 2012. In 2014, we performed the impairment analysis for goodwill for all our reporting units using the qualitative approach and concluded that it was more likely than not that the estimated fair values of our reporting units were greater than their carrying amounts. After reaching this conclusion, no further testing was performed. In 2014 and 2012, we recognized pre-tax impairment charges in ESSA for nonamortizable intangible assets of $23 million in each year. We recognized no impairment charges for nonamortizable intangible assets in 2013. Based on our year-end assessment, the estimated fair values of our indefinite-lived reacquired and acquired franchise rights recorded at NAB exceed their carrying values. However, there could be an impairment of the carrying value of NAB’s reacquired and acquired franchise rights if future revenues and their contribution to the operating results of NAB’s CSD business do not achieve our estimated future cash flows or if macroeconomic conditions result in a future increase in the weighted-average cost of capital used to estimate fair value. We have also analyzed the impact of the recent economic and political developments in Russia on the estimated fair value of our indefinite-lived intangible assets in Russia and have concluded that there is no impairment as of December 27, 2014. However, a further deterioration in these conditions in Russia could potentially require us to record an impairment charge for these assets in the future. For additional information on our policies for nonamortizable intangible assets, see Note 2 to our consolidated financial statements. The change in the book value of nonamortizable intangible assets is as follows: Balance, Acquisitions/(Divestitures) Translation Balance, Translation Balance, FLNA Goodwill $ 316 $ — $ (11 ) $ 305 $ (14 ) $ 291 Brands 31 — (2 ) 29 (2 ) 27 347 — (13 ) 334 (16 ) 318 QFNA Goodwill 175 — — 175 — 175 NAB Goodwill 9,931 5 (42 ) 9,894 (48 ) 9,846 Reacquired franchise rights 7,337 16 (72 ) 7,281 (88 ) 7,193 Acquired franchise rights 1,573 (8 ) (14 ) 1,551 (13 ) 1,538 Brands 108 — — 108 — 108 18,949 13 (128 ) 18,834 (149 ) 18,685 Latin America Goodwill 773 — (64 ) 709 (65 ) 644 Brands 268 — (24 ) 244 (21 ) 223 1,041 — (88 ) 953 (86 ) 867 ESSA (a) Goodwill 5,214 — (187 ) 5,027 (1,488 ) 3,539 Reacquired franchise rights 772 — (12 ) 760 (189 ) 571 Acquired franchise rights 223 — 7 230 (31 ) 199 Brands 4,284 — (213 ) 4,071 (1,408 ) 2,663 10,493 — (405 ) 10,088 (3,116 ) 6,972 AMENA Goodwill 562 (4 ) (55 ) 503 (33 ) 470 Brands 148 — (21 ) 127 (10 ) 117 710 (4 ) (76 ) 630 (43 ) 587 Total goodwill 16,971 1 (359 ) 16,613 (1,648 ) 14,965 Total reacquired franchise rights 8,109 16 (84 ) 8,041 (277 ) 7,764 Total acquired franchise rights 1,796 (8 ) (7 ) 1,781 (44 ) 1,737 Total brands 4,839 — (260 ) 4,579 (1,441 ) 3,138 $ 31,715 $ 9 $ (710 ) $ 31,014 $ (3,410 ) $ 27,604 (a) The change in 2014 primarily reflects the depreciation of the Russian ruble.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 27, 2014
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The components of income before income taxes are as follows: 2014 2013 2012 U.S. $ 2,557 $ 3,078 $ 3,234 Foreign 6,200 5,813 5,070 $ 8,757 $ 8,891 $ 8,304 The provision for income taxes consisted of the following: 2014 2013 2012 Current: U.S. Federal $ 1,364 $ 1,092 $ 911 Foreign 851 807 940 State 210 124 153 2,425 2,023 2,004 Deferred: U.S. Federal (33 ) 87 154 Foreign (60 ) 11 (95 ) State (133 ) (17 ) 27 (226 ) 81 86 $ 2,199 $ 2,104 $ 2,090 A reconciliation of the U.S. Federal statutory tax rate to our annual tax rate is as follows: 2014 2013 2012 U.S. Federal statutory tax rate 35.0 % 35.0 % 35.0 % State income tax, net of U.S. Federal tax benefit 0.6 1.2 1.4 Lower taxes on foreign results (8.6 ) (8.8 ) (6.9 ) Tax benefits — (2.4 ) (2.6 ) Other, net (1.9 ) (1.3 ) (1.7 ) Annual tax rate 25.1 % 23.7 % 25.2 % Deferred tax liabilities and assets are comprised of the following: Deferred tax liabilities 2014 2013 Pension benefits $ — $ 84 Debt guarantee of wholly owned subsidiary 842 828 Property, plant and equipment 2,174 2,327 Intangible assets other than nondeductible goodwill 4,068 4,348 Other 264 361 Gross deferred tax liabilities 7,348 7,948 Deferred tax assets Net carryforwards 1,329 1,485 Stock-based compensation 265 303 Retiree medical benefits 388 384 Other employee-related benefits 646 627 Pension benefits 263 — Deductible state tax and interest benefits 158 155 Long-term debt obligations acquired 98 125 Other 1,002 959 Gross deferred tax assets 4,149 4,038 Valuation allowances (1,230 ) (1,360 ) Deferred tax assets, net 2,919 2,678 Net deferred tax liabilities $ 4,429 $ 5,270 Deferred taxes are included within the following balance sheet accounts: 2014 2013 Assets: Prepaid expenses and other current assets $ 875 $ 716 Liabilities: Deferred income taxes $ 5,304 $ 5,986 A summary of our valuation allowance activity is as follows: 2014 2013 2012 Balance, beginning of year $ 1,360 $ 1,233 $ 1,264 (Benefit)/provision (25 ) 111 68 Other (deductions)/additions (105 ) 16 (99 ) Balance, end of year $ 1,230 $ 1,360 $ 1,233 The Patient Protection and Affordable Care Act (PPACA), which was signed into law in the second quarter of 2010, changed the tax treatment related to an existing retiree drug subsidy (RDS) available to sponsors of retiree health benefit plans that provide a benefit that is at least actuarially equivalent to the benefits under Medicare Part D. As a result of the PPACA, RDS payments became taxable in tax years beginning in 2013, by requiring the amount of the subsidy received to be offset against our deduction for health care expenses. In the first quarter of 2012, we began pre-paying funds within our 401(h) accounts intended to fully cover prescription drug benefit liabilities for Medicare eligible retirees. As a result, the receipt of future Medicare subsidy payments for prescription drugs will not be taxable and consequently we recorded a $55 million tax benefit reflecting this change in the first quarter of 2012. For additional unaudited information on our income tax policies, including our reserves for income taxes, see “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations. Reserves A number of years may elapse before a particular matter, for which we have established a reserve, is audited and finally resolved. The number of years with open tax audits varies depending on the tax jurisdiction. Our major taxing jurisdictions and the related open tax audits are as follows: Jurisdiction Years Open to Audit Years Currently Under Audit United States 2010-2013 2010-2011 Mexico 2009-2013 None United Kingdom 2012-2013 None Canada (Domestic) 2010-2013 2010-2012 Canada (International) 2008-2013 2008-2012 Russia 2009-2013 2009-2013 While it is often difficult to predict the final outcome or the timing of resolution of any particular tax matter, we believe that our reserves reflect the probable outcome of known tax contingencies. We adjust these reserves, as well as the related interest, in light of changing facts and circumstances. Settlement of any particular issue would usually require the use of cash. Favorable resolution would be recognized as a reduction to our annual tax rate in the year of resolution. For further unaudited information on the impact of the resolution of open tax issues, see “Other Consolidated Results” in Management’s Discussion and Analysis of Financial Condition and Results of Operations. We believe that it is reasonably possible that our reserves for uncertain tax positions could decrease by approximately $300 million within the next 12 months as a result of the completion of audits in various jurisdictions. In the fourth quarter of 2013, we reached an agreement with the IRS resolving all open matters related to the audits for taxable years 2003 through 2009. As a result, we made U.S. Federal net cash tax payments of $ 758 million , including interest. The settlement reduced our 2013 net cash provided by operating activities and our reserves for uncertain tax positions for the tax years 2003 through 2012 and resulted in a non-cash tax benefit of $ 209 million in the fourth quarter of 2013. In addition, payments for other U.S. Federal, state and local tax matters related to open tax years totaling $ 226 million were made in 2013. In 2012, we received a favorable tax court decision related to the classification of financial instruments resulting in a non-cash tax benefit of $ 217 million in the fourth quarter of 2012. See additional unaudited information in “Items Affecting Comparability” in Management’s Discussion and Analysis of Financial Condition and Results of Operations. As of December 27, 2014 , the total gross amount of reserves for income taxes, reported in other liabilities, was $1,587 million . We accrue interest related to reserves for income taxes in our provision for income taxes and any associated penalties are recorded in selling, general and administrative expenses. The gross amount of interest accrued, reported in other liabilities, was $141 million as of December 27, 2014 , of which $31 million of expense was recognized in 2014 . The gross amount of interest accrued, reported in other liabilities, was $164 million as of December 28, 2013 , of which $36 million of expense was recognized in 2013 . A rollforward of our reserves for all federal, state and foreign tax jurisdictions, is as follows: 2014 2013 Balance, beginning of year $ 1,268 $ 2,425 Additions for tax positions related to the current year 349 238 Additions for tax positions from prior years 215 273 Reductions for tax positions from prior years (81 ) (327 ) Settlement payments (70 ) (1,306 ) Statutes of limitations expiration (42 ) (30 ) Translation and other (52 ) (5 ) Balance, end of year $ 1,587 $ 1,268 Carryforwards and Allowances Operating loss carryforwards totaling $10.4 billion at year-end 2014 are being carried forward in a number of foreign and state jurisdictions where we are permitted to use tax operating losses from prior periods to reduce future taxable income. These operating losses will expire as follows: $0.1 billion in 2015 , $9.8 billion between 2016 and 2034 and $0.5 billion may be carried forward indefinitely. We establish valuation allowances for our deferred tax assets if, based on the available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Undistributed International Earnings As of December 27, 2014 , we had approximately $37.8 billion of undistributed international earnings. We intend to continue to reinvest earnings outside the U.S. for the foreseeable future and, therefore, have not recognized any U.S. tax expense on these earnings. It is not practicable for us to determine the amount of unrecognized U.S. tax expense on these reinvested international earnings.

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
	Dec. 27, 2014
Share-based Compensation [Abstract]
Stock-Based Compensation	Stock-Based Compensation Our stock-based compensation program is designed to attract and retain employees while also aligning employees’ interests with the interests of our shareholders. Stock options, restricted stock units (RSUs), performance stock units (PSUs) and PepsiCo equity performance units (PEPunits) are granted to employees under the shareholder-approved 2007 Long-Term Incentive Plan (LTIP). Each RSU represents our obligation to deliver to the holder one share of PepsiCo common stock when the award vests at the end of the service period. PSUs are awards where the number of shares delivered to the holder upon vesting at the end of the service period depends on PepsiCo’s performance against specified targets. During the vesting period, RSUs and PSUs accrue dividend equivalents that pay out in cash (without interest) if and when the applicable RSU or PSU vests and becomes payable. PEPunits provide an opportunity to earn shares of PepsiCo common stock with a value that adjusts based upon changes in PepsiCo’s absolute stock price as well as PepsiCo’s Total Shareholder Return relative to the S&P 500 over a three -year performance period. The Company may use authorized and unissued shares to meet share requirements resulting from the exercise of stock options and the vesting of RSUs and PSUs as well as PEPunits. As of December 27, 2014 , 98 million shares were available for future stock-based compensation grants. The following table summarizes our total stock-based compensation expense: 2014 2013 2012 Stock-based compensation expense $ 297 $ 303 $ 278 Merger and integration charges — — 2 Restructuring and impairment benefits (3 ) — (7 ) Total $ 294 $ 303 $ 273 Income tax benefits recognized in earnings related to stock-based compensation $ 75 $ 76 $ 73 Method of Accounting and Our Assumptions We account for our employee stock options under the fair value method of accounting using a Black-Scholes valuation model to measure stock option expense at the date of grant. The fair value of RSUs is measured at the market price of the Company’s stock on the date of grant. The fair value of PSUs is measured at the market price of the Company’s stock on the date of grant with the exception of market-based awards, for which we use the Monte-Carlo simulation option-pricing model to determine the fair value. The Monte-Carlo simulation option-pricing model uses the same input assumptions as the Black-Scholes model; however, it also further incorporates into the fair-value determination the possibility that the market condition may not be satisfied. Compensation costs related to these awards are recognized regardless of whether the market condition is satisfied, provided that the requisite service has been provided. All stock option grants have an exercise price equal to the fair market value of our common stock on the date of grant and generally have a 10 -year term. We do not backdate, reprice or grant stock-based compensation awards retroactively. Repricing of awards would require shareholder approval under the LTIP. The fair value of stock-based award grants is amortized to expense over the vesting period, primarily three years. Awards to employees eligible for retirement prior to the award becoming fully vested are amortized to expense over the period through the date that the employee first becomes eligible to retire and is no longer required to provide service to earn the award. Executives who are awarded long-term incentives based on their performance may generally elect to receive their grant in the form of stock options or RSUs, or a combination thereof. Executives who elect RSUs receive one RSU for every four stock options that would have otherwise been granted. Certain executive officers and other senior executives do not have a choice and are granted a combination of 60% PEPunits measuring both absolute and relative stock price performance and 40% long-term cash based on achievement of specific performance operating metrics. Certain executives are granted performance-based stock units which require the achievement of specified financial and/or operational performance metrics. The number of shares may be increased to the maximum or reduced to the minimum threshold based on the results of these performance metrics in accordance with the terms established at the time of the award. Our weighted-average Black-Scholes fair value assumptions are as follows: 2014 2013 2012 Expected life 6 years 6 years 6 years Risk-free interest rate 1.9 % 1.1 % 1.3 % Expected volatility 16 % 17 % 17 % Expected dividend yield 2.9 % 2.7 % 3.0 % The expected life is the period over which our employee groups are expected to hold their options. It is based on our historical experience with similar grants. The risk-free interest rate is based on the expected U.S. Treasury rate over the expected life. Volatility reflects movements in our stock price over the most recent historical period equivalent to the expected life. Dividend yield is estimated over the expected life based on our stated dividend policy and forecasts of net income, share repurchases and stock price. A summary of our stock-based compensation activity for the year ended December 27, 2014 is as follows: Our Stock Option Activity Options (a) Average Price (b) Average Life (years) (c) Aggregate Intrinsic Value (d) Outstanding at December 28, 2013 49,462 $ 61.58 Granted 3,416 $ 81.27 Exercised (12,898 ) $ 58.56 Forfeited/expired (1,123 ) $ 70.62 Outstanding at December 27, 2014 38,857 $ 64.06 4.67 $ 1,282,200 Exercisable at December 27, 2014 30,237 $ 60.94 3.66 $ 1,091,815 Expected to vest as of December 27, 2014 8,111 $ 74.59 8.19 $ 182,132 (a) Options are in thousands and include options previously granted under The Pepsi Bottling Group, Inc. (PBG) and PepsiAmericas, Inc. (PAS) plans. No additional options or shares were granted under the PBG and PAS plans after 2009. (b) Weighted-average exercise price. (c) Weighted-average contractual life remaining. (d) In thousands. Our RSU and PSU Activity RSUs/PSUs (a) Average Intrinsic Value (b) Average Life (years) (c) Aggregate Intrinsic Value (d) Outstanding at December 28, 2013 11,939 $ 69.04 Granted (e) 4,379 $ 80.39 Converted (3,713 ) $ 64.77 Forfeited (1,171 ) $ 73.71 Actual performance change (f) (206 ) $ 64.19 Outstanding at December 27, 2014 (g) 11,228 $ 74.49 1.42 $ 1,089,707 Expected to vest as of December 27, 2014 10,745 $ 73.74 1.28 $ 1,042,781 (a) RSUs and PSUs are in thousands and include RSUs previously granted under the PBG plan. No additional RSUs or shares were granted under the PBG plan after 2009. (b) Weighted-average intrinsic value at grant date. (c) Weighted-average contractual life remaining. (d) In thousands. (e) Grant activity for all PSUs are disclosed at target. (f) Reflects the net number of PSUs above and below target levels based on actual performance measured at the end of the performance period. (g) The outstanding PSUs for which the performance period has not ended as of December 27, 2014, at the threshold, target and maximum award levels were zero , 0.7 million and 1.1 million , respectively. Our PEPunit Activity PEPunits (a) Average Intrinsic Value (b) Average Life (years) (c) Aggregate Intrinsic Value (d) Outstanding at December 28, 2013 675 $ 66.65 Granted (e) 387 $ 50.95 Converted — $ — Forfeited (109 ) $ 59.85 Outstanding at December 27, 2014 (f) 953 $ 61.04 1.24 $ 92,451 Expected to vest as of December 27, 2014 843 $ 60.97 1.21 $ 81,770 (a) PEPunits are in thousands. (b) Weighted-average intrinsic value at grant date. (c) Weighted-average contractual life remaining. (d) In thousands. (e) Grant activity for all PEPunits are disclosed at target. (f) The outstanding PEPunits for which the performance period has not ended as of December 27, 2014, at the threshold, target and maximum award levels were zero , 1.0 million and 1.7 million , respectively. Other Stock-Based Compensation Data 2014 2013 2012 Stock Options Total number of options granted (a) 3,416 2,868 3,696 Weighted-average fair value of options granted $ 8.79 $ 8.14 $ 6.86 Total intrinsic value of options exercised (a) $ 423,251 $ 471,475 $ 512,636 Total fair value of options vested (a) $ 42,353 $ 88,750 $ 148,835 RSUs/PSUs Total number of RSUs/PSUs granted (a) 4,379 4,231 4,404 Weighted-average intrinsic value of RSUs/PSUs granted $ 80.39 $ 76.30 $ 66.64 Total intrinsic value of RSUs/PSUs converted (a) $ 319,820 $ 294,065 $ 236,575 Total fair value of RSUs/PSUs vested (a) $ 241,836 $ 236,688 $ 188,723 PEPunits Total number of PEPunits granted (a) 387 355 410 Weighted-average intrinsic value of PEPunits granted $ 50.95 $ 68.48 $ 64.85 Total intrinsic value of PEPunits converted (a) $ — $ 3,868 $ — Total fair value of PEPunits vested (a) $ 5,072 $ 5,896 $ — (a) In thousands. As of December 27, 2014 and December 28, 2013 , there were approximately 324,000 and 290,000 outstanding awards, respectively, consisting primarily of phantom stock units that were granted under the PepsiCo Director Deferral Program and will be settled in shares of PepsiCo common stock pursuant to the LTIP at the end of the applicable deferral period, not included in the tables above. As of December 27, 2014 , there was $382 million of total unrecognized compensation cost related to nonvested share-based compensation grants. This unrecognized compensation cost is expected to be recognized over a weighted-average period of two years.

Pension, Retiree Medical and Sa

Pension, Retiree Medical and Savings Plans	12 Months Ended
	Dec. 27, 2014
General Discussion of Pension and Other Postretirement Benefits [Abstract]
Pension, Retiree Medical and Savings Plans	Pension, Retiree Medical and Savings Plans In the fourth quarter of 2014 and 2012, the Company offered certain former employees who had vested benefits in our U.S. defined benefit pension plans the option of receiving a one-time lump sum payment equal to the present value of the participant’s pension benefit (payable in cash or rolled over into a qualified retirement plan or IRA). In December 2014 and 2012, we made a discretionary contribution of $388 million and $405 million , respectively, to fund substantially all of these payments. The Company recorded a pre-tax non-cash settlement charge of $141 million ( $88 million after-tax or $0.06 per share) in 2014 and $195 million ( $131 million after-tax or $0.08 per share) in 2012 as a result of these transactions. See additional unaudited information in “Items Affecting Comparability” in Management’s Discussion and Analysis of Financial Condition and Results of Operations. The provisions of both the PPACA and the Health Care and Education Reconciliation Act are reflected in our retiree medical expenses and liabilities and were not material to our financial statements. During 2014, we revised our mortality assumptions to incorporate the new set of mortality tables issued by the Society of Actuaries, adjusted to reflect our experience and future expectations. This resulted in an increase in the projected benefit obligation of our U.S. pension and retiree medical programs. We also reviewed and revised other demographic assumptions to reflect recent experience. The net effect of these changes and certain plan design changes resulted in an increase of approximately $150 million in the projected benefit obligation at December 27, 2014. Gains and losses resulting from actual experience differing from our assumptions, including the difference between the actual return on plan assets and the expected return on plan assets, and from changes in our assumptions are determined at each measurement date. If this net accumulated gain or loss exceeds 10% of the greater of the market-related value of plan assets or plan liabilities, a portion of the net gain or loss is included in expense for the following year based upon the average remaining service period of active plan participants, which is approximately 11 years for pension expense and approximately 8 years for retiree medical expense. The cost or benefit of plan changes that increase or decrease benefits for prior employee service (prior service cost/(credit)) is included in earnings on a straight-line basis over the average remaining service period of active plan participants. Selected financial information for our pension and retiree medical plans is as follows: Pension Retiree Medical U.S. International 2014 2013 2014 2013 2014 2013 Change in projected benefit liability Liability at beginning of year $ 11,825 $ 12,886 $ 2,859 $ 2,788 $ 1,384 $ 1,511 Service cost 393 467 98 111 36 45 Interest cost 580 527 131 118 58 54 Plan amendments (122 ) 22 — (1 ) (125 ) — Participant contributions — — 3 3 — — Experience loss/(gain) 1,635 (1,522 ) 512 (65 ) 190 (128 ) Benefit payments (349 ) (533 ) (86 ) (91 ) (101 ) (97 ) Settlement/curtailment (577 ) (44 ) (25 ) (3 ) — — Special termination benefits 24 22 — — 3 2 Foreign currency adjustment — — (245 ) (2 ) (6 ) (3 ) Other — — — 1 — — Liability at end of year $ 13,409 $ 11,825 $ 3,247 $ 2,859 $ 1,439 $ 1,384 Change in fair value of plan assets Fair value at beginning of year $ 11,462 $ 10,817 $ 2,777 $ 2,463 $ 406 $ 365 Actual return on plan assets 1,254 1,159 401 265 46 76 Employer contributions/funding 434 63 157 137 64 62 Participant contributions — — 3 3 — — Benefit payments (349 ) (533 ) (86 ) (91 ) (101 ) (97 ) Settlement (577 ) (44 ) (24 ) (8 ) — — Foreign currency adjustment — — (226 ) 8 — — Fair value at end of year $ 12,224 $ 11,462 $ 3,002 $ 2,777 $ 415 $ 406 Funded status $ (1,185 ) $ (363 ) $ (245 ) $ (82 ) $ (1,024 ) $ (978 ) Pension Retiree Medical U.S. International 2014 2013 2014 2013 2014 2013 Amounts recognized Other assets $ 97 $ 603 $ 37 $ 74 $ — $ — Other current liabilities (42 ) (41 ) (1 ) (1 ) (57 ) (72 ) Other liabilities (1,240 ) (925 ) (281 ) (155 ) (967 ) (906 ) Net amount recognized $ (1,185 ) $ (363 ) $ (245 ) $ (82 ) $ (1,024 ) $ (978 ) Amounts included in accumulated other comprehensive loss (pre-tax) Net loss/(gain) $ 2,918 $ 2,069 $ 1,003 $ 849 $ (49 ) $ (222 ) Prior service (credit)/cost (18 ) 125 (7 ) (6 ) (166 ) (69 ) Total $ 2,900 $ 2,194 $ 996 $ 843 $ (215 ) $ (291 ) Components of the increase/(decrease) in net loss/(gain) included in accumulated other comprehensive loss Change in discount rate $ 1,424 $ (1,532 ) $ 636 $ (166 ) $ 98 $ (117 ) Employee-related assumption changes 345 24 (112 ) 91 58 2 Liability-related experience different from assumptions (104 ) (14 ) (12 ) 10 34 (13 ) Actual asset return different from expected return (470 ) (336 ) (225 ) (108 ) (19 ) (49 ) Amortization and settlement of losses (316 ) (285 ) (61 ) (68 ) 4 (1 ) Other, including foreign currency adjustments (30 ) — (72 ) (6 ) (2 ) — Total $ 849 $ (2,143 ) $ 154 $ (247 ) $ 173 $ (178 ) Liability at end of year for service to date $ 12,206 $ 10,803 $ 2,721 $ 2,369 The components of benefit expense are as follows: Pension Retiree Medical U.S. International 2014 2013 2012 2014 2013 2012 2014 2013 2012 Components of benefit expense Service cost $ 393 $ 467 $ 407 $ 98 $ 111 $ 100 $ 36 $ 45 $ 50 Interest cost 580 527 534 131 118 115 58 54 65 Expected return on plan assets (784 ) (823 ) (796 ) (176 ) (157 ) (146 ) (27 ) (27 ) (22 ) Amortization of prior service cost/(credit) 21 18 17 — 1 1 (28 ) (23 ) (26 ) Amortization of net loss/(gain) 175 289 259 53 66 53 (4 ) 1 — 385 478 421 106 139 123 35 50 67 Settlement/curtailment loss/(gain) (a) 141 (4 ) 185 7 7 4 — — — Special termination benefits 24 22 8 — — 1 3 2 5 Total $ 550 $ 496 $ 614 $ 113 $ 146 $ 128 $ 38 $ 52 $ 72 (a) U.S. includes pension lump sum settlement charge of $141 million in 2014 and $195 million in 2012. These charges are reflected in items affecting comparability (see additional unaudited information in “Items Affecting Comparability” in Management’s Discussion and Analysis of Financial Condition and Results of Operations). The estimated amounts to be amortized from accumulated other comprehensive loss into expense in 2015 for our pension and retiree medical plans are as follows: Pension Retiree Medical U.S. International Net loss $ 205 $ 74 $ — Prior service credit (3 ) — (38 ) Total $ 202 $ 74 $ (38 ) The following table provides the weighted-average assumptions used to determine projected benefit liability and benefit expense for our pension and retiree medical plans: Pension Retiree Medical U.S. International 2014 2013 2012 2014 2013 2012 2014 2013 2012 Weighted-average assumptions Liability discount rate 4.2 % 5.0 % 4.2 % 3.8 % 4.7 % 4.4 % 3.8 % 4.6 % 3.7 % Expense discount rate 5.0 % 4.2 % 4.6 % 4.7 % 4.4 % 4.8 % 4.3 % 3.7 % 4.4 % Expected return on plan assets 7.5 % 7.8 % 7.8 % 6.6 % 6.6 % 6.7 % 7.5 % 7.8 % 7.8 % Liability rate of salary increases 3.5 % 3.7 % 3.7 % 3.6 % 3.9 % 3.9 % Expense rate of salary increases 3.7 % 3.7 % 3.7 % 3.9 % 3.9 % 4.1 % The following table provides selected information about plans with liability for service to date and total projected benefit liability in excess of plan assets: Pension Retiree Medical U.S. International 2014 2013 2014 2013 2014 2013 Selected information for plans with liability for service to date in excess of plan assets Liability for service to date $ (661 ) $ (577 ) $ (333 ) $ (310 ) Fair value of plan assets $ 2 $ 2 $ 288 $ 259 Selected information for plans with projected benefit liability in excess of plan assets Benefit liability $ (7,385 ) $ (6,555 ) $ (2,865 ) $ (2,291 ) $ (1,439 ) $ (1,384 ) Fair value of plan assets $ 6,103 $ 5,589 $ 2,583 $ 2,135 $ 415 $ 406 Of the total projected pension benefit liability at year-end 2014 , $808 million relates to plans that we do not fund because the funding of such plans does not receive favorable tax treatment. Future Benefit Payments and Funding Our estimated future benefit payments are as follows: 2015 2016 2017 2018 2019 2020-24 Pension $ 700 $ 730 $ 775 $ 830 $ 880 $ 5,160 Retiree medical (a) $ 120 $ 125 $ 125 $ 125 $ 125 $ 560 (a) Expected future benefit payments for our retiree medical plans do not reflect any estimated subsidies expected to be received under the 2003 Medicare Act. Subsidies are expected to be approximately $3 million for each of the years from 2015 through 2019 and approximately $13 million in total for 2020 through 2024. These future benefit payments to beneficiaries include payments from both funded and unfunded plans. In 2015 , we expect to make pension and retiree medical contributions of approximately $225 million , with approximately $55 million for retiree medical benefits. Plan Assets Our pension plan investment strategy includes the use of actively managed securities and is reviewed periodically in conjunction with plan liabilities, an evaluation of market conditions, tolerance for risk and cash requirements for benefit payments. This strategy is also applicable to funds held for the retiree medical plans. Our investment objective is to ensure that funds are available to meet the plans’ benefit obligations when they become due. Our overall investment strategy is to prudently invest plan assets in a well-diversified portfolio of equity and high-quality debt securities and real estate to achieve our long-term return expectations. Our investment policy also permits the use of derivative instruments which are primarily used to reduce risk. Our expected long-term rate of return on U.S. plan assets is 7.5% for 2015 and 2014 . Our target investment allocations for U.S. plan assets are as follows: 2015 2014 Fixed income 40 % 40 % U.S. equity 33 % 33 % International equity 22 % 22 % Real estate 5 % 5 % Actual investment allocations may vary from our target investment allocations due to prevailing market conditions. We regularly review our actual investment allocations and periodically rebalance our investments to our target allocations. The expected return on plan assets is based on our plan investment strategy and our expectations for long-term rates of return by asset class, taking into account volatility and correlation among asset classes and our historical experience. We also review current levels of interest rates and inflation to assess the reasonableness of the long-term rates. We evaluate our expected return assumptions annually to ensure that they are reasonable. To calculate the expected return on plan assets, our market-related value of assets for fixed income is the actual fair value. For all other asset categories, we use a method that recognizes investment gains or losses (the difference between the expected and actual return based on the market-related value of assets) over a five -year period. This has the effect of reducing year-to-year volatility. Contributions to our pension and retiree medical plans were as follows: Pension Retiree Medical 2014 2013 2012 2014 2013 2012 Discretionary (a) $ 407 $ 23 $ 1,375 $ — $ — $ 140 Non-discretionary 184 177 239 64 62 111 Total $ 591 $ 200 $ 1,614 $ 64 $ 62 $ 251 (a) Includes $388 million and $405 million in 2014 and 2012, respectively, pertaining to pension lump sum payments. Plan assets measured at fair value as of fiscal year-end 2014 and 2013 are categorized consistently by level in both years, and are as follows: 2014 2013 Total Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total U.S. plan assets (a) Equity securities: U.S. common stock (b) $ 966 $ 966 $ — $ — $ 732 U.S. commingled funds (c) (d) 3,437 — 3,437 — 3,334 International common stock (b) 1,488 1,488 — — 1,669 International commingled fund (e) 876 — 876 — 902 Preferred stock (f) 22 — 22 — 18 Fixed income securities: Government securities (f) 1,279 — 1,279 — 1,264 Corporate bonds (f) (g) 3,338 — 3,338 — 2,958 Mortgage-backed securities (f) 274 — 274 — 220 Other: Contracts with insurance companies (h) 6 — — 6 6 Real estate commingled funds (i) 629 — — 629 552 Cash and cash equivalents 267 267 — — 154 Sub-total U.S. plan assets 12,582 $ 2,721 $ 9,226 $ 635 11,809 Dividends and interest receivable 57 59 Total U.S. plan assets $ 12,639 $ 11,868 International plan assets Equity securities: U.S. common stock (b) $ 5 $ 5 $ — $ — $ 4 U.S. commingled funds (c) 373 — 373 — 334 International common stock (b) 171 171 — — 176 International commingled funds (e) 918 — 918 — 914 Preferred stock (f) 1 — 1 — 1 Fixed income securities: Government securities (f) 454 — 454 — 207 Corporate bonds (f) 320 — 320 — 261 Fixed income commingled funds (j) 517 — 517 — 650 Other: Contracts with insurance companies (h) 36 — — 36 34 Currency commingled fund (k) 87 — 87 — 91 Real estate commingled fund (i) 92 — — 92 83 Cash and cash equivalents 21 21 — — 15 Sub-total international plan assets 2,995 $ 197 $ 2,670 $ 128 2,770 Dividends and interest receivable 7 7 Total international plan assets $ 3,002 $ 2,777 (a) 2014 and 2013 amounts include $415 million and $ 406 million , respectively, of retiree medical plan assets that are restricted for purposes of providing health benefits for U.S. retirees and their beneficiaries. (b) Based on quoted market prices in active markets. (c) Based on the fair value of the investments owned by these funds that track various U.S. large, mid-cap and small company indices. (d) Includes one large-cap fund that represents 25% of total U.S. plan assets for both 2014 and 2013 . (e) Based on the fair value of the investments owned by these funds that track various non-U.S. equity indices. (f) Based on quoted bid prices for comparable securities in the marketplace and broker/dealer quotes in active markets. (g) Corporate bonds of U.S.-based companies represent 23% and 21% , respectively, of total U.S. plan assets for 2014 and 2013 . (h) Based on the fair value of the contracts as determined by the insurance companies using inputs that are not observable. (i) Based on the appraised value of the investments owned by these funds as determined by independent third parties using inputs that are not observable. (j) Based on the fair value of the investments owned by these funds that track various government and corporate bond indices. (k) Based on the fair value of the investments owned by this fund that invests primarily in derivatives to hedge currency exposure. The changes in Level 3 plan assets are as follows: Balance, Beginning 2013 Return on Assets Held at Year-End Purchases and Sales, Net Balance, End of 2013 Return on Assets Held at Year-End Purchases and Sales, Net Balance, End of 2014 Real estate commingled funds $ 391 $ 56 $ 188 $ 635 $ 68 $ 18 $ 721 Contracts with insurance companies 62 (1 ) (21 ) 40 2 — 42 Total $ 453 $ 55 $ 167 $ 675 $ 70 $ 18 $ 763 Retiree Medical Cost Trend Rates An average increase of 6% in the cost of covered retiree medical benefits is assumed for 2015 . This average increase is then projected to decline gradually to 5% in 2025 and thereafter. These assumed health care cost trend rates have an impact on the retiree medical plan expense and liability, however the cap on our share of retiree medical costs limits the impact. A 1-percentage-point change in the assumed health care trend rate would have the following effects: 1% 1% 2014 service and interest cost components $ 4 $ (3 ) 2014 benefit liability $ 46 $ (40 ) Savings Plan Certain U.S. employees are eligible to participate in 401(k) savings plans, which are voluntary defined contribution plans. The plans are designed to help employees accumulate additional savings for retirement, and we make Company matching contributions for certain employees on a portion of eligible pay based on years of service. As of February 2012, certain U.S. employees earning a benefit under one of our defined benefit pension plans were no longer eligible for Company matching contributions on their 401(k) contributions. Certain U.S. salaried employees, who are not eligible to participate in a defined benefit pension plan, are also eligible to receive an employer contribution to the 401(k) savings plan based on age and years of service regardless of employee contribution. In 2014 , 2013 and 2012 , our total Company contributions were $130 million , $122 million and $109 million , respectively. For additional unaudited information on our pension and retiree medical plans and related accounting policies and assumptions, see “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 27, 2014
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions Our related party transactions in 2014 , 2013 and 2012 are not material. We coordinate, on an aggregate basis, the contract negotiations of sweeteners and other raw material requirements, including aluminum cans and plastic bottles and closures for us and certain of our independent bottlers. Once we have negotiated the contracts, the bottlers order and take delivery directly from the supplier and pay the suppliers directly. Consequently, these transactions are not reflected in our consolidated financial statements. As the contracting party, we could be liable to these suppliers in the event of any nonpayment by our bottlers, but we consider this exposure to be remote. In addition, our joint ventures with Unilever (under the Lipton brand name) and Starbucks sell finished goods (ready-to-drink teas and coffees, respectively) to us and our noncontrolled bottling affiliates. Consistent with accounting for equity method investments, our joint venture revenue is not included in our consolidated net revenue. Certain members of our Board of Directors also serve on the boards of certain vendors and customers. These Board members do not participate in our vendor selection and negotiations nor in our customer negotiations. Our transactions with these vendors and customers are in the normal course of business and are consistent with terms negotiated with other vendors and customers. In addition, certain of our employees serve on the boards of Pepsi Bottling Ventures LLC and other affiliated companies of PepsiCo and do not receive incremental compensation for such services.

Debt Obligations and Commitment

Debt Obligations and Commitments	12 Months Ended
	Dec. 27, 2014
Debt Obligations and Commitments [Abstract]
Debt Obligations And Commitments	Debt Obligations and Commitments The following table summarizes the Company’s debt obligations: 2014 2013 Short-term debt obligations Current maturities of long-term debt $ 4,096 $ 2,224 Commercial paper (0.1% and 0.1%) 746 2,924 Other borrowings (17.7% and 12.4%) 234 158 $ 5,076 $ 5,306 Long-term debt obligations Notes due 2014 (5.3%) $ — $ 2,219 Notes due 2015 (1.4% and 1.2%) 4,093 4,116 Notes due 2016 (2.6% and 2.5%) 3,099 3,106 Notes due 2017 (1.6% and 2.0%) 2,004 1,258 Notes due 2018 (4.4% and 4.3%) 3,410 3,439 Notes due 2019 (3.7% and 3.7%) 1,631 1,635 Notes due 2020-2044 (3.9% and 4.0%) 13,640 10,738 Other, due 2015-2019 (4.4% and 4.4%) 40 46 27,917 26,557 Less: current maturities of long-term debt obligations (4,096 ) (2,224 ) Total $ 23,821 $ 24,333 The interest rates in the above table reflect weighted-average rates at year-end. In 2014 , we issued: • $750 million of 0.950% senior notes maturing in February 2017 ; • $1.250 billion of 3.600% senior notes maturing in March 2024 ; • €500 million of 1.750% senior notes maturing in April 2021 ; • €500 million of 2.625% senior notes maturing in April 2026 ; and • $500 million of 4.250% senior notes maturing in October 2044 . The net proceeds from the issuances of the above notes were used for general corporate purposes, including the repayment of commercial paper. In 2014 , $2.2 billion of senior notes matured and were paid. In 2014 , we entered into a new five-year unsecured revolving credit agreement (Five-Year Credit Agreement) which expires on June 9, 2019. The Five-Year Credit Agreement enables us and our borrowing subsidiaries to borrow up to $3.7725 billion , subject to customary terms and conditions. We may request that commitments under this agreement be increased up to $4.5 billion . Additionally, we may, once a year, request renewal of the agreement for an additional one-year period. Also, in 2014 , we entered into a new 364-day unsecured revolving credit agreement (364-Day Credit Agreement) which expires on June 8, 2015. The 364-Day Credit Agreement enables us and our borrowing subsidiaries to borrow up to $3.7725 billion , subject to customary terms and conditions. We may request that commitments under this agreement be increased up to $4.5 billion . We may request renewal of this facility for an additional 364-day period or convert any amounts outstanding into a term loan for a period of up to one year, which would mature no later than the then effective termination date. The Five-Year Credit Agreement and the 364-Day Credit Agreement together replaced our $2.925 billion five-year credit agreement dated as of June 10, 2013 and our $2.925 billion 364-Day credit agreement dated as of June 10, 2013. Funds borrowed under the Five-Year Credit Agreement and the 364-Day Credit Agreement may be used for general corporate purposes. Subject to certain conditions, we may borrow, prepay and reborrow amounts under these agreements. As of December 27, 2014 , there were no outstanding borrowings under the Five-Year Credit Agreement or the 364-Day Credit Agreement. In addition, as of December 27, 2014 , our international debt of $228 million was related to borrowings from external parties including various lines of credit. These lines of credit are subject to normal banking terms and conditions and are fully committed at least to the extent of our borrowings. Long-Term Contractual Commitments (a) The following table summarizes our long-term contractual commitments by period: Payments Due by Period Total 2015 2016 – 2017 2018 – 2019 2020 and beyond Long-term debt obligations (b) $ 23,446 $ — $ 5,108 $ 4,863 $ 13,475 Interest on debt obligations (c) 8,839 873 1,553 1,245 5,168 Operating leases 1,894 403 631 387 473 Purchasing commitments (d) 1,985 693 873 293 126 Marketing commitments (d) 2,178 391 647 525 615 $ 38,342 $ 2,360 $ 8,812 $ 7,313 $ 19,857 (a) Based on year-end foreign exchange rates. We expect to make net cash tax payments of approximately $300 million within the next 12 months, as discussed further in Note 5. Reserves for uncertain tax positions are excluded from the table above as we are unable to reasonably predict the ultimate amount or timing of any other settlements. (b) Excludes $4,096 million related to current maturities of long-term debt, $196 million related to the fair value step-up of debt acquired in connection with our acquisitions of PBG and PAS and $179 million related to the increase in carrying value of long-term debt representing the gains on our fair value interest rate swaps. (c) Interest payments on floating-rate debt are estimated using interest rates effective as of December 27, 2014 . (d) Primarily reflects non-cancelable commitments as of December 27, 2014 . Most long-term contractual commitments, except for our long-term debt obligations, are not recorded on our balance sheet. Operating leases primarily represent building leases. Non-cancelable purchasing commitments are primarily for oranges and orange juice. Non-cancelable marketing commitments are primarily for sports marketing. Bottler funding to independent bottlers is not reflected in our long-term contractual commitments as it is negotiated on an annual basis. Accrued liabilities for pension and retiree medical plans are not reflected in our long-term contractual commitments. See Note 7 for additional information regarding our pension and retiree medical obligations. Off-Balance-Sheet Arrangements It is not our business practice to enter into off-balance-sheet arrangements, other than in the normal course of business. See Note 8 regarding contracts related to certain of our bottlers. See “Our Liquidity and Capital Resources” in Management’s Discussion and Analysis of Financial Condition and Results of Operations for further unaudited information on our borrowings.

Financial Instruments

Financial Instruments	12 Months Ended
	Dec. 27, 2014
Derivative Instruments and Hedges, Assets [Abstract]
Financial Instruments	Financial Instruments Derivatives We are exposed to market risks arising from adverse changes in: • commodity prices, affecting the cost of our raw materials and energy; • foreign exchange rates and currency restrictions; and • interest rates. In the normal course of business, we manage commodity price, foreign exchange and interest rate risks through a variety of strategies, including productivity initiatives, global purchasing programs and hedging. Ongoing productivity initiatives involve the identification and effective implementation of meaningful cost-saving opportunities or efficiencies, including the use of derivatives. Our global purchasing programs include fixed-price purchase orders and pricing agreements. Our hedging strategies include the use of derivatives. Certain derivatives are designated as either cash flow or fair value hedges and qualify for hedge accounting treatment, while others do not qualify and are marked to market through earnings. Cash flows from derivatives used to manage commodity price, foreign exchange or interest rate risks are classified as operating activities in the Consolidated Statement of Cash Flows. We classify both the earnings and cash flow impact from these derivatives consistent with the underlying hedged item. See “Our Business Risks” in Management’s Discussion and Analysis of Financial Condition and Results of Operations for further unaudited information on our business risks. For cash flow hedges, the effective portion of changes in fair value are deferred in accumulated other comprehensive loss within common shareholders’ equity until the underlying hedged item is recognized in net income. For fair value hedges, changes in fair value are recognized immediately in earnings, consistent with the underlying hedged item. Hedging transactions are limited to an underlying exposure. As a result, any change in the value of our derivative instruments would be substantially offset by an opposite change in the value of the underlying hedged items. We do not use derivative instruments for trading or speculative purposes. We perform assessments of our counterparty credit risk regularly, including reviewing netting agreements, if any, and a review of credit ratings, credit default swap rates and potential nonperformance of the counterparty. Based on our most recent assessment of our counterparty credit risk, we consider this risk to be low. In addition, we enter into derivative contracts with a variety of financial institutions that we believe are creditworthy in order to reduce our concentration of credit risk. Commodity Prices We are subject to commodity price risk because our ability to recover increased costs through higher pricing may be limited in the competitive environment in which we operate. This risk is managed through the use of fixed-price contracts and purchase orders, pricing agreements and derivative instruments, which include swaps and futures. In addition, risk to our supply of certain raw materials is mitigated through purchases from multiple geographies and suppliers. We use derivatives, with terms of no more than three years, to economically hedge price fluctuations related to a portion of our anticipated commodity purchases, primarily for agricultural products, energy and metals. Ineffectiveness for those derivatives that qualify for hedge accounting treatment was not material for all periods presented. Derivatives used to hedge commodity price risk that do not qualify for hedge accounting treatment are marked to market each period with the resulting gains and losses recorded in corporate unallocated expenses as either cost of sales or selling, general and administrative expenses, depending on the underlying commodity. These gains and losses are subsequently reflected in division results when the divisions recognize the cost of the underlying commodity in operating profit. Our open commodity derivative contracts had a notional value of $1.2 billion as of December 27, 2014 and $1.4 billion as of December 28, 2013 . Foreign Exchange Our operations outside of the U.S. generate 49% of our net revenue, with Russia, Mexico, Canada, the United Kingdom and Brazil comprising approximately 23% of our net revenue in 2014 . As a result, we are exposed to foreign exchange risks. Additionally, we are exposed to foreign exchange risk from foreign currency purchases and foreign currency assets and liabilities created in the normal course of business. We manage this risk through sourcing purchases from local suppliers, negotiating contracts in local currencies with foreign suppliers and through the use of derivatives, primarily forward contracts with terms of no more than two years. Exchange rate gains or losses related to foreign currency transactions are recognized as transaction gains or losses in our income statement as incurred. Our foreign currency derivatives had a total notional value of $2.7 billion as of December 27, 2014 and $2.5 billion as of December 28, 2013 . Ineffectiveness for those derivatives that qualify for hedge accounting was not material for all periods presented. For foreign currency derivatives that do not qualify for hedge accounting treatment, all losses and gains were offset by changes in the underlying hedged items, resulting in no material net impact on earnings. Interest Rates We centrally manage our debt and investment portfolios considering investment opportunities and risks, tax consequences and overall financing strategies. We use various interest rate derivative instruments including, but not limited to, interest rate swaps, cross-currency interest rate swaps, Treasury locks and swap locks to manage our overall interest expense and foreign exchange risk. These instruments effectively change the interest rate and currency of specific debt issuances. Certain of our fixed rate indebtedness has been swapped to floating rates. The notional amount, interest payment and maturity date of the interest rate and cross-currency interest rate swaps match the principal, interest payment and maturity date of the related debt. Our Treasury locks and swap locks are entered into to protect against unfavorable interest rate changes relating to forecasted debt transactions. The notional values of the interest rate derivative instruments outstanding as of December 27, 2014 and December 28, 2013 were $9.3 billion and $7.9 billion , respectively. Ineffectiveness, for those interest rate derivative instruments that qualify for cash flow hedge accounting were not material for all periods presented. As of December 27, 2014 , approximately 25% of total debt, after the impact of the related interest rate derivative instruments, was exposed to variable rates, compared to 31% as of December 28, 2013 . Available-for-Sale Securities Investments in debt and equity marketable securities, other than investments accounted for under the equity method, are classified as available-for-sale. All highly liquid investments with original maturities of three months or less are classified as cash equivalents. Our investments in available-for-sale securities are reported at fair value. Unrealized gains and losses related to changes in the fair value of available-for-sale securities are recognized in accumulated other comprehensive loss within common shareholders’ equity. Unrealized gains and losses on our investments in marketable debt securities as of December 27, 2014 were not material. The pre-tax unrealized gains on our investments in marketable equity securities were $111 million and $122 million as of December 27, 2014 and December 28, 2013 , respectively. Changes in the fair value of available-for-sale securities impact net income only when such securities are sold or an other-than-temporary impairment is recognized. We regularly review our investment portfolio to determine if any security is other-than-temporarily impaired. In making this judgment, we evaluate, among other things, the duration and extent to which the fair value of a security is less than its cost; the financial condition of the issuer and any changes thereto; and our intent to sell, or whether we will more likely than not be required to sell, the security before recovery of its amortized cost basis. Our assessment on whether a security is other-than-temporarily impaired could change in the future due to new developments or changes in assumptions related to any particular security. We recorded no other-than-temporary impairment charges for the years ended December 27, 2014 and December 28, 2013 . Fair Value Measurements The fair values of our financial assets and liabilities as of December 27, 2014 and December 28, 2013 are categorized as follows: 2014 2013 Assets (a) Liabilities (a) Assets (a) Liabilities (a) Available-for-sale securities: Equity securities (b) $ 124 $ — $ 135 $ — Debt securities (c) 3,167 — — — $ 3,291 $ — $ 135 $ — Short-term investments (d) $ 197 $ — $ 184 $ — Prepaid forward contracts (e) $ 26 $ — $ 24 $ — Deferred compensation (f) $ — $ 504 $ — $ 504 Derivatives designated as fair value hedging instruments: Interest rate (g) $ 140 $ — $ 176 $ 10 Derivatives designated as cash flow hedging instruments: Foreign exchange (h) $ 76 $ 12 $ 22 $ 13 Interest rate (h) 1 117 19 — Commodity (i) 3 10 6 29 $ 80 $ 139 $ 47 $ 42 Derivatives not designated as hedging instruments: Foreign exchange (h) $ 12 $ 13 $ 12 $ 8 Interest rate (g) 57 75 71 94 Commodity (i) 18 166 20 89 $ 87 $ 254 $ 103 $ 191 Total derivatives at fair value (j) $ 307 $ 393 $ 326 $ 243 Total $ 3,821 $ 897 $ 669 $ 747 (a) Unless otherwise noted, financial assets are classified on our consolidated balance sheet within prepaid expenses and other current assets and other assets. Financial liabilities are classified on our consolidated balance sheet within accounts payable and other current liabilities and other liabilities. Unless specifically indicated, all financial assets and liabilities are categorized as Level 2 assets or liabilities. (b) Based on the price of common stock. Categorized as a Level 1 asset. These equity securities are classified as investments in noncontrolled affiliates. (c) Based on quoted broker prices or other significant inputs derived from or corroborated by observable market data. As of December 27, 2014 , $0.8 billion and $2.4 billion of debt securities were classified as cash equivalents and short-term investments, respectively. All of the Company’s available-for-sale debt securities have contractual maturities of one year or less. (d) Based on the price of index funds. Categorized as a Level 1 asset. These investments are classified as short-term investments and are used to manage a portion of market risk arising from our deferred compensation liability. (e) Based primarily on the price of our common stock. (f) Based on the fair value of investments corresponding to employees’ investment elections. (g) Based on LIBOR forward rates and recently reported market transactions of spot and forward rates. As of December 27, 2014 and December 28, 2013 , amounts related to non-designated instruments are presented as a net liability on our consolidated balance sheet. (h) Based on recently reported market transactions of spot and forward rates. (i) Based on recently reported market transactions, primarily swap arrangements. (j) Unless otherwise noted, derivative assets and liabilities are presented on a gross basis on our consolidated balance sheet. Amounts subject to enforceable master netting arrangements or similar agreements which are not offset on the consolidated balance sheet as of December 27, 2014 and December 28, 2013 were immaterial. Collateral received against any of our asset positions was immaterial. The carrying amounts of our cash and cash equivalents and short-term investments approximate fair value due to their short-term maturity. The fair value of our debt obligations as of December 27, 2014 and December 28, 2013 was $31 billion and $30 billion , respectively, based upon prices of similar instruments in the marketplace. Pre-tax losses/(gains) on our derivative instruments are categorized as follows: Fair Value/Non- designated Hedges Cash Flow Hedges Losses/(Gains) Recognized in Income Statement (a) Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement (b) 2014 2013 2014 2013 2014 2013 Foreign exchange $ 2 $ (9 ) $ (70 ) $ (24 ) $ (16 ) $ — Interest rate 21 99 135 (13 ) 233 3 Commodity 170 126 23 57 32 42 Total $ 193 $ 216 $ 88 $ 20 $ 249 $ 45 (a) Foreign exchange derivative gains/losses are primarily included in selling, general and administrative expenses. Interest rate derivative gains/losses are primarily from fair value hedges and are included in interest expense. These gains/losses are substantially offset by increases/decreases in the value of the underlying debt, which are also included in interest expense. Commodity derivative gains/losses are included in either cost of sales or selling, general and administrative expenses, depending on the underlying commodity. (b) Foreign exchange derivative gains/losses are primarily included in cost of sales. Interest rate derivative gains/losses are included in interest expense. Commodity derivative gains/losses are included in either cost of sales or selling, general and administrative expenses, depending on the underlying commodity. During the next 12 months, we expect to reclassify net gains of $21 million related to our cash flow hedges from accumulated other comprehensive loss into net income.

Net Income Attributable to Peps

Net Income Attributable to PepsiCo per Common Share	12 Months Ended
	Dec. 27, 2014
Earnings Per Share [Abstract]
Net Income Attributable To PepsiCo Per Common Share	Net Income Attributable to PepsiCo per Common Share Basic net income attributable to PepsiCo per common share is net income available for PepsiCo common shareholders divided by the weighted average of common shares outstanding during the period. Diluted net income attributable to PepsiCo per common share is calculated using the weighted average of common shares outstanding adjusted to include the effect that would occur if in-the-money employee stock options were exercised and RSUs, PSUs, PEPunits and preferred shares were converted into common shares. Out-of-the-money options during 2014 were nominal. Options to purchase 0.6 million shares in 2013 and 9.6 million shares in 2012 were not included in the calculation of diluted earnings per common share because these options were out-of-the-money. These out-of-the-money options had average exercise prices of $82.25 in 2014, $75.69 in 2013 and $67.64 in 2012 . The computations of basic and diluted net income attributable to PepsiCo per common share are as follows: 2014 2013 2012 Income Shares (a) Income Shares (a) Income Shares (a) Net income attributable to PepsiCo $ 6,513 $ 6,740 $ 6,178 Preferred shares: Dividends (1 ) (1 ) (1 ) Redemption premium (9 ) (7 ) (6 ) Net income available for PepsiCo common shareholders $ 6,503 1,509 $ 6,732 1,541 $ 6,171 1,557 Basic net income attributable to PepsiCo per common share $ 4.31 $ 4.37 $ 3.96 Net income available for PepsiCo common shareholders $ 6,503 1,509 $ 6,732 1,541 $ 6,171 1,557 Dilutive securities: Stock options, RSUs, PSUs, PEPunits and Other — 17 — 18 — 17 ESOP convertible preferred stock 10 1 8 1 7 1 Diluted $ 6,513 1,527 $ 6,740 1,560 $ 6,178 1,575 Diluted net income attributable to PepsiCo per common share $ 4.27 $ 4.32 $ 3.92 (a) Weighted-average common shares outstanding (in millions).

Preferred Stock

Preferred Stock	12 Months Ended
	Dec. 27, 2014
Equity [Abstract]
Preferred Stock	Preferred Stock As of December 27, 2014 and December 28, 2013 , there were 3 million shares of convertible preferred stock authorized. The preferred stock was issued for an ESOP established by Quaker and these shares are redeemable for common stock by the ESOP participants. The preferred stock accrues dividends at an annual rate of $5.46 per share. As of December 27, 2014 and December 28, 2013 , there were 803,953 preferred shares issued and 145,453 and 167,053 shares outstanding, respectively. The outstanding preferred shares had a fair value of $70 million as of December 27, 2014 and $69 million as of December 28, 2013 . Each share is convertible at the option of the holder into 4.9625 shares of common stock. Under certain conditions, the preferred shares may be called by us upon written notice at $78 per share plus accrued and unpaid dividends. Quaker made the final award to its ESOP in June 2001. The following summarizes our preferred stock activity: 2014 2013 2012 Shares (a) Amount Shares (a) Amount Shares (a) Amount Preferred stock 0.8 $ 41 0.8 $ 41 0.8 $ 41 Repurchased preferred stock Balance, beginning of year 0.6 $ 171 0.6 $ 164 0.6 $ 157 Redemptions 0.1 10 — 7 — 7 Balance, end of year 0.7 $ 181 0.6 $ 171 0.6 $ 164

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss Attributable to Pepsico	12 Months Ended
	Dec. 27, 2014
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Comprehensive Income (Loss) Note [Text Block]	Accumulated Other Comprehensive Loss Attributable to PepsiCo Comprehensive income is a measure of income which includes both net income and other comprehensive income or loss. Other comprehensive income or loss results from items deferred from recognition into our income statement. Accumulated other comprehensive income or loss is separately presented on our balance sheet as part of common shareholders’ equity. Other comprehensive (loss)/income attributable to PepsiCo was $(5,542) million in 2014 , $360 million in 2013 and $742 million in 2012 . The accumulated balances for each component of other comprehensive loss attributable to PepsiCo are as follows: 2014 2013 2012 Currency translation adjustment (a) $ (8,255 ) $ (3,247 ) $ (1,946 ) Cash flow hedges, net of tax 34 (76 ) (94 ) Unamortized pension and retiree medical, net of tax (b) (2,500 ) (1,861 ) (3,491 ) Unrealized gain on securities, net of tax 87 93 64 Other (35 ) (36 ) (20 ) Accumulated other comprehensive loss attributable to PepsiCo $ (10,669 ) $ (5,127 ) $ (5,487 ) (a) The change from 2013 to 2014 primarily reflects depreciation of the Russian ruble. (b) Net of taxes of $1,260 million in 2014 , $945 million in 2013 and $1,832 million in 2012 . The following table summarizes the reclassifications from Accumulated Other Comprehensive Loss to the Consolidated Statement of Income for the years ended December 27, 2014 and December 28, 2013 : 2014 2013 Amount Reclassified from Accumulated Other Comprehensive Loss Affected Line Item in the Consolidated Statement of Income (Gains)/Losses on cash flow hedges: Foreign exchange contracts $ (16 ) $ — Cost of sales Interest rate derivatives 233 3 Interest expense Commodity contracts 31 44 Cost of sales Commodity contracts 1 (2 ) Selling, general and administrative expenses Net losses before tax 249 45 Tax amounts (95 ) (17 ) Net losses after tax $ 154 $ 28 Pension and retiree medical items: Amortization of net prior service credit (a) $ (6 ) $ (2 ) Amortization of net actuarial losses (a) 226 357 Settlement/curtailment (a) 149 (2 ) Net losses before tax 369 353 Tax amounts (122 ) (123 ) Net losses after tax 247 230 Total net losses reclassified for the period, net of tax $ 401 $ 258 (a) These items are included in the components of net periodic benefit cost for pension and retiree medical plans (see Note 7 for additional details).

Supplemental Financial Informat

Supplemental Financial Information	12 Months Ended
	Dec. 27, 2014
Supplemental Financial Information [Abstract]
Additional Financial Information Disclosure [Text Block]	Supplemental Financial Information Supplemental information for accounts and notes receivable and inventories is summarized as follows: 2014 2013 2012 Accounts and notes receivable Trade receivables $ 5,817 $ 6,178 Other receivables 971 921 6,788 7,099 Allowance, beginning of year 145 157 $ 157 Net amounts charged to expense 38 29 28 Deductions (a) (27 ) (34 ) (27 ) Other (b) (19 ) (7 ) (1 ) Allowance, end of year 137 145 $ 157 Net receivables $ 6,651 $ 6,954 Inventories (c) Raw materials $ 1,593 $ 1,732 Work-in-process 173 168 Finished goods 1,377 1,509 $ 3,143 $ 3,409 (a) Includes accounts written off. (b) Includes adjustments related to acquisitions and divestitures, currency translation and other adjustments. (c) Approximately 3% of the inventory cost in both 2014 and 2013 was computed using the LIFO method. The differences between LIFO and FIFO methods of valuing these inventories were not material. Supplemental information for other assets and accounts payable and other current liabilities is summarized as follows: 2014 2013 Other assets Noncurrent notes and accounts receivable $ 93 $ 105 Deferred marketplace spending 179 214 Pension plans (a) 141 687 Other 447 419 $ 860 $ 1,425 Accounts payable and other current liabilities Accounts payable $ 5,127 $ 4,874 Accrued marketplace spending 2,222 2,245 Accrued compensation and benefits 1,746 1,789 Dividends payable 1,009 899 Other current liabilities 2,912 2,726 $ 13,016 $ 12,533 (a) See Note 7 for additional information regarding our pension plans. The following table summarizes other supplemental information: 2014 2013 2012 Other supplemental information Rent expense $ 707 $ 639 $ 581 Interest paid $ 925 $ 1,007 $ 1,074 Income taxes paid, net of refunds $ 1,847 $ 3,076 $ 1,840

Acquisitions

Acquisitions	12 Months Ended
	Dec. 27, 2014
Business Combinations [Abstract]
Acquisitions	Acquisitions and Divestitures Tingyi-Asahi Beverages Holding Co. Ltd. On March 31, 2012, we completed a transaction with Tingyi. Under the terms of the agreement, we contributed our Company-owned and joint venture bottling operations in China to Tingyi’s beverage subsidiary, Tingyi-Asahi Beverages Holding Co. Ltd. (TAB), and received as consideration a 5% indirect equity interest in TAB. As a result of this transaction, TAB is now our franchise bottler in China. We also have a call option to increase our indirect holding in TAB to 20% by the fourth quarter of 2015. We recorded restructuring and other charges of $150 million ( $176 million after-tax or $0.11 per share), primarily consisting of employee-related charges, in our 2012 results. This charge is reflected in items affecting comparability. See additional unaudited information in “Items Affecting Comparability” in Management’s Discussion and Analysis of Financial Condition and Results of Operations. Suntory Holdings Limited During our second quarter of 2013, as part of the refranchising of our beverage business in Vietnam, we completed a transaction with Suntory Holdings Limited. Under the terms of the agreement, we sold a controlling interest in our Vietnam bottling operations. The alliance serves as the franchise bottler for both companies. As a result of this transaction, we recorded a pre- and after-tax gain of $137 million (or $0.09 per share) in our 2013 results.

Our Significant Accounting Po23

Our Significant Accounting Policies (Policy)	12 Months Ended
	Dec. 27, 2014
Accounting Policies [Abstract]
Goodwill and Intangible Assets, Policy [Policy Text Block]	Goodwill and Other Intangible Assets Indefinite-lived intangible assets and goodwill are not amortized and are assessed for impairment at least annually, using either a qualitative or quantitative approach. We perform this annual assessment during our third quarter. Where we use the qualitative assessment, first we determine if, based on qualitative factors, it is more likely than not that an impairment exists. Factors considered include macroeconomic, industry and competitive conditions, legal and regulatory environment, historical financial performance and significant changes in the brand or reporting unit. If the qualitative assessment indicates that it is more likely than not that an impairment exists, then a quantitative assessment is performed. The quantitative assessment requires an analysis of several estimates including future cash flows or income consistent with management’s strategic business plans, annual sales growth rates and the selection of assumptions underlying a discount rate (weighted average cost of capital) based on market data available at the time. In the quantitative assessment of indefinite-lived intangible assets, if the carrying amount of the indefinite-lived intangible asset exceeds its estimated fair value, as determined by its discounted cash flows or another income-based approach, an impairment loss is recognized in an amount equal to that excess. Quantitative assessment of goodwill is performed using a two-step impairment test at the reporting unit level. A reporting unit can be a division or business within a division. The first step compares the carrying value of a reporting unit, including goodwill, with its estimated fair value, as determined by its discounted cash flows. If the carrying value of a reporting unit exceeds its estimated fair value, we complete the second step to determine the amount of goodwill impairment loss that we should record, if any. In the second step, we determine an implied fair value of the reporting unit’s goodwill by allocating the estimated fair value of the reporting unit to all of the assets and liabilities other than goodwill (including any unrecognized intangible assets). The amount of impairment loss is equal to the excess of the carrying value of the goodwill over the implied fair value of that goodwill. Quantitative assessments described above are primarily based on expected future levels of sales and operating profit which are inputs from our annual long-range planning process that are used to estimate future cash flows. Additionally, they are also impacted by estimates of discount rates, perpetuity growth assumptions and other factors. Significant management judgment is necessary to estimate the impact of competitive operating, macroeconomic and other factors to estimate future levels of sales, operating profit or cash flows. All assumptions used in our impairment evaluations for nonamortizable intangible assets, such as forecasted growth rates and weighted average cost of capital, are based on the best available market information and are consistent with our internal forecasts and operating plans. Amortizable intangible assets are only evaluated for impairment upon a significant change in the operating or macroeconomic environment. If an evaluation of the undiscounted future cash flows indicates impairment, the asset is written down to its estimated fair value, which is based on its discounted future cash flows or another income-based approach. For additional unaudited information on goodwill and other intangible assets see “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Other Significant Accounting Policies [Policy Text Block]	Other Significant Accounting Policies Our other significant accounting policies are disclosed as follows: • Property, Plant and Equipment and Intangible Assets – Note 4. • Income Taxes – Note 5, and for additional unaudited information see “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations. • Stock-Based Compensation – Note 6. • Pension, Retiree Medical and Savings Plans – Note 7, and for additional unaudited information see “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations. • Financial Instruments – Note 10, and for additional unaudited information, see “Our Business Risks” in Management’s Discussion and Analysis of Financial Condition and Results of Operations. • Inventories – Note 14. Inventories are valued at the lower of cost or market. Cost is determined using the average; first-in, first-out (FIFO) or last-in, first-out (LIFO) methods. • Translation of Financial Statements of Foreign Subsidiaries – Financial statements of foreign subsidiaries are translated into U.S. dollars using period-end exchange rates for assets and liabilities and weighted-average exchange rates for revenues and expenses. Adjustments resulting from translating net assets are reported as a separate component of accumulated other comprehensive loss within common shareholders’ equity as currency translation adjustment.
Revenue Recognition	Revenue Recognition We recognize revenue upon shipment or delivery to our customers based on written sales terms that do not allow for a right of return. However, our policy for DSD and certain chilled products is to remove and replace damaged and out-of-date products from store shelves to ensure that consumers receive the product quality and freshness they expect. Similarly, our policy for certain warehouse-distributed products is to replace damaged and out-of-date products. Based on our experience with this practice, we have reserved for anticipated damaged and out-of-date products. For additional unaudited information on our revenue recognition and related policies, including our policy on bad debts, see “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations. We are exposed to concentration of credit risk from our customers, including Wal-Mart. In 2014 , sales to Wal-Mart (including Sam’s) represented approximately 12% of our total net revenue, including concentrate sales to our independent bottlers, which are used in finished goods sold by them to Wal-Mart. We have not experienced credit issues with these customers.
Sales Incentives And Other Marketplace Spending	Total Marketplace Spending We offer sales incentives and discounts through various programs to customers and consumers. Total marketplace spending includes sales incentives, discounts, advertising and other marketing activities. Sales incentives and discounts are primarily accounted for as a reduction of revenue and totaled $35.8 billion in 2014 and $34.7 billion in both 2013 and 2012 . Sales incentives and discounts include payments to customers for performing merchandising activities on our behalf, such as payments for in-store displays, payments to gain distribution of new products, payments for shelf space and discounts to promote lower retail prices. It also includes support provided to our independent bottlers through funding of advertising and other marketing activities. While most of these incentive arrangements have terms of no more than one year, certain arrangements, such as fountain pouring rights, may extend beyond one year. Costs incurred to obtain these arrangements are recognized over the shorter of the economic or contractual life, primarily as a reduction of revenue, and the remaining balances of $355 million as of December 27, 2014 and $410 million as of December 28, 2013 are included in prepaid expenses and other current assets and other assets on our balance sheet. For additional unaudited information on our sales incentives, see “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations. Advertising and other marketing activities, reported as selling, general and administrative expenses, totaled $3.9 billion in 2014 and 2013 and $3.7 billion in 2012 , including advertising expenses of $2.3 billion in 2014 , $2.4 billion in 2013 and $ 2.2 billion in 2012 . Deferred advertising costs are not expensed until the year first used and consist of: • media and personal service prepayments; • promotional materials in inventory; and • production costs of future media advertising. Deferred advertising costs of $42 million and $68 million as of December 27, 2014 and December 28, 2013 , respectively, are classified as prepaid expenses on our balance sheet.
Distribution Costs	Distribution Costs Distribution costs, including the costs of shipping and handling activities, are reported as selling, general and administrative expenses. Shipping and handling expenses were $9.7 billion in 2014 , $9.4 billion in 2013 and $9.1 billion in 2012 .
Cash Equivalents	Cash Equivalents Cash equivalents are highly liquid investments with original maturities of three months or less.
Software Costs	Software Costs We capitalize certain computer software and software development costs incurred in connection with developing or obtaining computer software for internal use when both the preliminary project stage is completed and it is probable that the software will be used as intended. Capitalized software costs include only (i) external direct costs of materials and services utilized in developing or obtaining computer software, (ii) compensation and related benefits for employees who are directly associated with the software project and (iii) interest costs incurred while developing internal-use computer software. Capitalized software costs are included in property, plant and equipment on our balance sheet and amortized on a straight-line basis when placed into service over the estimated useful lives of the software, which approximate 5 to 10 years. Software amortization totaled $208 million in 2014 , $197 million in 2013 and $196 million in 2012 . Net capitalized software and development costs were $0.9 billion and $1.1 billion as of December 27, 2014 and December 28, 2013 , respectively.
Commitments And Contingencies	Commitments and Contingencies We are subject to various claims and contingencies related to lawsuits, certain taxes and environmental matters, as well as commitments under contractual and other commercial obligations. We recognize liabilities for contingencies and commitments when a loss is probable and estimable. For additional information on our commitments, see Note 9 to our consolidated financial statements.
Research And Development	Research and Development We engage in a variety of research and development activities and continue to invest to accelerate growth to drive innovation globally. These activities principally involve production, processing and packaging and include: development of new ingredients and products; reformulation and improvement in the quality of existing products; improvement and modernization of manufacturing processes; improvements in product quality, safety and integrity; development of, and improvements in, packaging technology and dispensing equipment; and efforts focused on identifying opportunities to transform, grow and broaden our product portfolio, including the development of sweetener alternatives and flavor modifiers to reduce added sugar, and recipes that allow us to reduce sodium levels in certain of our products. We also made investments to minimize our impact on the environment, including innovation in our packaging to make it increasingly sustainable, and developed and implemented new technologies to enhance the quality and value of our current and future products, as well as made investments to incorporate into our operations best practices and technology to support sustainable agriculture and to minimize our impact on the environment. We continue to make investments to conserve energy and raw materials, reduce waste in our facilities, recycle containers, use renewable resources and optimize package design to use fewer materials. Consumer research is excluded from research and development costs and included in other marketing costs. Research and development costs were $718 million , $665 million and $552 million in 2014 , 2013 and 2012 , respectively, and are reported within selling, general and administrative expenses.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In June 2014, the Financial Accounting Standards Board (FASB) issued accounting guidance for share-based payments when the terms of an award provide that a performance target could be achieved after the requisite service period. The guidance requires that a performance target that could be achieved after the requisite service period is treated as a performance condition that affects the vesting of the award rather than factored into the grant date fair value. The guidance is effective as of the beginning of our 2016 fiscal year and can be applied prospectively to all share-based payments granted or modified on or after the effective date with early adoption permissible. This guidance is not expected to have any impact on our financial statements. In May 2014, the FASB issued accounting guidance on revenue recognition, which provides for a single five-step model to be applied to all revenue contracts with customers. The standard also requires additional financial statement disclosures that will enable users to understand the nature, amount, timing and uncertainty of revenue and cash flows relating to customer contracts. Companies have an option to use either a retrospective approach or cumulative effect adjustment approach to implement the standard. There is no option for early adoption. The provisions of this guidance will be effective as of the beginning of our 2017 fiscal year. We are currently evaluating the impact of the guidance on our financial statements and have not yet selected a transition approach to implement the standard. In July 2013, the FASB issued accounting guidance that requires an entity to net its liability for unrecognized tax positions against a net operating loss carryforward, a similar tax loss or a tax credit carryforward when settlement in this manner is available under the tax law. The provisions of this guidance were effective as of the beginning of our 2014 fiscal year and did not have a material impact on our financial statements. In February 2013, the FASB issued guidance that requires an entity to disclose information showing the effect of the items reclassified from accumulated other comprehensive income on the line items of net income. The provisions of this guidance were effective prospectively as of the beginning of our 2013 fiscal year. Accordingly, we included enhanced footnote disclosure for the years ended December 27, 2014 and December 28, 2013 in Note 13. In July 2012, the FASB issued accounting guidance that permits an entity to first assess qualitative factors to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired as a basis for determining whether it is necessary to perform a quantitative impairment test. An entity would continue to calculate the fair value of an indefinite-lived intangible asset if the asset fails the qualitative assessment, while no further analysis would be required if it passes. The provisions of this guidance were effective for 2013 and have had no impact on our annual indefinite-lived intangible asset impairment test results. In December 2011, the FASB issued disclosure requirements that were intended to enhance current disclosures on offsetting financial assets and liabilities. The disclosures required an entity to disclose both gross and net information about derivative instruments accounted for in accordance with the guidance on derivatives and hedging that are eligible for offset on the balance sheet and instruments and transactions subject to an agreement similar to a master netting arrangement. The provisions of these disclosure requirements were effective as of the beginning of our 2014 fiscal year. Accordingly, we included enhanced footnote disclosure in Note 10.

Basis of Presentation and Our24

Basis of Presentation and Our Divisions (Tables)	12 Months Ended
	Dec. 27, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule Of Quarterly Reporting	The following chart details our quarterly reporting schedule for all reporting periods presented: Quarter U.S. and Canada International First Quarter 12 weeks January, February Second Quarter 12 weeks March, April and May Third Quarter 12 weeks June, July and August Fourth Quarter 16 weeks September, October, November and December
Schedule of Segment Reporting Information, by Segment	Net revenue and operating profit of each division are as follows: Net Revenue Operating Profit (a) 2014 2013 2012 2014 2013 2012 FLNA $ 14,502 $ 14,126 $ 13,574 $ 4,054 $ 3,877 $ 3,646 QFNA 2,568 2,612 2,636 621 617 695 NAB 20,171 20,083 20,428 2,421 2,580 2,569 Latin America 9,425 9,335 8,761 1,636 1,617 1,427 ESSA 13,399 13,828 13,506 1,389 1,327 1,361 AMENA 6,618 6,431 6,587 985 1,140 716 Total division 66,683 66,415 65,492 11,106 11,158 10,414 Corporate Unallocated Mark-to-market net (losses)/gains (68 ) (72 ) 65 Restructuring and impairment charges (41 ) (11 ) (10 ) Pension lump sum settlement charges (141 ) — (195 ) Venezuela remeasurement charges (126 ) (124 ) — Other (1,149 ) (1,246 ) (1,162 ) $ 66,683 $ 66,415 $ 65,492 $ 9,581 $ 9,705 $ 9,112 (a) For information on the impact of restructuring and impairment charges on our divisions, see Note 3 to our consolidated financial statements. See also Note 15 to our consolidated financial statements for more information on our transaction with Tingyi and refranchising of our beverage business in Vietnam in our AMENA segment.
Segment Reporting Information By Total Assets And Capital Spending	Total assets and capital spending of each division are as follows: Total Assets Capital Spending 2014 2013 2014 2013 2012 FLNA $ 5,307 $ 5,308 $ 519 $ 423 $ 365 QFNA 982 983 58 38 37 NAB 28,665 29,176 708 705 681 Latin America 6,283 6,003 379 395 457 ESSA (a) 13,934 18,725 502 551 576 AMENA 5,855 5,731 517 530 509 Total division 61,026 65,926 2,683 2,642 2,625 Corporate (b) 9,483 11,552 176 153 89 $ 70,509 $ 77,478 $ 2,859 $ 2,795 $ 2,714 (a) The change in total assets in 2014 primarily reflects the depreciation of the Russian ruble. (b) Corporate assets consist principally of cash and cash equivalents, short-term investments, derivative instruments, property, plant and equipment and certain pension and tax assets. In 2014, the change in total Corporate assets was primarily due to the decrease in cash and cash equivalents and certain pension assets, partially offset by an increase in short-term investments.
Segment Reporting Information By Amortization Of Intangible Assets And Depreciation And Other Amortization	Amortization of intangible assets and depreciation and other amortization of each division are as follows: Amortization of Intangible Depreciation and 2014 2013 2012 2014 2013 2012 FLNA $ 7 $ 7 $ 7 $ 424 $ 430 $ 445 QFNA — — — 51 51 53 NAB 43 55 55 837 843 842 Latin America 10 11 14 273 273 261 ESSA 28 32 36 471 525 522 AMENA 4 5 7 313 283 305 Total division 92 110 119 2,369 2,405 2,428 Corporate — — — 164 148 142 $ 92 $ 110 $ 119 $ 2,533 $ 2,553 $ 2,570
Segment Reporting Information By Net Revenue And Long-Lived Assets	Net revenue and long-lived assets by country are as follows: Net Revenue Long-Lived Assets (a) 2014 2013 2012 2014 2013 U.S. $ 34,219 $ 33,626 $ 33,348 $ 27,964 $ 28,157 Russia (b) 4,414 4,908 4,861 4,520 7,922 Mexico 4,113 4,347 3,955 1,126 1,233 Canada 3,022 3,195 3,290 2,815 3,067 United Kingdom 2,174 2,115 2,102 1,155 1,219 Brazil 1,790 1,835 1,866 928 1,005 All other countries 16,951 16,389 16,070 10,478 11,247 $ 66,683 $ 66,415 $ 65,492 $ 48,986 $ 53,850 (a) Long-lived assets represent property, plant and equipment, nonamortizable intangible assets, amortizable intangible assets and investments in noncontrolled affiliates. These assets are reported in the country where they are primarily used. (b) Change in long-lived assets in 2014 primarily reflects the depreciation of the Russian ruble.

Restructuring, Impairment and25

Restructuring, Impairment and Integration Charges (Tables)	12 Months Ended
	Dec. 27, 2014
Restructuring and Related Activities [Abstract]
Summary Of 2014 Productivity Plan Activity [Table Text Block] [Table Text Block]	2014 Multi-Year Productivity Plan The 2014 Productivity Plan includes the next generation of productivity initiatives that we believe will strengthen our food, snack and beverage businesses by: accelerating our investment in manufacturing automation; further optimizing our global manufacturing footprint, including closing certain manufacturing facilities; re-engineering our go-to-market systems in developed markets; expanding shared services; and implementing simplified organization structures to drive efficiency. The 2014 Productivity Plan is in addition to the 2012 Productivity Plan and is expected to continue the benefits of that plan. In 2014 and 2013 , we incurred restructuring charges of $357 million ($ 262 million after-tax or $ 0.17 per share) and $53 million ($ 39 million after-tax or $ 0.02 per share), respectively, in conjunction with our 2014 Productivity Plan. All of these charges were recorded in selling, general and administrative expenses and primarily relate to severance and other employee-related costs, asset impairments (all non-cash), and contract termination costs. Substantially all of the restructuring accrual at December 27, 2014 is expected to be paid by the end of 2015 . A summary of our 2014 Productivity Plan charges is as follows: 2014 2013 Severance and Other Asset Impairments Other Costs Total Severance and Other Other Costs Total FLNA $ 25 $ 10 $ 11 $ 46 $ 11 $ — $ 11 QFNA 12 — 2 14 3 — 3 NAB 60 56 56 172 9 — 9 Latin America 15 3 10 28 6 — 6 ESSA 24 4 14 42 10 — 10 AMENA 14 — 8 22 1 — 1 Corporate (a) (2 ) — 35 33 12 1 13 $ 148 $ 73 $ 136 $ 357 $ 52 $ 1 $ 53 (a) Income amount represents adjustments of previously recorded amounts. A summary of our 2014 Productivity Plan activity is as follows: Severance and Other Asset Impairments Other Costs Total 2013 restructuring charges $ 52 $ — $ 1 $ 53 Non-cash charges (22 ) — — (22 ) Liability as of December 28, 2013 30 — 1 31 2014 restructuring charges 148 73 136 357 Cash payments (56 ) — (109 ) (165 ) Non-cash charges (33 ) (73 ) (4 ) (110 ) Liability as of December 27, 2014 $ 89 $ — $ 24 $ 113
Summary Of Productivity Plan Activity	2012 Multi-Year Productivity Plan The 2012 Productivity Plan includes actions in every aspect of our business that we believe will strengthen our complementary food, snack and beverage businesses by: leveraging new technologies and processes across PepsiCo’s operations, go-to-market and information systems; heightening the focus on best practice sharing across the globe; consolidating manufacturing, warehouse and sales facilities; and implementing simplified organization structures, with wider spans of control and fewer layers of management. The 2012 Productivity Plan continues to enhance PepsiCo’s cost-competitiveness and provide a source of funding for future brand-building and innovation initiatives. In 2014 , 2013 and 2012 , we incurred restructuring charges of $61 million ($ 54 million after-tax or $ 0.04 per share), $110 million ( $90 million after-tax or $ 0.06 per share) and $279 million ($ 215 million after-tax or $ 0.14 per share), respectively, in conjunction with our 2012 Productivity Plan. All of these charges were recorded in selling, general and administrative expenses and primarily relate to severance and other employee-related costs, asset impairments (all non-cash), and contract termination costs. All of the restructuring accrual at December 27, 2014 is expected to be paid by the end of 2015 . A summary of our 2012 Productivity Plan charges is as follows: 2014 2013 2012 Severance and Other Asset Impairments Other Costs Total Severance and Other Asset Impairments Other Costs Total Severance and Other Asset Impairments Other Costs Total FLNA (a) $ (1 ) $ — $ 3 $ 2 $ 4 $ — $ 4 $ 8 $ 14 $ 8 $ 16 $ 38 QFNA — — — — — — 1 1 — — 9 9 NAB (3 ) 1 9 7 8 — 13 21 27 43 18 88 Latin America (a) 19 — (19 ) — 5 2 — 7 22 8 34 64 ESSA 6 5 18 29 36 2 12 50 14 16 12 42 AMENA 12 — 3 15 21 2 2 25 18 — 10 28 Corporate (a) (2 ) — 10 8 — — (2 ) (2 ) (6 ) — 16 10 $ 31 $ 6 $ 24 $ 61 $ 74 $ 6 $ 30 $ 110 $ 89 $ 75 $ 115 $ 279 (a) Income amounts represent adjustments of previously recorded amounts. A summary of our 2012 Productivity Plan activity is as follows: Severance and Other Asset Impairments Other Costs Total Liability as of December 31, 2011 $ 249 $ — $ 27 $ 276 2012 restructuring charges 89 75 115 279 Cash payments (239 ) — (104 ) (343 ) Non-cash charges (8 ) (75 ) (2 ) (85 ) Liability as of December 29, 2012 91 — 36 127 2013 restructuring charges 74 6 30 110 Cash payments (89 ) — (44 ) (133 ) Non-cash charges (8 ) (6 ) (5 ) (19 ) Liability as of December 28, 2013 68 — 17 85 2014 restructuring charges 31 6 24 61 Cash payments (65 ) — (36 ) (101 ) Non-cash charges (6 ) (6 ) — (12 ) Liability as of December 27, 2014 $ 28 $ — $ 5 $ 33

Property, Plant and Equipment26

Property, Plant and Equipment and Intangible Assets (Tables)	12 Months Ended
	Dec. 27, 2014
Property, Plant And Equipment And Intangible Assets [Abstract]
Property, Plant and Equipment	A summary of our property, plant and equipment is as follows: Average 2014 2013 2012 Property, plant and equipment, net Land $ 1,288 $ 1,340 Buildings and improvements 15 – 44 8,114 8,375 Machinery and equipment, including fleet and software 5 – 15 25,146 25,415 Construction in progress 1,752 1,831 36,300 36,961 Accumulated depreciation (19,056 ) (18,386 ) $ 17,244 $ 18,575 Depreciation expense $ 2,441 $ 2,472 $ 2,489
Amortizable Intangible Assets, Net	Property, plant and equipment is recorded at historical cost. Depreciation and amortization are recognized on a straight-line basis over an asset’s estimated useful life. Land is not depreciated and construction in progress is not depreciated until ready for service. A summary of our amortizable intangible assets is as follows: 2014 2013 2012 Amortizable intangible assets, net Average Gross Accumulated Net Gross Accumulated Net Acquired franchise rights 56 – 60 $ 879 $ (89 ) $ 790 $ 910 $ (83 ) $ 827 Reacquired franchise rights 5 – 14 107 (95 ) 12 108 (86 ) 22 Brands 20 – 40 1,361 (1,004 ) 357 1,400 (996 ) 404 Other identifiable intangibles 10 – 24 595 (305 ) 290 686 (301 ) 385 $ 2,942 $ (1,493 ) $ 1,449 $ 3,104 $ (1,466 ) $ 1,638 Amortization expense $ 92 $ 110 $ 119
Future Amortization of Intangible Assets	Amortization of intangible assets for each of the next five years, based on existing intangible assets as of December 27, 2014 and using average 2014 foreign exchange rates, is expected to be as follows: 2015 2016 2017 2018 2019 Five-year projected amortization $ 82 $ 74 $ 68 $ 66 $ 63 Depreciable and amortizable assets are only evaluated for impairment upon a significant change in the operating or macroeconomic environment. In these circumstances, if an evaluation of the undiscounted cash flows indicates impairment, the asset is written down to its estimated fair value, which is based on discounted future cash flows. Useful lives are periodically evaluated to determine whether events or circumstances have occurred which indicate the need for revision. For additional unaudited information on our policies for amortizable brands, see “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations. Nonamortizable Intangible Assets We did not recognize any impairment charges for goodwill in each of the fiscal years ended December 27, 2014, December 28, 2013 and December 29, 2012. In 2014, we performed the impairment analysis for goodwill for all our reporting units using the qualitative approach and concluded that it was more likely than not that the estimated fair values of our reporting units were greater than their carrying amounts. After reaching this conclusion, no further testing was performed. In 2014 and 2012, we recognized pre-tax impairment charges in ESSA for nonamortizable intangible assets of $23 million in each year. We recognized no impairment charges for nonamortizable intangible assets in 2013. Based on our year-end assessment, the estimated fair values of our indefinite-lived reacquired and acquired franchise rights recorded at NAB exceed their carrying values. However, there could be an impairment of the carrying value of NAB’s reacquired and acquired franchise rights if future revenues and their contribution to the operating results of NAB’s CSD business do not achieve our estimated future cash flows or if macroeconomic conditions result in a future increase in the weighted-average cost of capital used to estimate fair value. We have also analyzed the impact of the recent economic and political developments in Russia on the estimated fair value of our indefinite-lived intangible assets in Russia and have concluded that there is no impairment as of December 27, 2014. However, a further deterioration in these conditions in Russia could potentially require us to record an impairment charge for these assets in the future. For additional information on our policies for nonamortizable intangible assets, see Note 2 to our consolidated financial statements.
Change in Book Value of Nonamortizable Intangible Assets	The change in the book value of nonamortizable intangible assets is as follows: Balance, Acquisitions/(Divestitures) Translation Balance, Translation Balance, FLNA Goodwill $ 316 $ — $ (11 ) $ 305 $ (14 ) $ 291 Brands 31 — (2 ) 29 (2 ) 27 347 — (13 ) 334 (16 ) 318 QFNA Goodwill 175 — — 175 — 175 NAB Goodwill 9,931 5 (42 ) 9,894 (48 ) 9,846 Reacquired franchise rights 7,337 16 (72 ) 7,281 (88 ) 7,193 Acquired franchise rights 1,573 (8 ) (14 ) 1,551 (13 ) 1,538 Brands 108 — — 108 — 108 18,949 13 (128 ) 18,834 (149 ) 18,685 Latin America Goodwill 773 — (64 ) 709 (65 ) 644 Brands 268 — (24 ) 244 (21 ) 223 1,041 — (88 ) 953 (86 ) 867 ESSA (a) Goodwill 5,214 — (187 ) 5,027 (1,488 ) 3,539 Reacquired franchise rights 772 — (12 ) 760 (189 ) 571 Acquired franchise rights 223 — 7 230 (31 ) 199 Brands 4,284 — (213 ) 4,071 (1,408 ) 2,663 10,493 — (405 ) 10,088 (3,116 ) 6,972 AMENA Goodwill 562 (4 ) (55 ) 503 (33 ) 470 Brands 148 — (21 ) 127 (10 ) 117 710 (4 ) (76 ) 630 (43 ) 587 Total goodwill 16,971 1 (359 ) 16,613 (1,648 ) 14,965 Total reacquired franchise rights 8,109 16 (84 ) 8,041 (277 ) 7,764 Total acquired franchise rights 1,796 (8 ) (7 ) 1,781 (44 ) 1,737 Total brands 4,839 — (260 ) 4,579 (1,441 ) 3,138 $ 31,715 $ 9 $ (710 ) $ 31,014 $ (3,410 ) $ 27,604 (a) The change in 2014 primarily reflects the depreciation of the Russian ruble.

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 27, 2014
Income Tax Contingency [Line Items]
Undistributed International Earnings [Text Block]	Undistributed International Earnings As of December 27, 2014 , we had approximately $37.8 billion of undistributed international earnings. We intend to continue to reinvest earnings outside the U.S. for the foreseeable future and, therefore, have not recognized any U.S. tax expense on these earnings. It is not practicable for us to determine the amount of unrecognized U.S. tax expense on these reinvested international earnings.
Summary of Income Tax Contingencies [Table Text Block]	Reserves A number of years may elapse before a particular matter, for which we have established a reserve, is audited and finally resolved. The number of years with open tax audits varies depending on the tax jurisdiction. Our major taxing jurisdictions and the related open tax audits are as follows: Jurisdiction Years Open to Audit Years Currently Under Audit United States 2010-2013 2010-2011 Mexico 2009-2013 None United Kingdom 2012-2013 None Canada (Domestic) 2010-2013 2010-2012 Canada (International) 2008-2013 2008-2012 Russia 2009-2013 2009-2013 While it is often difficult to predict the final outcome or the timing of resolution of any particular tax matter, we believe that our reserves reflect the probable outcome of known tax contingencies. We adjust these reserves, as well as the related interest, in light of changing facts and circumstances. Settlement of any particular issue would usually require the use of cash. Favorable resolution would be recognized as a reduction to our annual tax rate in the year of resolution. For further unaudited information on the impact of the resolution of open tax issues, see “Other Consolidated Results” in Management’s Discussion and Analysis of Financial Condition and Results of Operations. We believe that it is reasonably possible that our reserves for uncertain tax positions could decrease by approximately $300 million within the next 12 months as a result of the completion of audits in various jurisdictions. In the fourth quarter of 2013, we reached an agreement with the IRS resolving all open matters related to the audits for taxable years 2003 through 2009. As a result, we made U.S. Federal net cash tax payments of $ 758 million , including interest. The settlement reduced our 2013 net cash provided by operating activities and our reserves for uncertain tax positions for the tax years 2003 through 2012 and resulted in a non-cash tax benefit of $ 209 million in the fourth quarter of 2013. In addition, payments for other U.S. Federal, state and local tax matters related to open tax years totaling $ 226 million were made in 2013. In 2012, we received a favorable tax court decision related to the classification of financial instruments resulting in a non-cash tax benefit of $ 217 million in the fourth quarter of 2012. See additional unaudited information in “Items Affecting Comparability” in Management’s Discussion and Analysis of Financial Condition and Results of Operations. As of December 27, 2014 , the total gross amount of reserves for income taxes, reported in other liabilities, was $1,587 million . We accrue interest related to reserves for income taxes in our provision for income taxes and any associated penalties are recorded in selling, general and administrative expenses. The gross amount of interest accrued, reported in other liabilities, was $141 million as of December 27, 2014 , of which $31 million of expense was recognized in 2014 . The gross amount of interest accrued, reported in other liabilities, was $164 million as of December 28, 2013 , of which $36 million of expense was recognized in 2013 .
Income Tax Carryforwards and Allowances [Text Block]	Carryforwards and Allowances Operating loss carryforwards totaling $10.4 billion at year-end 2014 are being carried forward in a number of foreign and state jurisdictions where we are permitted to use tax operating losses from prior periods to reduce future taxable income. These operating losses will expire as follows: $0.1 billion in 2015 , $9.8 billion between 2016 and 2034 and $0.5 billion may be carried forward indefinitely. We establish valuation allowances for our deferred tax assets if, based on the available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized.
Income Taxes	Income Taxes The components of income before income taxes are as follows: 2014 2013 2012 U.S. $ 2,557 $ 3,078 $ 3,234 Foreign 6,200 5,813 5,070 $ 8,757 $ 8,891 $ 8,304 The provision for income taxes consisted of the following: 2014 2013 2012 Current: U.S. Federal $ 1,364 $ 1,092 $ 911 Foreign 851 807 940 State 210 124 153 2,425 2,023 2,004 Deferred: U.S. Federal (33 ) 87 154 Foreign (60 ) 11 (95 ) State (133 ) (17 ) 27 (226 ) 81 86 $ 2,199 $ 2,104 $ 2,090 A reconciliation of the U.S. Federal statutory tax rate to our annual tax rate is as follows: 2014 2013 2012 U.S. Federal statutory tax rate 35.0 % 35.0 % 35.0 % State income tax, net of U.S. Federal tax benefit 0.6 1.2 1.4 Lower taxes on foreign results (8.6 ) (8.8 ) (6.9 ) Tax benefits — (2.4 ) (2.6 ) Other, net (1.9 ) (1.3 ) (1.7 ) Annual tax rate 25.1 % 23.7 % 25.2 % Deferred tax liabilities and assets are comprised of the following: Deferred tax liabilities 2014 2013 Pension benefits $ — $ 84 Debt guarantee of wholly owned subsidiary 842 828 Property, plant and equipment 2,174 2,327 Intangible assets other than nondeductible goodwill 4,068 4,348 Other 264 361 Gross deferred tax liabilities 7,348 7,948 Deferred tax assets Net carryforwards 1,329 1,485 Stock-based compensation 265 303 Retiree medical benefits 388 384 Other employee-related benefits 646 627 Pension benefits 263 — Deductible state tax and interest benefits 158 155 Long-term debt obligations acquired 98 125 Other 1,002 959 Gross deferred tax assets 4,149 4,038 Valuation allowances (1,230 ) (1,360 ) Deferred tax assets, net 2,919 2,678 Net deferred tax liabilities $ 4,429 $ 5,270 Deferred taxes are included within the following balance sheet accounts: 2014 2013 Assets: Prepaid expenses and other current assets $ 875 $ 716 Liabilities: Deferred income taxes $ 5,304 $ 5,986 A summary of our valuation allowance activity is as follows: 2014 2013 2012 Balance, beginning of year $ 1,360 $ 1,233 $ 1,264 (Benefit)/provision (25 ) 111 68 Other (deductions)/additions (105 ) 16 (99 ) Balance, end of year $ 1,230 $ 1,360 $ 1,233 The Patient Protection and Affordable Care Act (PPACA), which was signed into law in the second quarter of 2010, changed the tax treatment related to an existing retiree drug subsidy (RDS) available to sponsors of retiree health benefit plans that provide a benefit that is at least actuarially equivalent to the benefits under Medicare Part D. As a result of the PPACA, RDS payments became taxable in tax years beginning in 2013, by requiring the amount of the subsidy received to be offset against our deduction for health care expenses. In the first quarter of 2012, we began pre-paying funds within our 401(h) accounts intended to fully cover prescription drug benefit liabilities for Medicare eligible retirees. As a result, the receipt of future Medicare subsidy payments for prescription drugs will not be taxable and consequently we recorded a $55 million tax benefit reflecting this change in the first quarter of 2012. For additional unaudited information on our income tax policies, including our reserves for income taxes, see “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Reserves Rollforward	A rollforward of our reserves for all federal, state and foreign tax jurisdictions, is as follows: 2014 2013 Balance, beginning of year $ 1,268 $ 2,425 Additions for tax positions related to the current year 349 238 Additions for tax positions from prior years 215 273 Reductions for tax positions from prior years (81 ) (327 ) Settlement payments (70 ) (1,306 ) Statutes of limitations expiration (42 ) (30 ) Translation and other (52 ) (5 ) Balance, end of year $ 1,587 $ 1,268

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
	Dec. 27, 2014
Share-based Compensation [Abstract]
Summary of Compensation Costs	Stock-Based Compensation Our stock-based compensation program is designed to attract and retain employees while also aligning employees’ interests with the interests of our shareholders. Stock options, restricted stock units (RSUs), performance stock units (PSUs) and PepsiCo equity performance units (PEPunits) are granted to employees under the shareholder-approved 2007 Long-Term Incentive Plan (LTIP). Each RSU represents our obligation to deliver to the holder one share of PepsiCo common stock when the award vests at the end of the service period. PSUs are awards where the number of shares delivered to the holder upon vesting at the end of the service period depends on PepsiCo’s performance against specified targets. During the vesting period, RSUs and PSUs accrue dividend equivalents that pay out in cash (without interest) if and when the applicable RSU or PSU vests and becomes payable. PEPunits provide an opportunity to earn shares of PepsiCo common stock with a value that adjusts based upon changes in PepsiCo’s absolute stock price as well as PepsiCo’s Total Shareholder Return relative to the S&P 500 over a three -year performance period. The Company may use authorized and unissued shares to meet share requirements resulting from the exercise of stock options and the vesting of RSUs and PSUs as well as PEPunits. As of December 27, 2014 , 98 million shares were available for future stock-based compensation grants. The following table summarizes our total stock-based compensation expense: 2014 2013 2012 Stock-based compensation expense $ 297 $ 303 $ 278 Merger and integration charges — — 2 Restructuring and impairment benefits (3 ) — (7 ) Total $ 294 $ 303 $ 273 Income tax benefits recognized in earnings related to stock-based compensation $ 75 $ 76 $ 73 Method of Accounting and Our Assumptions We account for our employee stock options under the fair value method of accounting using a Black-Scholes valuation model to measure stock option expense at the date of grant. The fair value of RSUs is measured at the market price of the Company’s stock on the date of grant. The fair value of PSUs is measured at the market price of the Company’s stock on the date of grant with the exception of market-based awards, for which we use the Monte-Carlo simulation option-pricing model to determine the fair value. The Monte-Carlo simulation option-pricing model uses the same input assumptions as the Black-Scholes model; however, it also further incorporates into the fair-value determination the possibility that the market condition may not be satisfied. Compensation costs related to these awards are recognized regardless of whether the market condition is satisfied, provided that the requisite service has been provided. All stock option grants have an exercise price equal to the fair market value of our common stock on the date of grant and generally have a 10 -year term. We do not backdate, reprice or grant stock-based compensation awards retroactively. Repricing of awards would require shareholder approval under the LTIP. The fair value of stock-based award grants is amortized to expense over the vesting period, primarily three years. Awards to employees eligible for retirement prior to the award becoming fully vested are amortized to expense over the period through the date that the employee first becomes eligible to retire and is no longer required to provide service to earn the award. Executives who are awarded long-term incentives based on their performance may generally elect to receive their grant in the form of stock options or RSUs, or a combination thereof. Executives who elect RSUs receive one RSU for every four stock options that would have otherwise been granted. Certain executive officers and other senior executives do not have a choice and are granted a combination of 60% PEPunits measuring both absolute and relative stock price performance and 40% long-term cash based on achievement of specific performance operating metrics. Certain executives are granted performance-based stock units which require the achievement of specified financial and/or operational performance metrics. The number of shares may be increased to the maximum or reduced to the minimum threshold based on the results of these performance metrics in accordance with the terms established at the time of the award.
Schedule Of Weighted-Average Black-Scholes Fair Value Assumptions	Our weighted-average Black-Scholes fair value assumptions are as follows: 2014 2013 2012 Expected life 6 years 6 years 6 years Risk-free interest rate 1.9 % 1.1 % 1.3 % Expected volatility 16 % 17 % 17 % Expected dividend yield 2.9 % 2.7 % 3.0 % The expected life is the period over which our employee groups are expected to hold their options. It is based on our historical experience with similar grants. The risk-free interest rate is based on the expected U.S. Treasury rate over the expected life. Volatility reflects movements in our stock price over the most recent historical period equivalent to the expected life. Dividend yield is estimated over the expected life based on our stated dividend policy and forecasts of net income, share repurchases and stock price.
Stock Option Activity	A summary of our stock-based compensation activity for the year ended December 27, 2014 is as follows: Our Stock Option Activity Options (a) Average Price (b) Average Life (years) (c) Aggregate Intrinsic Value (d) Outstanding at December 28, 2013 49,462 $ 61.58 Granted 3,416 $ 81.27 Exercised (12,898 ) $ 58.56 Forfeited/expired (1,123 ) $ 70.62 Outstanding at December 27, 2014 38,857 $ 64.06 4.67 $ 1,282,200 Exercisable at December 27, 2014 30,237 $ 60.94 3.66 $ 1,091,815 Expected to vest as of December 27, 2014 8,111 $ 74.59 8.19 $ 182,132 (a) Options are in thousands and include options previously granted under The Pepsi Bottling Group, Inc. (PBG) and PepsiAmericas, Inc. (PAS) plans. No additional options or shares were granted under the PBG and PAS plans after 2009. (b) Weighted-average exercise price. (c) Weighted-average contractual life remaining. (d) In thousands.
Restricted Stock Units Activity	Our RSU and PSU Activity RSUs/PSUs (a) Average Intrinsic Value (b) Average Life (years) (c) Aggregate Intrinsic Value (d) Outstanding at December 28, 2013 11,939 $ 69.04 Granted (e) 4,379 $ 80.39 Converted (3,713 ) $ 64.77 Forfeited (1,171 ) $ 73.71 Actual performance change (f) (206 ) $ 64.19 Outstanding at December 27, 2014 (g) 11,228 $ 74.49 1.42 $ 1,089,707 Expected to vest as of December 27, 2014 10,745 $ 73.74 1.28 $ 1,042,781 (a) RSUs and PSUs are in thousands and include RSUs previously granted under the PBG plan. No additional RSUs or shares were granted under the PBG plan after 2009. (b) Weighted-average intrinsic value at grant date. (c) Weighted-average contractual life remaining. (d) In thousands. (e) Grant activity for all PSUs are disclosed at target. (f) Reflects the net number of PSUs above and below target levels based on actual performance measured at the end of the performance period. (g) The outstanding PSUs for which the performance period has not ended as of December 27, 2014, at the threshold, target and maximum award levels were zero , 0.7 million and 1.1 million , respectively.
Our PEPUnit Activity	Our PEPunit Activity PEPunits (a) Average Intrinsic Value (b) Average Life (years) (c) Aggregate Intrinsic Value (d) Outstanding at December 28, 2013 675 $ 66.65 Granted (e) 387 $ 50.95 Converted — $ — Forfeited (109 ) $ 59.85 Outstanding at December 27, 2014 (f) 953 $ 61.04 1.24 $ 92,451 Expected to vest as of December 27, 2014 843 $ 60.97 1.21 $ 81,770 (a) PEPunits are in thousands. (b) Weighted-average intrinsic value at grant date. (c) Weighted-average contractual life remaining. (d) In thousands. (e) Grant activity for all PEPunits are disclosed at target. (f) The outstanding PEPunits for which the performance period has not ended as of December 27, 2014, at the threshold, target and maximum award levels were zero , 1.0 million and 1.7 million , respectively.
Other Stock-Based Compensation Data	Other Stock-Based Compensation Data 2014 2013 2012 Stock Options Total number of options granted (a) 3,416 2,868 3,696 Weighted-average fair value of options granted $ 8.79 $ 8.14 $ 6.86 Total intrinsic value of options exercised (a) $ 423,251 $ 471,475 $ 512,636 Total fair value of options vested (a) $ 42,353 $ 88,750 $ 148,835 RSUs/PSUs Total number of RSUs/PSUs granted (a) 4,379 4,231 4,404 Weighted-average intrinsic value of RSUs/PSUs granted $ 80.39 $ 76.30 $ 66.64 Total intrinsic value of RSUs/PSUs converted (a) $ 319,820 $ 294,065 $ 236,575 Total fair value of RSUs/PSUs vested (a) $ 241,836 $ 236,688 $ 188,723 PEPunits Total number of PEPunits granted (a) 387 355 410 Weighted-average intrinsic value of PEPunits granted $ 50.95 $ 68.48 $ 64.85 Total intrinsic value of PEPunits converted (a) $ — $ 3,868 $ — Total fair value of PEPunits vested (a) $ 5,072 $ 5,896 $ — (a) In thousands. As of December 27, 2014 and December 28, 2013 , there were approximately 324,000 and 290,000 outstanding awards, respectively, consisting primarily of phantom stock units that were granted under the PepsiCo Director Deferral Program and will be settled in shares of PepsiCo common stock pursuant to the LTIP at the end of the applicable deferral period, not included in the tables above. As of December 27, 2014 , there was $382 million of total unrecognized compensation cost related to nonvested share-based compensation grants. This unrecognized compensation cost is expected to be recognized over a weighted-average period of two years.

Pension, Retiree Medical and 29

Pension, Retiree Medical and Savings Plans (Tables)	12 Months Ended
	Dec. 27, 2014
Defined Benefit Plan Disclosure [Line Items]
Pension and Retiree Medical Plan Contributions [Table Text Block]	Contributions to our pension and retiree medical plans were as follows: Pension Retiree Medical 2014 2013 2012 2014 2013 2012 Discretionary (a) $ 407 $ 23 $ 1,375 $ — $ — $ 140 Non-discretionary 184 177 239 64 62 111 Total $ 591 $ 200 $ 1,614 $ 64 $ 62 $ 251 (a) Includes $388 million and $405 million in 2014 and 2012, respectively, pertaining to pension lump sum payments.
Schedule Of Plan Assets Measured At Fair Value Table Text Block	Plan assets measured at fair value as of fiscal year-end 2014 and 2013 are categorized consistently by level in both years, and are as follows: 2014 2013 Total Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total U.S. plan assets (a) Equity securities: U.S. common stock (b) $ 966 $ 966 $ — $ — $ 732 U.S. commingled funds (c) (d) 3,437 — 3,437 — 3,334 International common stock (b) 1,488 1,488 — — 1,669 International commingled fund (e) 876 — 876 — 902 Preferred stock (f) 22 — 22 — 18 Fixed income securities: Government securities (f) 1,279 — 1,279 — 1,264 Corporate bonds (f) (g) 3,338 — 3,338 — 2,958 Mortgage-backed securities (f) 274 — 274 — 220 Other: Contracts with insurance companies (h) 6 — — 6 6 Real estate commingled funds (i) 629 — — 629 552 Cash and cash equivalents 267 267 — — 154 Sub-total U.S. plan assets 12,582 $ 2,721 $ 9,226 $ 635 11,809 Dividends and interest receivable 57 59 Total U.S. plan assets $ 12,639 $ 11,868 International plan assets Equity securities: U.S. common stock (b) $ 5 $ 5 $ — $ — $ 4 U.S. commingled funds (c) 373 — 373 — 334 International common stock (b) 171 171 — — 176 International commingled funds (e) 918 — 918 — 914 Preferred stock (f) 1 — 1 — 1 Fixed income securities: Government securities (f) 454 — 454 — 207 Corporate bonds (f) 320 — 320 — 261 Fixed income commingled funds (j) 517 — 517 — 650 Other: Contracts with insurance companies (h) 36 — — 36 34 Currency commingled fund (k) 87 — 87 — 91 Real estate commingled fund (i) 92 — — 92 83 Cash and cash equivalents 21 21 — — 15 Sub-total international plan assets 2,995 $ 197 $ 2,670 $ 128 2,770 Dividends and interest receivable 7 7 Total international plan assets $ 3,002 $ 2,777 (a) 2014 and 2013 amounts include $415 million and $ 406 million , respectively, of retiree medical plan assets that are restricted for purposes of providing health benefits for U.S. retirees and their beneficiaries. (b) Based on quoted market prices in active markets. (c) Based on the fair value of the investments owned by these funds that track various U.S. large, mid-cap and small company indices. (d) Includes one large-cap fund that represents 25% of total U.S. plan assets for both 2014 and 2013 . (e) Based on the fair value of the investments owned by these funds that track various non-U.S. equity indices. (f) Based on quoted bid prices for comparable securities in the marketplace and broker/dealer quotes in active markets. (g) Corporate bonds of U.S.-based companies represent 23% and 21% , respectively, of total U.S. plan assets for 2014 and 2013 . (h) Based on the fair value of the contracts as determined by the insurance companies using inputs that are not observable. (i) Based on the appraised value of the investments owned by these funds as determined by independent third parties using inputs that are not observable. (j) Based on the fair value of the investments owned by these funds that track various government and corporate bond indices. (k) Based on the fair value of the investments owned by this fund that invests primarily in derivatives to hedge currency exposure.
Selected Financial Information For Pension And Retiree Medical Plans	Pension, Retiree Medical and Savings Plans In the fourth quarter of 2014 and 2012, the Company offered certain former employees who had vested benefits in our U.S. defined benefit pension plans the option of receiving a one-time lump sum payment equal to the present value of the participant’s pension benefit (payable in cash or rolled over into a qualified retirement plan or IRA). In December 2014 and 2012, we made a discretionary contribution of $388 million and $405 million , respectively, to fund substantially all of these payments. The Company recorded a pre-tax non-cash settlement charge of $141 million ( $88 million after-tax or $0.06 per share) in 2014 and $195 million ( $131 million after-tax or $0.08 per share) in 2012 as a result of these transactions. See additional unaudited information in “Items Affecting Comparability” in Management’s Discussion and Analysis of Financial Condition and Results of Operations. The provisions of both the PPACA and the Health Care and Education Reconciliation Act are reflected in our retiree medical expenses and liabilities and were not material to our financial statements. During 2014, we revised our mortality assumptions to incorporate the new set of mortality tables issued by the Society of Actuaries, adjusted to reflect our experience and future expectations. This resulted in an increase in the projected benefit obligation of our U.S. pension and retiree medical programs. We also reviewed and revised other demographic assumptions to reflect recent experience. The net effect of these changes and certain plan design changes resulted in an increase of approximately $150 million in the projected benefit obligation at December 27, 2014. Gains and losses resulting from actual experience differing from our assumptions, including the difference between the actual return on plan assets and the expected return on plan assets, and from changes in our assumptions are determined at each measurement date. If this net accumulated gain or loss exceeds 10% of the greater of the market-related value of plan assets or plan liabilities, a portion of the net gain or loss is included in expense for the following year based upon the average remaining service period of active plan participants, which is approximately 11 years for pension expense and approximately 8 years for retiree medical expense. The cost or benefit of plan changes that increase or decrease benefits for prior employee service (prior service cost/(credit)) is included in earnings on a straight-line basis over the average remaining service period of active plan participants. Selected financial information for our pension and retiree medical plans is as follows: Pension Retiree Medical U.S. International 2014 2013 2014 2013 2014 2013 Change in projected benefit liability Liability at beginning of year $ 11,825 $ 12,886 $ 2,859 $ 2,788 $ 1,384 $ 1,511 Service cost 393 467 98 111 36 45 Interest cost 580 527 131 118 58 54 Plan amendments (122 ) 22 — (1 ) (125 ) — Participant contributions — — 3 3 — — Experience loss/(gain) 1,635 (1,522 ) 512 (65 ) 190 (128 ) Benefit payments (349 ) (533 ) (86 ) (91 ) (101 ) (97 ) Settlement/curtailment (577 ) (44 ) (25 ) (3 ) — — Special termination benefits 24 22 — — 3 2 Foreign currency adjustment — — (245 ) (2 ) (6 ) (3 ) Other — — — 1 — — Liability at end of year $ 13,409 $ 11,825 $ 3,247 $ 2,859 $ 1,439 $ 1,384 Change in fair value of plan assets Fair value at beginning of year $ 11,462 $ 10,817 $ 2,777 $ 2,463 $ 406 $ 365 Actual return on plan assets 1,254 1,159 401 265 46 76 Employer contributions/funding 434 63 157 137 64 62 Participant contributions — — 3 3 — — Benefit payments (349 ) (533 ) (86 ) (91 ) (101 ) (97 ) Settlement (577 ) (44 ) (24 ) (8 ) — — Foreign currency adjustment — — (226 ) 8 — — Fair value at end of year $ 12,224 $ 11,462 $ 3,002 $ 2,777 $ 415 $ 406 Funded status $ (1,185 ) $ (363 ) $ (245 ) $ (82 ) $ (1,024 ) $ (978 ) Pension Retiree Medical U.S. International 2014 2013 2014 2013 2014 2013 Amounts recognized Other assets $ 97 $ 603 $ 37 $ 74 $ — $ — Other current liabilities (42 ) (41 ) (1 ) (1 ) (57 ) (72 ) Other liabilities (1,240 ) (925 ) (281 ) (155 ) (967 ) (906 ) Net amount recognized $ (1,185 ) $ (363 ) $ (245 ) $ (82 ) $ (1,024 ) $ (978 ) Amounts included in accumulated other comprehensive loss (pre-tax) Net loss/(gain) $ 2,918 $ 2,069 $ 1,003 $ 849 $ (49 ) $ (222 ) Prior service (credit)/cost (18 ) 125 (7 ) (6 ) (166 ) (69 ) Total $ 2,900 $ 2,194 $ 996 $ 843 $ (215 ) $ (291 ) Components of the increase/(decrease) in net loss/(gain) included in accumulated other comprehensive loss Change in discount rate $ 1,424 $ (1,532 ) $ 636 $ (166 ) $ 98 $ (117 ) Employee-related assumption changes 345 24 (112 ) 91 58 2 Liability-related experience different from assumptions (104 ) (14 ) (12 ) 10 34 (13 ) Actual asset return different from expected return (470 ) (336 ) (225 ) (108 ) (19 ) (49 ) Amortization and settlement of losses (316 ) (285 ) (61 ) (68 ) 4 (1 ) Other, including foreign currency adjustments (30 ) — (72 ) (6 ) (2 ) — Total $ 849 $ (2,143 ) $ 154 $ (247 ) $ 173 $ (178 ) Liability at end of year for service to date $ 12,206 $ 10,803 $ 2,721 $ 2,369
Estimated Amounts To Be Amortized From Accumulated Other Comprehensive Loss Into Benefit Expense In 2012 For Pension And Retiree Medical Plans	The estimated amounts to be amortized from accumulated other comprehensive loss into expense in 2015 for our pension and retiree medical plans are as follows: Pension Retiree Medical U.S. International Net loss $ 205 $ 74 $ — Prior service credit (3 ) — (38 ) Total $ 202 $ 74 $ (38 )
Weighted-Average Assumptions Used To Determine Projected Benefit Liability And Benefit Expense For Pension And Retiree Medical Plans	The following table provides the weighted-average assumptions used to determine projected benefit liability and benefit expense for our pension and retiree medical plans: Pension Retiree Medical U.S. International 2014 2013 2012 2014 2013 2012 2014 2013 2012 Weighted-average assumptions Liability discount rate 4.2 % 5.0 % 4.2 % 3.8 % 4.7 % 4.4 % 3.8 % 4.6 % 3.7 % Expense discount rate 5.0 % 4.2 % 4.6 % 4.7 % 4.4 % 4.8 % 4.3 % 3.7 % 4.4 % Expected return on plan assets 7.5 % 7.8 % 7.8 % 6.6 % 6.6 % 6.7 % 7.5 % 7.8 % 7.8 % Liability rate of salary increases 3.5 % 3.7 % 3.7 % 3.6 % 3.9 % 3.9 % Expense rate of salary increases 3.7 % 3.7 % 3.7 % 3.9 % 3.9 % 4.1 %
Selected Information About Plans With Liability For Service To Date And Total Benefit Liability In Excess Of Plan Assets	The following table provides selected information about plans with liability for service to date and total projected benefit liability in excess of plan assets: Pension Retiree Medical U.S. International 2014 2013 2014 2013 2014 2013 Selected information for plans with liability for service to date in excess of plan assets Liability for service to date $ (661 ) $ (577 ) $ (333 ) $ (310 ) Fair value of plan assets $ 2 $ 2 $ 288 $ 259 Selected information for plans with projected benefit liability in excess of plan assets Benefit liability $ (7,385 ) $ (6,555 ) $ (2,865 ) $ (2,291 ) $ (1,439 ) $ (1,384 ) Fair value of plan assets $ 6,103 $ 5,589 $ 2,583 $ 2,135 $ 415 $ 406 Of the total projected pension benefit liability at year-end 2014 , $808 million relates to plans that we do not fund because the funding of such plans does not receive favorable tax treatment.
Future Benefit Payments	Our estimated future benefit payments are as follows: 2015 2016 2017 2018 2019 2020-24 Pension $ 700 $ 730 $ 775 $ 830 $ 880 $ 5,160 Retiree medical (a) $ 120 $ 125 $ 125 $ 125 $ 125 $ 560 (a) Expected future benefit payments for our retiree medical plans do not reflect any estimated subsidies expected to be received under the 2003 Medicare Act. Subsidies are expected to be approximately $3 million for each of the years from 2015 through 2019 and approximately $13 million in total for 2020 through 2024. These future benefit payments to beneficiaries include payments from both funded and unfunded plans. In 2015 , we expect to make pension and retiree medical contributions of approximately $225 million , with approximately $55 million for retiree medical benefits.
Target Investment Allocation	Plan Assets Our pension plan investment strategy includes the use of actively managed securities and is reviewed periodically in conjunction with plan liabilities, an evaluation of market conditions, tolerance for risk and cash requirements for benefit payments. This strategy is also applicable to funds held for the retiree medical plans. Our investment objective is to ensure that funds are available to meet the plans’ benefit obligations when they become due. Our overall investment strategy is to prudently invest plan assets in a well-diversified portfolio of equity and high-quality debt securities and real estate to achieve our long-term return expectations. Our investment policy also permits the use of derivative instruments which are primarily used to reduce risk. Our expected long-term rate of return on U.S. plan assets is 7.5% for 2015 and 2014 . Our target investment allocations for U.S. plan assets are as follows: 2015 2014 Fixed income 40 % 40 % U.S. equity 33 % 33 % International equity 22 % 22 % Real estate 5 % 5 % Actual investment allocations may vary from our target investment allocations due to prevailing market conditions. We regularly review our actual investment allocations and periodically rebalance our investments to our target allocations. The expected return on plan assets is based on our plan investment strategy and our expectations for long-term rates of return by asset class, taking into account volatility and correlation among asset classes and our historical experience. We also review current levels of interest rates and inflation to assess the reasonableness of the long-term rates. We evaluate our expected return assumptions annually to ensure that they are reasonable. To calculate the expected return on plan assets, our market-related value of assets for fixed income is the actual fair value. For all other asset categories, we use a method that recognizes investment gains or losses (the difference between the expected and actual return based on the market-related value of assets) over a five -year period. This has the effect of reducing year-to-year volatility.
Reconciliation of the Beginning and Ending Balances of Level 3 Plan Assets	The changes in Level 3 plan assets are as follows: Balance, Beginning 2013 Return on Assets Held at Year-End Purchases and Sales, Net Balance, End of 2013 Return on Assets Held at Year-End Purchases and Sales, Net Balance, End of 2014 Real estate commingled funds $ 391 $ 56 $ 188 $ 635 $ 68 $ 18 $ 721 Contracts with insurance companies 62 (1 ) (21 ) 40 2 — 42 Total $ 453 $ 55 $ 167 $ 675 $ 70 $ 18 $ 763
Effects Of 1-Percentage-Point Change In The Assumed Health Care Trend Rate	Retiree Medical Cost Trend Rates An average increase of 6% in the cost of covered retiree medical benefits is assumed for 2015 . This average increase is then projected to decline gradually to 5% in 2025 and thereafter. These assumed health care cost trend rates have an impact on the retiree medical plan expense and liability, however the cap on our share of retiree medical costs limits the impact. A 1-percentage-point change in the assumed health care trend rate would have the following effects: 1% 1% 2014 service and interest cost components $ 4 $ (3 ) 2014 benefit liability $ 46 $ (40 ) Savings Plan Certain U.S. employees are eligible to participate in 401(k) savings plans, which are voluntary defined contribution plans. The plans are designed to help employees accumulate additional savings for retirement, and we make Company matching contributions for certain employees on a portion of eligible pay based on years of service. As of February 2012, certain U.S. employees earning a benefit under one of our defined benefit pension plans were no longer eligible for Company matching contributions on their 401(k) contributions. Certain U.S. salaried employees, who are not eligible to participate in a defined benefit pension plan, are also eligible to receive an employer contribution to the 401(k) savings plan based on age and years of service regardless of employee contribution. In 2014 , 2013 and 2012 , our total Company contributions were $130 million , $122 million and $109 million , respectively. For additional unaudited information on our pension and retiree medical plans and related accounting policies and assumptions, see “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Schedule of Net Benefit Costs [Table Text Block]	The components of benefit expense are as follows: Pension Retiree Medical U.S. International 2014 2013 2012 2014 2013 2012 2014 2013 2012 Components of benefit expense Service cost $ 393 $ 467 $ 407 $ 98 $ 111 $ 100 $ 36 $ 45 $ 50 Interest cost 580 527 534 131 118 115 58 54 65 Expected return on plan assets (784 ) (823 ) (796 ) (176 ) (157 ) (146 ) (27 ) (27 ) (22 ) Amortization of prior service cost/(credit) 21 18 17 — 1 1 (28 ) (23 ) (26 ) Amortization of net loss/(gain) 175 289 259 53 66 53 (4 ) 1 — 385 478 421 106 139 123 35 50 67 Settlement/curtailment loss/(gain) (a) 141 (4 ) 185 7 7 4 — — — Special termination benefits 24 22 8 — — 1 3 2 5 Total $ 550 $ 496 $ 614 $ 113 $ 146 $ 128 $ 38 $ 52 $ 72 (a) U.S. includes pension lump sum settlement charge of $141 million in 2014 and $195 million in 2012. These charges are reflected in items affecting comparability (see additional unaudited information in “Items Affecting Comparability” in Management’s Discussion and Analysis of Financial Condition and Results of Operations).

Debt Obligations and Commitme30

Debt Obligations and Commitments (Tables)	12 Months Ended
	Dec. 27, 2014
Debt Obligations and Commitments [Abstract]
Schedule of Long and Short-Term Debt Contractural Commitments	Debt Obligations and Commitments The following table summarizes the Company’s debt obligations: 2014 2013 Short-term debt obligations Current maturities of long-term debt $ 4,096 $ 2,224 Commercial paper (0.1% and 0.1%) 746 2,924 Other borrowings (17.7% and 12.4%) 234 158 $ 5,076 $ 5,306 Long-term debt obligations Notes due 2014 (5.3%) $ — $ 2,219 Notes due 2015 (1.4% and 1.2%) 4,093 4,116 Notes due 2016 (2.6% and 2.5%) 3,099 3,106 Notes due 2017 (1.6% and 2.0%) 2,004 1,258 Notes due 2018 (4.4% and 4.3%) 3,410 3,439 Notes due 2019 (3.7% and 3.7%) 1,631 1,635 Notes due 2020-2044 (3.9% and 4.0%) 13,640 10,738 Other, due 2015-2019 (4.4% and 4.4%) 40 46 27,917 26,557 Less: current maturities of long-term debt obligations (4,096 ) (2,224 ) Total $ 23,821 $ 24,333 The interest rates in the above table reflect weighted-average rates at year-end. In 2014 , we issued: • $750 million of 0.950% senior notes maturing in February 2017 ; • $1.250 billion of 3.600% senior notes maturing in March 2024 ; • €500 million of 1.750% senior notes maturing in April 2021 ; • €500 million of 2.625% senior notes maturing in April 2026 ; and • $500 million of 4.250% senior notes maturing in October 2044 . The net proceeds from the issuances of the above notes were used for general corporate purposes, including the repayment of commercial paper. In 2014 , $2.2 billion of senior notes matured and were paid. In 2014 , we entered into a new five-year unsecured revolving credit agreement (Five-Year Credit Agreement) which expires on June 9, 2019. The Five-Year Credit Agreement enables us and our borrowing subsidiaries to borrow up to $3.7725 billion , subject to customary terms and conditions. We may request that commitments under this agreement be increased up to $4.5 billion . Additionally, we may, once a year, request renewal of the agreement for an additional one-year period. Also, in 2014 , we entered into a new 364-day unsecured revolving credit agreement (364-Day Credit Agreement) which expires on June 8, 2015. The 364-Day Credit Agreement enables us and our borrowing subsidiaries to borrow up to $3.7725 billion , subject to customary terms and conditions. We may request that commitments under this agreement be increased up to $4.5 billion . We may request renewal of this facility for an additional 364-day period or convert any amounts outstanding into a term loan for a period of up to one year, which would mature no later than the then effective termination date. The Five-Year Credit Agreement and the 364-Day Credit Agreement together replaced our $2.925 billion five-year credit agreement dated as of June 10, 2013 and our $2.925 billion 364-Day credit agreement dated as of June 10, 2013. Funds borrowed under the Five-Year Credit Agreement and the 364-Day Credit Agreement may be used for general corporate purposes. Subject to certain conditions, we may borrow, prepay and reborrow amounts under these agreements. As of December 27, 2014 , there were no outstanding borrowings under the Five-Year Credit Agreement or the 364-Day Credit Agreement. In addition, as of December 27, 2014 , our international debt of $228 million was related to borrowings from external parties including various lines of credit. These lines of credit are subject to normal banking terms and conditions and are fully committed at least to the extent of our borrowings.
Schedule Of Long-Term Contractual Commitments	Long-Term Contractual Commitments (a) The following table summarizes our long-term contractual commitments by period: Payments Due by Period Total 2015 2016 – 2017 2018 – 2019 2020 and beyond Long-term debt obligations (b) $ 23,446 $ — $ 5,108 $ 4,863 $ 13,475 Interest on debt obligations (c) 8,839 873 1,553 1,245 5,168 Operating leases 1,894 403 631 387 473 Purchasing commitments (d) 1,985 693 873 293 126 Marketing commitments (d) 2,178 391 647 525 615 $ 38,342 $ 2,360 $ 8,812 $ 7,313 $ 19,857 (a) Based on year-end foreign exchange rates. We expect to make net cash tax payments of approximately $300 million within the next 12 months, as discussed further in Note 5. Reserves for uncertain tax positions are excluded from the table above as we are unable to reasonably predict the ultimate amount or timing of any other settlements. (b) Excludes $4,096 million related to current maturities of long-term debt, $196 million related to the fair value step-up of debt acquired in connection with our acquisitions of PBG and PAS and $179 million related to the increase in carrying value of long-term debt representing the gains on our fair value interest rate swaps. (c) Interest payments on floating-rate debt are estimated using interest rates effective as of December 27, 2014 . (d) Primarily reflects non-cancelable commitments as of December 27, 2014 . Most long-term contractual commitments, except for our long-term debt obligations, are not recorded on our balance sheet. Operating leases primarily represent building leases. Non-cancelable purchasing commitments are primarily for oranges and orange juice. Non-cancelable marketing commitments are primarily for sports marketing. Bottler funding to independent bottlers is not reflected in our long-term contractual commitments as it is negotiated on an annual basis. Accrued liabilities for pension and retiree medical plans are not reflected in our long-term contractual commitments. See Note 7 for additional information regarding our pension and retiree medical obligations. Off-Balance-Sheet Arrangements It is not our business practice to enter into off-balance-sheet arrangements, other than in the normal course of business. See Note 8 regarding contracts related to certain of our bottlers. See “Our Liquidity and Capital Resources” in Management’s Discussion and Analysis of Financial Condition and Results of Operations for further unaudited information on our borrowings.

Financial Instruments (Tables)

Financial Instruments (Tables)	12 Months Ended
	Dec. 27, 2014
Derivative Instruments and Hedges, Assets [Abstract]
Derivative Instruments and Hedging Activities Disclosure [Text Block]	Financial Instruments Derivatives We are exposed to market risks arising from adverse changes in: • commodity prices, affecting the cost of our raw materials and energy; • foreign exchange rates and currency restrictions; and • interest rates. In the normal course of business, we manage commodity price, foreign exchange and interest rate risks through a variety of strategies, including productivity initiatives, global purchasing programs and hedging. Ongoing productivity initiatives involve the identification and effective implementation of meaningful cost-saving opportunities or efficiencies, including the use of derivatives. Our global purchasing programs include fixed-price purchase orders and pricing agreements. Our hedging strategies include the use of derivatives. Certain derivatives are designated as either cash flow or fair value hedges and qualify for hedge accounting treatment, while others do not qualify and are marked to market through earnings. Cash flows from derivatives used to manage commodity price, foreign exchange or interest rate risks are classified as operating activities in the Consolidated Statement of Cash Flows. We classify both the earnings and cash flow impact from these derivatives consistent with the underlying hedged item. See “Our Business Risks” in Management’s Discussion and Analysis of Financial Condition and Results of Operations for further unaudited information on our business risks. For cash flow hedges, the effective portion of changes in fair value are deferred in accumulated other comprehensive loss within common shareholders’ equity until the underlying hedged item is recognized in net income. For fair value hedges, changes in fair value are recognized immediately in earnings, consistent with the underlying hedged item. Hedging transactions are limited to an underlying exposure. As a result, any change in the value of our derivative instruments would be substantially offset by an opposite change in the value of the underlying hedged items. We do not use derivative instruments for trading or speculative purposes. We perform assessments of our counterparty credit risk regularly, including reviewing netting agreements, if any, and a review of credit ratings, credit default swap rates and potential nonperformance of the counterparty. Based on our most recent assessment of our counterparty credit risk, we consider this risk to be low. In addition, we enter into derivative contracts with a variety of financial institutions that we believe are creditworthy in order to reduce our concentration of credit risk. Commodity Prices We are subject to commodity price risk because our ability to recover increased costs through higher pricing may be limited in the competitive environment in which we operate. This risk is managed through the use of fixed-price contracts and purchase orders, pricing agreements and derivative instruments, which include swaps and futures. In addition, risk to our supply of certain raw materials is mitigated through purchases from multiple geographies and suppliers. We use derivatives, with terms of no more than three years, to economically hedge price fluctuations related to a portion of our anticipated commodity purchases, primarily for agricultural products, energy and metals. Ineffectiveness for those derivatives that qualify for hedge accounting treatment was not material for all periods presented. Derivatives used to hedge commodity price risk that do not qualify for hedge accounting treatment are marked to market each period with the resulting gains and losses recorded in corporate unallocated expenses as either cost of sales or selling, general and administrative expenses, depending on the underlying commodity. These gains and losses are subsequently reflected in division results when the divisions recognize the cost of the underlying commodity in operating profit. Our open commodity derivative contracts had a notional value of $1.2 billion as of December 27, 2014 and $1.4 billion as of December 28, 2013 . Foreign Exchange Our operations outside of the U.S. generate 49% of our net revenue, with Russia, Mexico, Canada, the United Kingdom and Brazil comprising approximately 23% of our net revenue in 2014 . As a result, we are exposed to foreign exchange risks. Additionally, we are exposed to foreign exchange risk from foreign currency purchases and foreign currency assets and liabilities created in the normal course of business. We manage this risk through sourcing purchases from local suppliers, negotiating contracts in local currencies with foreign suppliers and through the use of derivatives, primarily forward contracts with terms of no more than two years. Exchange rate gains or losses related to foreign currency transactions are recognized as transaction gains or losses in our income statement as incurred. Our foreign currency derivatives had a total notional value of $2.7 billion as of December 27, 2014 and $2.5 billion as of December 28, 2013 . Ineffectiveness for those derivatives that qualify for hedge accounting was not material for all periods presented. For foreign currency derivatives that do not qualify for hedge accounting treatment, all losses and gains were offset by changes in the underlying hedged items, resulting in no material net impact on earnings. Interest Rates We centrally manage our debt and investment portfolios considering investment opportunities and risks, tax consequences and overall financing strategies. We use various interest rate derivative instruments including, but not limited to, interest rate swaps, cross-currency interest rate swaps, Treasury locks and swap locks to manage our overall interest expense and foreign exchange risk. These instruments effectively change the interest rate and currency of specific debt issuances. Certain of our fixed rate indebtedness has been swapped to floating rates. The notional amount, interest payment and maturity date of the interest rate and cross-currency interest rate swaps match the principal, interest payment and maturity date of the related debt. Our Treasury locks and swap locks are entered into to protect against unfavorable interest rate changes relating to forecasted debt transactions. The notional values of the interest rate derivative instruments outstanding as of December 27, 2014 and December 28, 2013 were $9.3 billion and $7.9 billion , respectively. Ineffectiveness, for those interest rate derivative instruments that qualify for cash flow hedge accounting were not material for all periods presented. As of December 27, 2014 , approximately 25% of total debt, after the impact of the related interest rate derivative instruments, was exposed to variable rates, compared to 31% as of December 28, 2013 . Available-for-Sale Securities Investments in debt and equity marketable securities, other than investments accounted for under the equity method, are classified as available-for-sale. All highly liquid investments with original maturities of three months or less are classified as cash equivalents. Our investments in available-for-sale securities are reported at fair value. Unrealized gains and losses related to changes in the fair value of available-for-sale securities are recognized in accumulated other comprehensive loss within common shareholders’ equity. Unrealized gains and losses on our investments in marketable debt securities as of December 27, 2014 were not material. The pre-tax unrealized gains on our investments in marketable equity securities were $111 million and $122 million as of December 27, 2014 and December 28, 2013 , respectively. Changes in the fair value of available-for-sale securities impact net income only when such securities are sold or an other-than-temporary impairment is recognized. We regularly review our investment portfolio to determine if any security is other-than-temporarily impaired. In making this judgment, we evaluate, among other things, the duration and extent to which the fair value of a security is less than its cost; the financial condition of the issuer and any changes thereto; and our intent to sell, or whether we will more likely than not be required to sell, the security before recovery of its amortized cost basis. Our assessment on whether a security is other-than-temporarily impaired could change in the future due to new developments or changes in assumptions related to any particular security. We recorded no other-than-temporary impairment charges for the years ended December 27, 2014 and December 28, 2013 .
Fair Values Of Financial Assets And Liabilities	Fair Value Measurements The fair values of our financial assets and liabilities as of December 27, 2014 and December 28, 2013 are categorized as follows: 2014 2013 Assets (a) Liabilities (a) Assets (a) Liabilities (a) Available-for-sale securities: Equity securities (b) $ 124 $ — $ 135 $ — Debt securities (c) 3,167 — — — $ 3,291 $ — $ 135 $ — Short-term investments (d) $ 197 $ — $ 184 $ — Prepaid forward contracts (e) $ 26 $ — $ 24 $ — Deferred compensation (f) $ — $ 504 $ — $ 504 Derivatives designated as fair value hedging instruments: Interest rate (g) $ 140 $ — $ 176 $ 10 Derivatives designated as cash flow hedging instruments: Foreign exchange (h) $ 76 $ 12 $ 22 $ 13 Interest rate (h) 1 117 19 — Commodity (i) 3 10 6 29 $ 80 $ 139 $ 47 $ 42 Derivatives not designated as hedging instruments: Foreign exchange (h) $ 12 $ 13 $ 12 $ 8 Interest rate (g) 57 75 71 94 Commodity (i) 18 166 20 89 $ 87 $ 254 $ 103 $ 191 Total derivatives at fair value (j) $ 307 $ 393 $ 326 $ 243 Total $ 3,821 $ 897 $ 669 $ 747 (a) Unless otherwise noted, financial assets are classified on our consolidated balance sheet within prepaid expenses and other current assets and other assets. Financial liabilities are classified on our consolidated balance sheet within accounts payable and other current liabilities and other liabilities. Unless specifically indicated, all financial assets and liabilities are categorized as Level 2 assets or liabilities. (b) Based on the price of common stock. Categorized as a Level 1 asset. These equity securities are classified as investments in noncontrolled affiliates. (c) Based on quoted broker prices or other significant inputs derived from or corroborated by observable market data. As of December 27, 2014 , $0.8 billion and $2.4 billion of debt securities were classified as cash equivalents and short-term investments, respectively. All of the Company’s available-for-sale debt securities have contractual maturities of one year or less. (d) Based on the price of index funds. Categorized as a Level 1 asset. These investments are classified as short-term investments and are used to manage a portion of market risk arising from our deferred compensation liability. (e) Based primarily on the price of our common stock. (f) Based on the fair value of investments corresponding to employees’ investment elections. (g) Based on LIBOR forward rates and recently reported market transactions of spot and forward rates. As of December 27, 2014 and December 28, 2013 , amounts related to non-designated instruments are presented as a net liability on our consolidated balance sheet. (h) Based on recently reported market transactions of spot and forward rates. (i) Based on recently reported market transactions, primarily swap arrangements. (j) Unless otherwise noted, derivative assets and liabilities are presented on a gross basis on our consolidated balance sheet. Amounts subject to enforceable master netting arrangements or similar agreements which are not offset on the consolidated balance sheet as of December 27, 2014 and December 28, 2013 were immaterial. Collateral received against any of our asset positions was immaterial.
Effective Portion Of Pre-Tax (Gains)/Losses On Derivative Instruments	The carrying amounts of our cash and cash equivalents and short-term investments approximate fair value due to their short-term maturity. The fair value of our debt obligations as of December 27, 2014 and December 28, 2013 was $31 billion and $30 billion , respectively, based upon prices of similar instruments in the marketplace. Pre-tax losses/(gains) on our derivative instruments are categorized as follows: Fair Value/Non- designated Hedges Cash Flow Hedges Losses/(Gains) Recognized in Income Statement (a) Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement (b) 2014 2013 2014 2013 2014 2013 Foreign exchange $ 2 $ (9 ) $ (70 ) $ (24 ) $ (16 ) $ — Interest rate 21 99 135 (13 ) 233 3 Commodity 170 126 23 57 32 42 Total $ 193 $ 216 $ 88 $ 20 $ 249 $ 45 (a) Foreign exchange derivative gains/losses are primarily included in selling, general and administrative expenses. Interest rate derivative gains/losses are primarily from fair value hedges and are included in interest expense. These gains/losses are substantially offset by increases/decreases in the value of the underlying debt, which are also included in interest expense. Commodity derivative gains/losses are included in either cost of sales or selling, general and administrative expenses, depending on the underlying commodity. (b) Foreign exchange derivative gains/losses are primarily included in cost of sales. Interest rate derivative gains/losses are included in interest expense. Commodity derivative gains/losses are included in either cost of sales or selling, general and administrative expenses, depending on the underlying commodity. During the next 12 months, we expect to reclassify net gains of $21 million related to our cash flow hedges from accumulated other comprehensive loss into net income.

Net Income Attributable to Pe32

Net Income Attributable to PepsiCo per Common Share (Tables)	12 Months Ended
	Dec. 27, 2014
Earnings Per Share [Abstract]
Basic And Diluted Net Income Attributable To PepsiCo Per Common Share	The computations of basic and diluted net income attributable to PepsiCo per common share are as follows: 2014 2013 2012 Income Shares (a) Income Shares (a) Income Shares (a) Net income attributable to PepsiCo $ 6,513 $ 6,740 $ 6,178 Preferred shares: Dividends (1 ) (1 ) (1 ) Redemption premium (9 ) (7 ) (6 ) Net income available for PepsiCo common shareholders $ 6,503 1,509 $ 6,732 1,541 $ 6,171 1,557 Basic net income attributable to PepsiCo per common share $ 4.31 $ 4.37 $ 3.96 Net income available for PepsiCo common shareholders $ 6,503 1,509 $ 6,732 1,541 $ 6,171 1,557 Dilutive securities: Stock options, RSUs, PSUs, PEPunits and Other — 17 — 18 — 17 ESOP convertible preferred stock 10 1 8 1 7 1 Diluted $ 6,513 1,527 $ 6,740 1,560 $ 6,178 1,575 Diluted net income attributable to PepsiCo per common share $ 4.27 $ 4.32 $ 3.92 (a) Weighted-average common shares outstanding (in millions).

Preferred Stock (Tables)

Preferred Stock (Tables)	12 Months Ended
	Dec. 27, 2014
Equity [Abstract]
Schedule Of Preferred Stock	The following summarizes our preferred stock activity: 2014 2013 2012 Shares (a) Amount Shares (a) Amount Shares (a) Amount Preferred stock 0.8 $ 41 0.8 $ 41 0.8 $ 41 Repurchased preferred stock Balance, beginning of year 0.6 $ 171 0.6 $ 164 0.6 $ 157 Redemptions 0.1 10 — 7 — 7 Balance, end of year 0.7 $ 181 0.6 $ 171 0.6 $ 164

Accumulated Other Comprehensi34

Accumulated Other Comprehensive Loss Attributable to Pepsico (Tables)	12 Months Ended
	Dec. 27, 2014
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule Of Accumulated Other Comprehensive Income	Comprehensive income is a measure of income which includes both net income and other comprehensive income or loss. Other comprehensive income or loss results from items deferred from recognition into our income statement. Accumulated other comprehensive income or loss is separately presented on our balance sheet as part of common shareholders’ equity. Other comprehensive (loss)/income attributable to PepsiCo was $(5,542) million in 2014 , $360 million in 2013 and $742 million in 2012 . The accumulated balances for each component of other comprehensive loss attributable to PepsiCo are as follows: 2014 2013 2012 Currency translation adjustment (a) $ (8,255 ) $ (3,247 ) $ (1,946 ) Cash flow hedges, net of tax 34 (76 ) (94 ) Unamortized pension and retiree medical, net of tax (b) (2,500 ) (1,861 ) (3,491 ) Unrealized gain on securities, net of tax 87 93 64 Other (35 ) (36 ) (20 ) Accumulated other comprehensive loss attributable to PepsiCo $ (10,669 ) $ (5,127 ) $ (5,487 ) (a) The change from 2013 to 2014 primarily reflects depreciation of the Russian ruble. (b) Net of taxes of $1,260 million in 2014 , $945 million in 2013 and $1,832 million in 2012 .
Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]	The following table summarizes the reclassifications from Accumulated Other Comprehensive Loss to the Consolidated Statement of Income for the years ended December 27, 2014 and December 28, 2013 : 2014 2013 Amount Reclassified from Accumulated Other Comprehensive Loss Affected Line Item in the Consolidated Statement of Income (Gains)/Losses on cash flow hedges: Foreign exchange contracts $ (16 ) $ — Cost of sales Interest rate derivatives 233 3 Interest expense Commodity contracts 31 44 Cost of sales Commodity contracts 1 (2 ) Selling, general and administrative expenses Net losses before tax 249 45 Tax amounts (95 ) (17 ) Net losses after tax $ 154 $ 28 Pension and retiree medical items: Amortization of net prior service credit (a) $ (6 ) $ (2 ) Amortization of net actuarial losses (a) 226 357 Settlement/curtailment (a) 149 (2 ) Net losses before tax 369 353 Tax amounts (122 ) (123 ) Net losses after tax 247 230 Total net losses reclassified for the period, net of tax $ 401 $ 258 (a) These items are included in the components of net periodic benefit cost for pension and retiree medical plans (see Note 7 for additional details).

Supplemental Financial Inform35

Supplemental Financial Information (Tables)	12 Months Ended
	Dec. 27, 2014
Supplemental Financial Information [Abstract]
Additional Financial Information Disclosure [Text Block]	Supplemental Financial Information Supplemental information for accounts and notes receivable and inventories is summarized as follows: 2014 2013 2012 Accounts and notes receivable Trade receivables $ 5,817 $ 6,178 Other receivables 971 921 6,788 7,099 Allowance, beginning of year 145 157 $ 157 Net amounts charged to expense 38 29 28 Deductions (a) (27 ) (34 ) (27 ) Other (b) (19 ) (7 ) (1 ) Allowance, end of year 137 145 $ 157 Net receivables $ 6,651 $ 6,954 Inventories (c) Raw materials $ 1,593 $ 1,732 Work-in-process 173 168 Finished goods 1,377 1,509 $ 3,143 $ 3,409 (a) Includes accounts written off. (b) Includes adjustments related to acquisitions and divestitures, currency translation and other adjustments. (c) Approximately 3% of the inventory cost in both 2014 and 2013 was computed using the LIFO method. The differences between LIFO and FIFO methods of valuing these inventories were not material. Supplemental information for other assets and accounts payable and other current liabilities is summarized as follows: 2014 2013 Other assets Noncurrent notes and accounts receivable $ 93 $ 105 Deferred marketplace spending 179 214 Pension plans (a) 141 687 Other 447 419 $ 860 $ 1,425 Accounts payable and other current liabilities Accounts payable $ 5,127 $ 4,874 Accrued marketplace spending 2,222 2,245 Accrued compensation and benefits 1,746 1,789 Dividends payable 1,009 899 Other current liabilities 2,912 2,726 $ 13,016 $ 12,533 (a) See Note 7 for additional information regarding our pension plans. The following table summarizes other supplemental information: 2014 2013 2012 Other supplemental information Rent expense $ 707 $ 639 $ 581 Interest paid $ 925 $ 1,007 $ 1,074 Income taxes paid, net of refunds $ 1,847 $ 3,076 $ 1,840
Schedule of Accounts and Notes Receivables and Inventories [Table Text Block] [Table Text Block]	Supplemental Financial Information Supplemental information for accounts and notes receivable and inventories is summarized as follows: 2014 2013 2012 Accounts and notes receivable Trade receivables $ 5,817 $ 6,178 Other receivables 971 921 6,788 7,099 Allowance, beginning of year 145 157 $ 157 Net amounts charged to expense 38 29 28 Deductions (a) (27 ) (34 ) (27 ) Other (b) (19 ) (7 ) (1 ) Allowance, end of year 137 145 $ 157 Net receivables $ 6,651 $ 6,954 Inventories (c) Raw materials $ 1,593 $ 1,732 Work-in-process 173 168 Finished goods 1,377 1,509 $ 3,143 $ 3,409 (a) Includes accounts written off. (b) Includes adjustments related to acquisitions and divestitures, currency translation and other adjustments. (c) Approximately 3% of the inventory cost in both 2014 and 2013 was computed using the LIFO method. The differences between LIFO and FIFO methods of valuing these inventories were not material.
Schedule Of Supplemental Balance Sheet Information	Supplemental information for other assets and accounts payable and other current liabilities is summarized as follows: 2014 2013 Other assets Noncurrent notes and accounts receivable $ 93 $ 105 Deferred marketplace spending 179 214 Pension plans (a) 141 687 Other 447 419 $ 860 $ 1,425 Accounts payable and other current liabilities Accounts payable $ 5,127 $ 4,874 Accrued marketplace spending 2,222 2,245 Accrued compensation and benefits 1,746 1,789 Dividends payable 1,009 899 Other current liabilities 2,912 2,726 $ 13,016 $ 12,533 (a) See Note 7 for additional information regarding our pension plans.
Schedule Of Other Supplemental Information	The following table summarizes other supplemental information: 2014 2013 2012 Other supplemental information Rent expense $ 707 $ 639 $ 581 Interest paid $ 925 $ 1,007 $ 1,074 Income taxes paid, net of refunds $ 1,847 $ 3,076 $ 1,840

Basis of Presentation and Our36

Basis of Presentation and Our Divisions (Narrative) (Details) $ in Millions		12 Months Ended
		Dec. 27, 2014USD ($)country	Dec. 28, 2013USD ($)	Dec. 29, 2012USD ($)
Basis Of Presentation And Our Divisions [Line Items]
Operating Profit		$ 9,581	$ 9,705	$ 9,112
Manufacture and sell in (number of countries) | country		200
Corporate Unallocated Pension Lump Sum Settlement Charges [Domain]
Basis Of Presentation And Our Divisions [Line Items]
Operating Profit		$ (141,000)	0	(195,000)
FLNA
Basis Of Presentation And Our Divisions [Line Items]
Operating Profit	[1]	$ 4,054	3,877	3,646
Stock-based compensation percentage		15.00%
QFNA
Basis Of Presentation And Our Divisions [Line Items]
Operating Profit	[1]	$ 621	617	695
Stock-based compensation percentage		2.00%
NAB
Basis Of Presentation And Our Divisions [Line Items]
Operating Profit	[1]	$ 2,421	2,580	2,569
Stock-based compensation percentage		23.00%
Latin America
Basis Of Presentation And Our Divisions [Line Items]
Operating Profit	[1]	$ 1,636	1,617	1,427
Stock-based compensation percentage		7.00%
ESSA
Basis Of Presentation And Our Divisions [Line Items]
Operating Profit	[1]	$ 1,389	1,327	1,361
Stock-based compensation percentage		13.00%
AMENA
Basis Of Presentation And Our Divisions [Line Items]
Operating Profit	[1]	$ 985	$ 1,140	$ 716
Stock-based compensation percentage		10.00%
Corporate Unallocated
Basis Of Presentation And Our Divisions [Line Items]
Stock-based compensation percentage		30.00%
Maximum
Basis Of Presentation And Our Divisions [Line Items]
Ownership percentage of certain other affiliates		50.00%
[1]	For information on the impact of restructuring and impairment charges on our divisions, see Note 3 to our consolidated financial statements. See also Note 15 to our consolidated financial statements for more information on our transaction with Tingyi and refranchising of our beverage business in Vietnam in our AMENA segment.

Basis of Presentation and Our37

Basis of Presentation and Our Divisions (Schedule of Quarterly Reporting) (Details)	3 Months Ended			4 Months Ended
	Sep. 06, 2014	Jun. 14, 2014	Mar. 22, 2014	Dec. 27, 2014
U.S. and Canada
Segment Reporting Information [Line Items]
Quarterly reporting calendar, period	P12W	P12W	P12W	P16W
International Divisions
Segment Reporting Information [Line Items]
Quarterly reporting calendar, period	June, July and August	March, April and May	January, February	September, October, November and December

Basis of Presentation and Our38

Basis of Presentation and Our Divisions (Schedule of Segment Reporting Information, by Segment) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Segment Reporting Information [Line Items]
Net Revenue		$ 66,683	$ 66,415	$ 65,492
Operating Profit		9,581	9,705	9,112
FLNA
Segment Reporting Information [Line Items]
Net Revenue		14,502	14,126	13,574
Operating Profit	[1]	$ 4,054	3,877	3,646
Net Revenue, Percentage		22.00%
Operating Profit, Percentage		36.00%
QFNA
Segment Reporting Information [Line Items]
Net Revenue		$ 2,568	2,612	2,636
Operating Profit	[1]	$ 621	617	695
Net Revenue, Percentage		4.00%
Operating Profit, Percentage		6.00%
NAB
Segment Reporting Information [Line Items]
Net Revenue		$ 20,171	20,083	20,428
Operating Profit	[1]	$ 2,421	2,580	2,569
Net Revenue, Percentage		32.00%
Operating Profit, Percentage		26.00%
Latin America
Segment Reporting Information [Line Items]
Net Revenue		$ 9,425	9,335	8,761
Operating Profit	[1]	$ 1,636	1,617	1,427
Net Revenue, Percentage		12.00%
Operating Profit, Percentage		11.00%
ESSA
Segment Reporting Information [Line Items]
Net Revenue		$ 13,399	13,828	13,506
Operating Profit	[1]	$ 1,389	1,327	1,361
Net Revenue, Percentage		20.00%
Operating Profit, Percentage		12.00%
AMENA
Segment Reporting Information [Line Items]
Net Revenue		$ 6,618	6,431	6,587
Operating Profit	[1]	$ 985	1,140	716
Net Revenue, Percentage		10.00%
Operating Profit, Percentage		9.00%
Total Division
Segment Reporting Information [Line Items]
Operating Profit	[1]	$ 11,106	11,158	10,414
Corporate Unallocated Mark-To-Market Net Impact Gains (Losses)
Segment Reporting Information [Line Items]
Operating Profit		(68,000)	(72,000)	65,000
Corporate Unallocated Restructuring and Impairment Charges
Segment Reporting Information [Line Items]
Operating Profit		(41,000)	(11,000)	(10,000)
Corporate Unallocated Pension Lump Sum Settlement Charges [Domain]
Segment Reporting Information [Line Items]
Operating Profit		(141,000)	0	(195,000)
Corporate Unallocated Venezuela Currency Devaluation
Segment Reporting Information [Line Items]
Operating Profit		(126,000)	(124,000)	0
Corporate Unallocated Other
Segment Reporting Information [Line Items]
Operating Profit		$ (1,149,000)	$ (1,246,000)	$ (1,162,000)
[1]	For information on the impact of restructuring and impairment charges on our divisions, see Note 3 to our consolidated financial statements. See also Note 15 to our consolidated financial statements for more information on our transaction with Tingyi and refranchising of our beverage business in Vietnam in our AMENA segment.

Basis of Presentation and Our39

Basis of Presentation and Our Divisions (Segment Reporting Information by Total Assets and Capital Spending) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Segment Reporting Information [Line Items]
Total Assets		$ 70,509	$ 77,478
Capital Spending		2,859	2,795	$ 2,714
FLNA
Segment Reporting Information [Line Items]
Total Assets		5,307	5,308
Capital Spending		$ 519	423	365
Total Assets , Percentage		8.00%
Capital Spending, Percentage		18.00%
QFNA
Segment Reporting Information [Line Items]
Total Assets		$ 982	983
Capital Spending		$ 58	38	37
Total Assets , Percentage		1.00%
Capital Spending, Percentage		2.00%
NAB
Segment Reporting Information [Line Items]
Total Assets		$ 28,665	29,176
Capital Spending		$ 708	705	681
Total Assets , Percentage		43.00%
Capital Spending, Percentage		25.00%
Latin America
Segment Reporting Information [Line Items]
Total Assets		$ 6,283	6,003
Capital Spending		$ 379	395	457
Total Assets , Percentage		7.00%
Capital Spending, Percentage		13.00%
ESSA
Segment Reporting Information [Line Items]
Total Assets	[1]	$ 13,934	18,725
Capital Spending		$ 502	551	576
Total Assets , Percentage		20.00%
Capital Spending, Percentage		18.00%
AMENA
Segment Reporting Information [Line Items]
Total Assets		$ 5,855	5,731
Capital Spending		$ 517	530	509
Total Assets , Percentage		8.00%
Capital Spending, Percentage		18.00%
Total Division
Segment Reporting Information [Line Items]
Total Assets		$ 61,026	65,926
Capital Spending		2,683	2,642	2,625
Corporate
Segment Reporting Information [Line Items]
Total Assets	[2]	9,483	11,552
Capital Spending	[2]	$ 176	153	89
Total Assets , Percentage		13.00%
Capital Spending, Percentage		6.00%
Total, Capital Spending [Member]
Segment Reporting Information [Line Items]
Capital Spending		$ 2,859	$ 2,795	$ 2,714
[1]	The change in total assets in 2014 primarily reflects the depreciation of the Russian ruble.
[2]	Corporate assets consist principally of cash and cash equivalents, short-term investments, derivative instruments, property, plant and equipment and certain pension and tax assets. In 2014, the change in total Corporate assets was primarily due to the decrease in cash and cash equivalents and certain pension assets, partially offset by an increase in short-term investments.

Basis of Presentation and Our40

Basis of Presentation and Our Divisions (Segment Reporting Information by Amortization of Intangible Assets and Depreciation and Other Amortization) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Segment Reporting Information [Line Items]
Amortization of Intangible Assets	$ 92	$ 110	$ 119
Depreciation and Other Amortization	2,533	2,553	2,570
FLNA
Segment Reporting Information [Line Items]
Amortization of Intangible Assets	7	7	7
Depreciation and Other Amortization	424	430	445
QFNA
Segment Reporting Information [Line Items]
Depreciation and Other Amortization	51	51	53
NAB
Segment Reporting Information [Line Items]
Amortization of Intangible Assets	43	55	55
Depreciation and Other Amortization	837	843	842
Latin America
Segment Reporting Information [Line Items]
Amortization of Intangible Assets	10	11	14
Depreciation and Other Amortization	273	273	261
ESSA
Segment Reporting Information [Line Items]
Amortization of Intangible Assets	28	32	36
Depreciation and Other Amortization	471	525	522
AMENA
Segment Reporting Information [Line Items]
Amortization of Intangible Assets	4	5	7
Depreciation and Other Amortization	313	283	305
Total Division
Segment Reporting Information [Line Items]
Amortization of Intangible Assets	92	110	119
Depreciation and Other Amortization	2,369	2,405	2,428
Corporate
Segment Reporting Information [Line Items]
Depreciation and Other Amortization	$ 164	$ 148	$ 142

Basis of Presentation and Our41

Basis of Presentation and Our Divisions (Segment Reporting Information by Net Revenue and Long-Lived Assets) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Segment Reporting Information [Line Items]
Net Revenue		$ 66,683	$ 66,415	$ 65,492
Long-Lived Assets	[1]	48,986	53,850
United States
Segment Reporting Information [Line Items]
Net Revenue		34,219	33,626	33,348
Long-Lived Assets	[1]	$ 27,964	28,157
Net Revenue, Percentage		51.00%
Long-Lived Assets, Percentage		57.00%
Russia
Segment Reporting Information [Line Items]
Net Revenue		$ 4,414	4,908	4,861
Long-Lived Assets	[1],[2]	$ 4,520	7,922
Net Revenue, Percentage		7.00%
Long-Lived Assets, Percentage		9.00%
Mexico
Segment Reporting Information [Line Items]
Net Revenue		$ 4,113	4,347	3,955
Long-Lived Assets	[1]	$ 1,126	1,233
Net Revenue, Percentage		6.00%
Long-Lived Assets, Percentage		2.00%
Canada
Segment Reporting Information [Line Items]
Net Revenue		$ 3,022	3,195	3,290
Long-Lived Assets	[1]	$ 2,815	3,067
Net Revenue, Percentage		5.00%
Long-Lived Assets, Percentage		6.00%
United Kingdom
Segment Reporting Information [Line Items]
Net Revenue		$ 2,174	2,115	2,102
Long-Lived Assets	[1]	$ 1,155	1,219
Net Revenue, Percentage		3.00%
Long-Lived Assets, Percentage		2.00%
Brazil
Segment Reporting Information [Line Items]
Net Revenue		$ 1,790	1,835	1,866
Long-Lived Assets	[1]	$ 928	1,005
Net Revenue, Percentage		3.00%
Long-Lived Assets, Percentage		2.00%
All Other Countries
Segment Reporting Information [Line Items]
Net Revenue		$ 16,951	16,389	$ 16,070
Long-Lived Assets	[1]	$ 10,478	$ 11,247
Net Revenue, Percentage		25.00%
Long-Lived Assets, Percentage		22.00%
[1]	Long-lived assets represent property, plant and equipment, nonamortizable intangible assets, amortizable intangible assets and investments in noncontrolled affiliates. These assets are reported in the country where they are primarily used.
[2]	Change in long-lived assets in 2014 primarily reflects the depreciation of the Russian ruble.

Our Significant Accounting Po42

Our Significant Accounting Policies (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Property, Plant and Equipment [Line Items]
Sales Allowances, Goods	$ 35,800	$ 34,700	$ 34,700
Research and Development Expense	718	665	552
Software amortization	208	197	196
Net capitalized software and development costs	900	1,100
Marketing and Advertising Expense	$ 3,900	$ 3,900	$ 3,700
Minimum | Software
Property, Plant and Equipment [Line Items]
Software estimated useful lives	5 years
Maximum | Software
Property, Plant and Equipment [Line Items]
Software estimated useful lives	10 years

Our Significant Accounting Po43

Our Significant Accounting Policies (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Accounting Policies [Abstract]
Capitalized Computer Software, Amortization	$ 208	$ 197	$ 196
Sales Allowances, Goods	35,800	34,700	34,700
Shipping and handling expenses	9,700	9,400	9,100
Research and development costs	718	665	552
Amount of prepaid incentive arrangements	355	410
Advertising and other marketing activities	3,900	3,900	3,700
Advertising expenses	2,300	2,400	$ 2,200
Deferred advertising costs	42	68
Capitalized Computer Software, Net	$ 900	$ 1,100

Our Significant Accounting Po44

Our Significant Accounting Policies (Concentration of Credit Risk) (Details)	12 Months Ended
	Dec. 27, 2014
Customer Concentration Risk | Wal-Mart | Revenue, Net
Concentration Risk [Line Items]
Concentration risk, percentage	12.00%

Restructuring, Impairment and45

Restructuring, Impairment and Integration Charges (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions		12 Months Ended
		Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Restructuring Cost and Reserve [Line Items]
Merger and integration charges		$ 0	$ 10	$ 16
Productivity Plan
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions			110
2014 Productivity Plan
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		357	53
Restructuring and impairment provisions, after tax		$ 262	$ 39
Restructuring and impairment provisions, after-tax impact per share		$ 0.17	$ 0.02
2014 Productivity Plan | Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions	[1]	$ 33	$ 13
Productivity Plan
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		61	110	279
Restructuring and impairment provisions, after tax		$ 54	$ 90	$ 215
Restructuring and impairment provisions, after-tax impact per share		$ 0.04	$ 0.06	$ 0.14
Productivity Plan | Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions	[1]	$ 8	$ (2)
[1]	Income amount represents adjustments of previously recorded amounts.

Restructuring, Impairment and46

Restructuring, Impairment and Integration Charges Restructuring, Impairment, Integration Charges (Summary of 2014 Productivity Plan Charges) (Details) - USD ($) $ / shares in Units, $ in Millions		12 Months Ended
		Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Restructuring Cost and Reserve [Line Items]
Cash payments		$ (266)	$ (133)	$ (343)
Restructuring Reserve			30
2014 Productivity Plan
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		357	53
Cash payments		(165)
Non-cash charges		(110)	(22)
Restructuring Reserve		113	31
Restructuring and impairment provisions, after tax		$ 262	$ 39
Restructuring and impairment provisions, after-tax impact per share		$ 0.17	$ 0.02
2014 Productivity Plan | Severance And Other Employee Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		$ 148	$ 52
Cash payments		(56)
Non-cash charges		(33)	(22)
Restructuring Reserve		89
2014 Productivity Plan | Asset Impairments
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		73	0
Cash payments		0
Non-cash charges		(73)
Restructuring Reserve		0	0
2014 Productivity Plan | Other Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		136	1
Cash payments		(109)
Non-cash charges		(4)	0
Restructuring Reserve		24	1
2014 Productivity Plan | FLNA
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		46	11
2014 Productivity Plan | FLNA | Severance And Other Employee Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		25	11
2014 Productivity Plan | FLNA | Asset Impairments
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		10
2014 Productivity Plan | FLNA | Other Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		11	0
2014 Productivity Plan | QFNA
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		14	3
2014 Productivity Plan | QFNA | Severance And Other Employee Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		12	3
2014 Productivity Plan | QFNA | Asset Impairments
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		0
2014 Productivity Plan | QFNA | Other Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		2	0
2014 Productivity Plan | NAB
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		172	9
2014 Productivity Plan | NAB | Severance And Other Employee Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		60	9
2014 Productivity Plan | NAB | Asset Impairments
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		56
2014 Productivity Plan | NAB | Other Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		56	0
2014 Productivity Plan | Latin America
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		28	6
2014 Productivity Plan | Latin America | Severance And Other Employee Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		15	6
2014 Productivity Plan | Latin America | Asset Impairments
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		3
2014 Productivity Plan | Latin America | Other Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		10	0
2014 Productivity Plan | ESSA
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		42	10
2014 Productivity Plan | ESSA | Severance And Other Employee Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		24	10
2014 Productivity Plan | ESSA | Asset Impairments
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		4
2014 Productivity Plan | ESSA | Other Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		14	0
2014 Productivity Plan | AMENA
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		22	1
2014 Productivity Plan | AMENA | Severance And Other Employee Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		14	1
2014 Productivity Plan | AMENA | Asset Impairments
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		0
2014 Productivity Plan | AMENA | Other Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		8	0
2014 Productivity Plan | Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions	[1]	33	13
2014 Productivity Plan | Corporate | Severance And Other Employee Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions	[1]	(2)	12
2014 Productivity Plan | Corporate | Asset Impairments
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions	[1]	0
2014 Productivity Plan | Corporate | Other Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions	[1]	$ 35	$ 1
[1]	Income amount represents adjustments of previously recorded amounts.

Restructuring, Impairment and47

Restructuring, Impairment and Integration Charges (Summary of Productivity Plan Charges) (Details) - Productivity Plan - USD ($) $ / shares in Units, $ in Millions		12 Months Ended
		Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		$ 61	$ 110	$ 279
Restructuring, Settlement and Impairment Provisions, Net of Tax		$ 54	$ 90	$ 215
Restructuring and impairment provisions, after-tax impact per share		$ 0.04	$ 0.06	$ 0.14
Severance And Other Employee Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		$ 31	$ 74	$ 89
Asset Impairments
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		6	6	75
Other Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		24	30	115
FLNA
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		2	8	38
FLNA | Severance And Other Employee Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		(1)	4	14
FLNA | Asset Impairments
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		0	0	8
FLNA | Other Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		3	4	16
QFNA
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		0	1	9
QFNA | Severance And Other Employee Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		0	0	0
QFNA | Asset Impairments
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		0	0	0
QFNA | Other Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		0	1	9
NAB
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		7	21	88
NAB | Severance And Other Employee Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		(3)	8	27
NAB | Asset Impairments
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		1	0	43
NAB | Other Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		9	13	18
Latin America
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		0	7
Latin America | Severance And Other Employee Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		19	5	22
Latin America | Asset Impairments
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		0	2	8
Latin America | Other Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		(19)	0
ESSA
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		29	50	42
ESSA | Severance And Other Employee Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		6	36	14
ESSA | Asset Impairments
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		5	2	16
ESSA | Other Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		18	12	12
AMENA
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		15	25	28
AMENA | Severance And Other Employee Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		12	21	18
AMENA | Asset Impairments
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		0	2	0
AMENA | Other Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions		3	2	10
Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions	[1]	8	(2)
Corporate | Severance And Other Employee Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions	[1]	(2)	0	(6)
Corporate | Asset Impairments
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions	[1]	0	0	$ 0
Corporate | Other Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions	[1]	$ 10	$ (2)
[1]	Income amount represents adjustments of previously recorded amounts.

Restructuring, Impairment and48

Restructuring, Impairment and Integration Charges (Summary of Productivity Plan Activity) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Restructuring Reserve [Roll Forward]
Liability at beginning of period	$ 30
Cash payments for restructuring charges	(266)	$ (133)	$ (343)
Liability at end of period		30
2014 Productivity Plan
Restructuring Reserve [Roll Forward]
Liability at beginning of period	31
Restructuring, Settlement and Impairment Provisions	357	53
Cash payments for restructuring charges	(165)
Non-cash charges	(110)	(22)
Liability at end of period	113	31
2014 Productivity Plan | Severance And Other Employee Costs
Restructuring Reserve [Roll Forward]
Restructuring, Settlement and Impairment Provisions	148	52
Cash payments for restructuring charges	(56)
Non-cash charges	(33)	(22)
Liability at end of period	89
2014 Productivity Plan | Asset Impairments
Restructuring Reserve [Roll Forward]
Liability at beginning of period	0
Restructuring, Settlement and Impairment Provisions	73	0
Cash payments for restructuring charges	0
Non-cash charges	(73)
Liability at end of period	0	0
2014 Productivity Plan | Other Costs
Restructuring Reserve [Roll Forward]
Liability at beginning of period	1
Restructuring, Settlement and Impairment Provisions	136	1
Cash payments for restructuring charges	(109)
Non-cash charges	(4)	0
Liability at end of period	24	1
Productivity Plan
Restructuring Reserve [Roll Forward]
Liability at beginning of period	85	127	276
Restructuring, Settlement and Impairment Provisions	61	110	279
Cash payments for restructuring charges	(101)	(133)	(343)
Non-cash charges	(12)	(19)	(85)
Liability at end of period	33	85	127
Productivity Plan | Severance And Other Employee Costs
Restructuring Reserve [Roll Forward]
Liability at beginning of period	68	91	249
Restructuring, Settlement and Impairment Provisions	31	74	89
Cash payments for restructuring charges	(65)	(89)	(239)
Non-cash charges	(6)	(8)	(8)
Liability at end of period	28	68	91
Productivity Plan | Asset Impairments
Restructuring Reserve [Roll Forward]
Restructuring, Settlement and Impairment Provisions	6	6	75
Cash payments for restructuring charges	0
Non-cash charges	(6)	(6)	(75)
Productivity Plan | Other Costs
Restructuring Reserve [Roll Forward]
Liability at beginning of period	17	36	27
Restructuring, Settlement and Impairment Provisions	24	30	115
Cash payments for restructuring charges	(36)	(44)	(104)
Non-cash charges	0	(5)	(2)
Liability at end of period	$ 5	$ 17	$ 36

Restructuring, Impairment and49

Restructuring, Impairment and Integration Charges (Schedule of Merger and Integration Activity) (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Restructuring Cost and Reserve [Line Items]
Other Restructuring Costs	$ 67
Other Restructuring Costs, Net of Tax	$ 54
Other Restructuring Costs, Net of Tax, Per Share Amount	$ 0.04
Restructuring Reserve [Roll Forward]
Merger and integration charges	$ 0	$ 10	$ 16
Cash payments	0	$ (25)	$ (83)
Latin America
Restructuring Cost and Reserve [Line Items]
Other Restructuring Costs	11
ESSA
Restructuring Cost and Reserve [Line Items]
Other Restructuring Costs	26
AMENA
Restructuring Cost and Reserve [Line Items]
Other Restructuring Costs	$ 30

Property, Plant and Equipment50

Property, Plant and Equipment and Intangible Assets (Schedule of Property, Plant and Equipment and Intangible Assets) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Property, plant and equipment, net:
Property, plant and equipment, gross	$ 36,300	$ 36,961
Accumulated depreciation	(19,056)	(18,386)
Property, Plant and Equipment, net	17,244	18,575
Depreciation	2,441	2,472	$ 2,489
Amortizable intangible assets, net:
Amortizable intangible assets, gross	2,942	3,104
Accumulated amortization	(1,493)	(1,466)
Amortizable intangible assets, net	1,449	1,638
Amortization of intangible assets	92	110	$ 119
Land Improvements [Member]
Property, plant and equipment, net:
Property, plant and equipment, gross	$ 1,288	1,340
Land [Member] | Minimum
Property, plant and equipment, net:
Average Useful Life (Years)	0 years
Land [Member] | Maximum
Property, plant and equipment, net:
Average Useful Life (Years)	0 years
Buildings And Improvements
Property, plant and equipment, net:
Property, plant and equipment, gross	$ 8,114	8,375
Buildings And Improvements | Minimum
Property, plant and equipment, net:
Average Useful Life (Years)	15 years
Buildings And Improvements | Maximum
Property, plant and equipment, net:
Average Useful Life (Years)	44 years
Machinery And Equipment, Including Fleet And Software
Property, plant and equipment, net:
Property, plant and equipment, gross	$ 25,146	25,415
Machinery And Equipment, Including Fleet And Software | Minimum
Property, plant and equipment, net:
Average Useful Life (Years)	5 years
Machinery And Equipment, Including Fleet And Software | Maximum
Property, plant and equipment, net:
Average Useful Life (Years)	15 years
Construction In Progress
Property, plant and equipment, net:
Property, plant and equipment, gross	$ 1,752	1,831
Acquired Franchise Rights
Amortizable intangible assets, net:
Amortizable intangible assets, gross	879	910
Accumulated amortization	(89)	(83)
Amortizable intangible assets, net	$ 790	827
Acquired Franchise Rights | Minimum
Amortizable intangible assets, net:
Average Useful Life (Years)	56 years
Acquired Franchise Rights | Maximum
Amortizable intangible assets, net:
Average Useful Life (Years)	60 years
Reacquired Franchise Rights
Amortizable intangible assets, net:
Amortizable intangible assets, gross	$ 107	108
Accumulated amortization	(95)	(86)
Amortizable intangible assets, net	$ 12	22
Reacquired Franchise Rights | Minimum
Amortizable intangible assets, net:
Average Useful Life (Years)	5 years
Reacquired Franchise Rights | Maximum
Amortizable intangible assets, net:
Average Useful Life (Years)	14 years
Brands
Amortizable intangible assets, net:
Amortizable intangible assets, gross	$ 1,361	1,400
Accumulated amortization	(1,004)	(996)
Amortizable intangible assets, net	$ 357	404
Brands | Minimum
Amortizable intangible assets, net:
Average Useful Life (Years)	20 years
Brands | Maximum
Amortizable intangible assets, net:
Average Useful Life (Years)	40 years
Other Identifiable Intangibles
Amortizable intangible assets, net:
Amortizable intangible assets, gross	$ 595	686
Accumulated amortization	(305)	(301)
Amortizable intangible assets, net	$ 290	385
Other Identifiable Intangibles | Minimum
Amortizable intangible assets, net:
Average Useful Life (Years)	10 years
Other Identifiable Intangibles | Maximum
Amortizable intangible assets, net:
Average Useful Life (Years)	24 years
ESSA
Amortizable intangible assets, net:
Amortization of intangible assets	$ 28	32	$ 36
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)	$ 23	$ 0	$ 23

Property, Plant and Equipment51

Property, Plant and Equipment and Intangible Assets (Future Amortization) (Details) $ in Millions	Dec. 27, 2014USD ($)
Property, Plant And Equipment And Intangible Assets [Abstract]
2,014	$ 82
2,015	74
2,016	68
2,017	66
2,018	$ 63

Property, Plant and Equipment52

Property, Plant and Equipment and Intangible Assets (Schedule of Change in Book Value of Nonamortizable Intangible Assets) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2014		Dec. 28, 2013	Dec. 29, 2012
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	$ 31,014		$ 31,715
Acquisitions/(Divestitures)			9
Translation and Other	(3,410)		(710)
Balance, Ending	27,604		31,014	$ 31,715
FLNA
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	334		347
Acquisitions/(Divestitures)			0
Translation and Other	(16)		(13)
Balance, Ending	318		334	347
NAB
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	18,834		18,949
Acquisitions/(Divestitures)			13
Translation and Other	(149)		(128)
Balance, Ending	18,685		18,834	18,949
Latin America
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	953		1,041
Acquisitions/(Divestitures)			0
Translation and Other	(86)		(88)
Balance, Ending	867		953	1,041
ESSA
Property, Plant and Equipment [Line Items]
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)	23		0	23
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	10,088		10,493
Acquisitions/(Divestitures)			0
Translation and Other	(3,116)	[1]	(405)
Balance, Ending	6,972		10,088	10,493
AMENA
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	630		710
Acquisitions/(Divestitures)			(4)
Translation and Other	(43)		(76)
Balance, Ending	587		630	710
Goodwill
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	16,613		16,971
Acquisitions/(Divestitures)			1
Translation and Other	(1,648)		(359)
Balance, Ending	14,965		16,613	16,971
Goodwill | FLNA
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	305		316
Translation and Other	(14)		(11)
Balance, Ending	291		305	316
Goodwill | QFNA
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	175		175
Acquisitions/(Divestitures)			0
Translation and Other	0		0
Balance, Ending	175		175	175
Goodwill | NAB
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	9,894		9,931
Acquisitions/(Divestitures)			5
Translation and Other	(48)		(42)
Balance, Ending	9,846		9,894	9,931
Goodwill | Latin America
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	709		773
Translation and Other	(65)		(64)
Balance, Ending	644		709	773
Goodwill | ESSA
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	5,027		5,214
Translation and Other	(1,488)	[1]	(187)
Balance, Ending	3,539		5,027	5,214
Goodwill | AMENA
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	503		562
Acquisitions/(Divestitures)			(4)
Translation and Other	(33)		(55)
Balance, Ending	470		503	562
Reacquired Franchise Rights
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	8,041		8,109
Acquisitions/(Divestitures)			16
Translation and Other	(277)		(84)
Balance, Ending	7,764		8,041	8,109
Reacquired Franchise Rights | NAB
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	7,281		7,337
Acquisitions/(Divestitures)			16
Translation and Other	(88)		(72)
Balance, Ending	7,193		7,281	7,337
Reacquired Franchise Rights | ESSA
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	760		772
Translation and Other	(189)	[1]	(12)
Balance, Ending	571		760	772
Acquired Franchise Rights
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	1,781		1,796
Acquisitions/(Divestitures)			(8)
Translation and Other	(44)		(7)
Balance, Ending	1,737		1,781	1,796
Acquired Franchise Rights | NAB
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	1,551		1,573
Acquisitions/(Divestitures)			(8)
Translation and Other	(13)		(14)
Balance, Ending	1,538		1,551	1,573
Acquired Franchise Rights | ESSA
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	230		223
Translation and Other	(31)	[1]	7
Balance, Ending	199		230	223
Brands
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	4,579		4,839
Translation and Other	(1,441)		(260)
Balance, Ending	3,138		4,579	4,839
Brands | FLNA
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	29		31
Translation and Other	(2)		(2)
Balance, Ending	27		29	31
Brands | NAB
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	108		108
Balance, Ending	108		108	108
Brands | Latin America
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	244		268
Translation and Other	(21)		(24)
Balance, Ending	223		244	268
Brands | ESSA
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	4,071		4,284
Translation and Other	(1,408)	[1]	(213)
Balance, Ending	2,663		4,071	4,284
Brands | AMENA
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	127		148
Translation and Other	(10)		(21)
Balance, Ending	$ 117		$ 127	$ 148
[1]	The change in 2014 primarily reflects the depreciation of the Russian ruble.

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended	4 Months Ended		12 Months Ended
	Mar. 24, 2012	Dec. 28, 2013	Dec. 29, 2012	Dec. 27, 2014	Dec. 28, 2013
Income Tax Contingency [Line Items]
Deferred Tax Liabilities, Compensation and Benefits, Pensions		$ 84			$ 84
Provision for income taxes			$ 217
Prescription drug benefit subsidy, income tax benefit	$ 55
Total gross amount of reserves for income taxes				$ 1,587
Interest accrued		164		141	164
Interest accrued recognized				31	36
Operating loss carryforwards				10,400
Income tax undistributed international earnings				37,800
Expire in 2015
Income Tax Contingency [Line Items]
Operating loss carryforwards				100
Expire Between 2016 and 2034 Years
Income Tax Contingency [Line Items]
Operating loss carryforwards				9,800
Carried Forward Indefinitely
Income Tax Contingency [Line Items]
Operating loss carryforwards				$ 500
Tax Settlement, Years 2003-2009
Income Tax Contingency [Line Items]
Income Taxes Paid		758
Provision for income taxes		$ 209
Open Tax Years
Income Tax Contingency [Line Items]
Income Taxes Paid					$ 226

Income Taxes (Income Taxes) (De

Income Taxes (Income Taxes) (Details) - USD ($) $ in Millions	4 Months Ended		12 Months Ended
	Dec. 28, 2013	Dec. 29, 2012	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Income Tax Contingency [Line Items]
Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range Not Possible			300
Deferred Tax Liabilities, Compensation and Benefits, Pensions							$ 84
Income before income taxes in U.S			$ 2,557	$ 3,078	$ 3,234
Income before income taxes in Foreign			6,200	5,813	5,070
Income before income taxes			8,757	8,891	8,304
Provision for income taxes
Current: U.S. Federal			1,364	1,092	911
Current: Foreign			851	807	940
Current: State			210	124	153
Provision for income taxes, Current total			2,425	2,023	2,004
Deferred: U.S. Federal			(33)	87	154
Deferred: Foreign			(60)	11	(95)
Deferred: State			(133)	(17)	27
Provision for income taxes, Deferred total			(226)	81	86
Provision for income taxes			$ 2,199	$ 2,104	$ 2,090
U.S. Federal statutory tax rate
U.S. Federal statutory tax rate			35.00%	35.00%	35.00%
State income tax, net of U.S. Federal tax benefit			0.60%	1.20%	1.40%
Lower taxes on foreign results			(8.60%)	(8.80%)	(6.90%)
Tax benefits			0.00%	(2.40%)	(2.60%)
Other, net			(1.90%)	(1.30%)	(1.70%)
Annual tax rate			25.10%	23.70%	25.20%
Deferred tax liabilities
Debt guarantee of wholly owned subsidiary						$ 842	828
Property, plant and equipment						2,174	2,327
Intangible assets other than nondeductible goodwill						4,068	4,348
Other						264	361
Gross deferred tax liabilities						7,348	7,948
Deferred tax assets
Net carryforwards						1,329	1,485
Stock-based compensation						265	303
Retiree medical benefits						388	384
Other employee-related benefits						646	627
Pension benefits						263
Deductible state tax and interest benefits						158	155
Long-term debt obligations acquired						98	125
Other						1,002	959
Gross deferred tax assets						4,149	4,038
Valuation allowances	$ 1,360	$ 1,233	$ 1,360	$ 1,233	$ 1,264	1,230	1,360	$ 1,233
Deferred tax assets, net						2,919	2,678
Net deferred tax liabilities						4,429	5,270
Prepaid expenses and other current assets						2,143	2,162
Deferred income taxes						5,304	5,986
Valuation Allowance [Abstract]
Balance, beginning of year			(1,360)	(1,233)	(1,264)
(Benefit)/provision						(25)	111	$ 68
Other (deductions)/additions			(105)	16	(99)
Balance, end of year	(1,360)	(1,233)	$ (1,230)	(1,360)	$ (1,233)
non cash tax benefit		$ 217
Deferred Taxes
Deferred tax assets
Prepaid expenses and other current assets						$ 875	$ 716
Tax Settlement, Years 2003-2009
Income Tax Contingency [Line Items]
Income Taxes Paid	758
Valuation Allowance [Abstract]
non cash tax benefit	$ 209
Open Tax Years
Income Tax Contingency [Line Items]
Income Taxes Paid				$ 226

Income Taxes (Reserves Rollforw

Income Taxes (Reserves Rollforward) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2014	Dec. 28, 2013
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance, beginning of year	$ 1,268	$ 2,425
Additions for tax positions related to the current year	349	238
Additions for tax positions from prior years	215	273
Reductions for tax positions from prior years	(81)	(327)
Settlement payments	(70)	(1,306)
Statutes of limitations expiration	(42)	(30)
Translation and other	(52)	(5)
Balance, end of period	$ 1,587	$ 1,268

Stock-Based Compensation (Narra

Stock-Based Compensation (Narrative) (Details) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 27, 2014USD ($)option / rsu$ / sharesshares		Dec. 28, 2013USD ($)$ / sharesshares	Dec. 29, 2012USD ($)$ / shares
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Allocated Share-based Compensation Expense, After Merger/Integration and Restructuring/Impairment	$ 294		$ 303	$ 273
Allocated Share-based Compensation Expense	$ 297		$ 303	$ 278
Phantom Units Granted Under Director Deferral Program, Shares Outstanding | shares	324,000		290,000
Common stock, capital shares reserved for future issuance | shares	98,000,000
Acquisition-related awards remaining vesting period	3 years
Unrecognized compensation cost related to nonvested share-based compensation grants	$ 382
Weighted-average period for recognizing unrecognized compensation	2 years
Percent of liability awards granted to senior officers	40.00%
PEPUnit
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Award performance period	3 years
Percent of equity awards granted to Senior Officers as performance-based RSUs	60.00%
Restricted Stock Units (RSUs)
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Weighted-average intrinsic value of RSUs granted | $ / shares	$ 80.39	[1],[2]	$ 76.30	$ 66.64
Award equivalence, ratio of stock options to RSUs | option / rsu	1
Stock Options
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Stock option exercisable life	10 years
Award equivalence, ratio of stock options to RSUs | option / rsu	4
[1]	Grant activity for all PSUs are disclosed at target.
[2]	Weighted-average intrinsic value at grant date.

Stock-Based Compensation (Summa

Stock-Based Compensation (Summary of Compensation Costs) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restructuring, Settlement and Impairment Provisions, Share-based Compensation	$ (3)	$ 0	$ (7)
Merger and integration charges	0	0	2
Income tax benefits recognized in earnings related to stock-based compensation	$ 75	$ 76	$ 73

Stock-Based Compensation (Sched

Stock-Based Compensation (Schedule of Weighted-Average Black-Scholes Fair Value Assumptions) (Details)	12 Months Ended
	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Share-based Compensation [Abstract]
Expected life	6 years	6 years	6 years
Risk-free interest rate	1.90%	1.10%	1.30%
Expected volatility	16.00%	17.00%	17.00%
Expected dividend yield	2.90%	2.70%	3.00%

Stock-Based Compensation (Stock

Stock-Based Compensation (Stock Option Activity) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		12 Months Ended
		Dec. 27, 2014		Dec. 28, 2013	Dec. 29, 2012
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding at December 28, 2013	[1]	49,462
Granted	[2]	3,416	[1]	2,868	3,696
Exercised	[1]	(12,898)
Forfeited/expired	[1]	(1,123)
Outstanding at December 27, 2014	[1]	38,857		49,462
Exercisable at December 27, 2014	[1]	30,237
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Outstanding at December 29, 2012 (in USD per share)	[3]	$ 61.58
Granted (in USD per share)	[3]	81.27
Exercised (in USD per share)	[3]	58.56
Forfeited/expired (in USD per share)	[3]	70.62
Outstanding at December 28, 2013 (in USD per share)	[3]	64.06		$ 61.58
Exercisable at December 28, 2013 - average price	[3]	$ 60.94
Outstanding at December 28, 2013 - average life	[4]	4 years 8 months 2 days
Exercisable at December 28, 2013 - average life	[4]	3 years 7 months 28 days
Outstanding Aggregate Intrinsic Value, at December 28, 2013	[5]	$ 1,282,200
Exercisable Aggregate Intrinsic Value, at December 31, 2013	[5]	$ 1,091,815
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	[1]	8,111
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price	[3]	$ 74.59
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term	[4]	8 years 2 months 8 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value	[5]	$ 182,132
[1]	Options are in thousands and include options previously granted under The Pepsi Bottling Group, Inc. (PBG) and PepsiAmericas, Inc. (PAS) plans. No additional options or shares were granted under the PBG and PAS plans after 2009.
[2]	In thousands.
[3]	Weighted-average exercise price.
[4]	Weighted-average contractual life remaining.
[5]	In thousands.

Stock-Based Compensation (Restr

Stock-Based Compensation (Restricted Stock Units and PEPUnits Activity) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		12 Months Ended
		Dec. 27, 2014		Dec. 28, 2013	Dec. 29, 2012
PepsiCo Equity Performance Unit [Domain]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at December 27, 2014(g)	[2]	953	[1]	675
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Outstanding, Number	[2]	843
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Intrinsic Value [Roll Forward]
Outstanding at December 31, 2012 (in USD per share)	[3]	$ 66.65
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	[5]	387	[2],[4]	355	410
Granted (in USD per share)		$ 50.95	[3],[4]	$ 68.48	$ 64.85
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	[2]	(109)
Forfeited (in USD per share)	[3]	$ 59.85
Outstanding at December 29, 2013 (in USD per share)	[3]	61.04	[1]	$ 66.65
Expected to vest as of December 29, 2013(in USD per share)	[3]	$ 60.97
Outstanding, average life, at December 29, 2013	[1],[6]	1 year 2 months 25 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Aggregate Intrinsic Value	[1],[7]	$ 92,451
Expected to vest, average life, at December 29, 2013	[6]	1 year 2 months 16 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Aggregate Intrinsic Value	[7]	$ 81,770
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number	[8]	11,228	[9]	11,939
Granted(e)	[8],[10]	4,379
Converted	[8]	(3,713)
Forfeited	[8]	(1,171)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Outstanding, Number	[8]	10,745
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Intrinsic Value [Roll Forward]
Outstanding at December 31, 2012 (in USD per share)	[11]	$ 69.04
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	[5]	4,379		4,231	4,404
Granted (in USD per share)		$ 80.39	[10],[11]	$ 76.30	$ 66.64
Converted (in USD per share)	[11]	64.77
Forfeited (in USD per share)	[11]	73.71
Outstanding at December 29, 2013 (in USD per share)	[11]	74.49	[9]	$ 69.04
Expected to vest as of December 29, 2013(in USD per share)	[11]	$ 73.74
Outstanding, average life, at December 29, 2013	[12]	1 year 5 months 2 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Aggregate Intrinsic Value	[13]	$ 1,089,707
Expected to vest, average life, at December 29, 2013	[12]	1 year 3 months 10 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Aggregate Intrinsic Value	[13]	$ 1,042,781
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Intrinsic Value [Roll Forward]
Share-based Compensation Arrangement by Share-Based Payment Award, Equity instruments other than options, Performance Assumption Adjustment, Shares	[8],[14]	(206)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Performance Assumption Change, Intrinsic Value, Amount per Share	[11],[14]	$ 64.19
Maximum Award Level [Domain] | PepsiCo Equity Performance Unit [Domain]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-Based Payment Award, Equity instruments other than options, Performance Assumption Adjustment, Shares Outstanding	[2]	1,700
Maximum Award Level [Domain] | Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-Based Payment Award, Equity instruments other than options, Performance Assumption Adjustment, Shares Outstanding		1,100
Minimum Award Level [Domain] | PepsiCo Equity Performance Unit [Domain]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-Based Payment Award, Equity instruments other than options, Performance Assumption Adjustment, Shares Outstanding		0
Minimum Award Level [Domain] | Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-Based Payment Award, Equity instruments other than options, Performance Assumption Adjustment, Shares Outstanding		0
Target Award Level [Domain] [Domain] | PepsiCo Equity Performance Unit [Domain]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-Based Payment Award, Equity instruments other than options, Performance Assumption Adjustment, Shares Outstanding		1,000
Target Award Level [Domain] [Domain] | Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-Based Payment Award, Equity instruments other than options, Performance Assumption Adjustment, Shares Outstanding		700
[1]	(f)The outstanding PEPunits for which the performance period has not ended as of December 27, 2014, at the threshold, target and maximum award levels were zero, 1.0 million and 1.7 million, respectively.
[2]	PEPunits are in thousands.
[3]	Weighted-average intrinsic value at grant date.
[4]	(e)Grant activity for all PEPunits are disclosed at target.
[5]	In thousands.
[6]	Weighted-average contractual life remaining.
[7]	In thousands.
[8]	RSUs and PSUs are in thousands and include RSUs previously granted under the PBG plan. No additional RSUs or shares were granted under the PBG plan after 2009.
[9]	The outstanding PSUs for which the performance period has not ended as of December 27, 2014, at the threshold, target and maximum award levels were zero, 0.7 million and 1.1 million, respectively.
[10]	Grant activity for all PSUs are disclosed at target.
[11]	Weighted-average intrinsic value at grant date.
[12]	Weighted-average contractual life remaining.
[13]	In thousands.
[14]	Reflects the net number of PSUs above and below target levels based on actual performance measured at the end of the performance period.

Stock-Based Compensation (Other

Stock-Based Compensation (Other Stock-Based Compensation Data) (Details) - USD ($) $ / shares in Units, $ in Thousands		12 Months Ended
		Dec. 27, 2014		Dec. 28, 2013	Dec. 29, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Phantom Units Granted Under Director Deferral Program, Shares Outstanding		324,000		290,000
Stock Options
Granted	[1]	3,416,000	[2]	2,868,000	3,696,000
Weighted-average fair value of options granted		$ 8.79		$ 8.14	$ 6.86
Total intrinsic value of options exercised(a)	[1]	$ 423,251		$ 471,475	$ 512,636
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value		$ 42,353		$ 88,750	$ 148,835
RSUs and PEPUnits
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	[2]	38,857,000		49,462,000
Restricted Stock Units (RSUs)
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	[1]	4,379,000		4,231,000	4,404,000
RSUs and PEPUnits
Granted (in USD per share)		$ 80.39	[3],[4]	$ 76.30	$ 66.64
Total intrinsic value of converted units	[1]	$ 319,820		$ 294,065	$ 236,575
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value	[1]	$ 241,836		$ 236,688	$ 188,723
PEPUnit
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	[1]	387,000	[5],[6]	355,000	410,000
RSUs and PEPUnits
Granted (in USD per share)		$ 50.95	[5],[7]	$ 68.48	$ 64.85
Total intrinsic value of converted units	[1]			$ 3,868
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value	[1]	$ 5,072		$ 5,896	$ 0
[1]	In thousands.
[2]	Options are in thousands and include options previously granted under The Pepsi Bottling Group, Inc. (PBG) and PepsiAmericas, Inc. (PAS) plans. No additional options or shares were granted under the PBG and PAS plans after 2009.
[3]	Grant activity for all PSUs are disclosed at target.
[4]	Weighted-average intrinsic value at grant date.
[5]	(e)Grant activity for all PEPunits are disclosed at target.
[6]	PEPunits are in thousands.
[7]	Weighted-average intrinsic value at grant date.

Pension, Retiree Medical and 62

Pension, Retiree Medical and Savings Plans (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Defined Benefit Plan Disclosure [Line Items]
Lower limit of net accumulated gain or loss	10.00%
Average remaining service period of active plan participants, pension expense	11 years
Average remaining service period of active plan participants, retiree medical expense	8 years
Expected future employer contributions in 2015	$ 225
Pension strategy investment term, years	5 years
Average increase in the cost of covered retiree medical benefits	6.00%
Net impact of mortality and other changes	$ 150
Pension Plans, Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Unfunded plans included in total projected benefit liability	808
Employer contributions	591	$ 200	$ 1,614
Retiree Medical Plan
Defined Benefit Plan Disclosure [Line Items]
Expected future employer contributions in 2015	$ 55
Expected return on plan assets	7.50%	7.80%	7.80%
Employer contributions	$ 64	$ 62	$ 251
United States Pension Plan of US Entity, Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Expected return on plan assets	7.50%	7.80%	7.80%
Employer contributions	$ 434	$ 63
Discretionary contribution to fund pension settlement	388		$ 405
Pre-tax non-cash settlement charge	141		195
Pre-tax non-cash settlement charge, after-tax	$ 88		$ 131
Pre-tax non-cash settlement charge, net of tax, per share	$ 0.06		$ 0.08
U.S. Savings Plan
Defined Benefit Plan Disclosure [Line Items]
Defined Contribution Plan, Cost Recognized	$ 130	$ 122	$ 109
2025 And Thereafter
Defined Benefit Plan Disclosure [Line Items]
Average increase is then projected to decline	5.00%

Pension, Retiree Medical and 63

Pension, Retiree Medical and Savings Plans (Selected Financial Information for Pension and Retiree Medical Plans) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Pension Plans, Defined Benefit
Change in fair value of plan assets
Employer contributions/funding	$ 591	$ 200	$ 1,614
United States Pension Plan of US Entity, Defined Benefit
Change in projected benefit liability
Liability at beginning of year	11,825	12,886
Service cost	393	467	407
Interest cost	580	527	534
Plan amendments	(122)	22
Experience loss/(gain)	1,635	(1,522)
Benefit payments	(349)	(533)
Settlement/curtailment	(577)	(44)
Special termination benefits	24	22
Liability at end of year	13,409	11,825	12,886
Change in fair value of plan assets
Fair value at beginning of year	11,462	10,817
Actual return on plan assets	1,254	1,159
Employer contributions/funding	434	63
Benefit payments	(349)	(533)
Defined Benefit Plan, Settlements, Plan Assets	(577)	(44)
Fair value at end of year	12,224	11,462	10,817
Funded status	(1,185)	(363)
Amounts recognized
Other assets	97	603
Other current liabilities	(42)	(41)
Other liabilities	(1,240)	(925)
Net amount recognized	(1,185)	(363)
Amounts included in accumulated other comprehensive loss (pre-tax)
Net loss/(gain)	2,918	2,069
Prior service (credit)/cost	(18)	125
Total	2,900	2,194
Components of the increase/(decrease) in net loss/(gain) included in accumulated other comprehensive loss
Change in discount rate	1,424	(1,532)
Employee-related assumption changes	345	24
Liability-related experience different from assumptions	(104)	(14)
Actual asset return different from expected return	(470)	(336)
Amortization and settlement of losses	(316)	(285)
Other, including foreign currency adjustments	(30)
Total	849	(2,143)
Liability at end of year for service to date	12,206	10,803
International
Change in projected benefit liability
Liability at beginning of year	2,859	2,788
Service cost	98	111	100
Interest cost	131	118	115
Plan amendments		(1)
Participant contributions	3	3
Experience loss/(gain)	512	(65)
Benefit payments	(86)	(91)
Settlement/curtailment	(25)	(3)
Foreign currency adjustment	(245)	(2)
Defined Benefit Plan, Other Changes		1
Liability at end of year	3,247	2,859	2,788
Change in fair value of plan assets
Fair value at beginning of year	2,777	2,463
Actual return on plan assets	401	265
Employer contributions/funding	157	137
Benefit payments	(86)	(91)
Defined Benefit Plan, Settlements, Plan Assets	(24)	(8)
Foreign currency adjustment	(226)	8
Fair value at end of year	3,002	2,777	2,463
Funded status	(245)	(82)
Amounts recognized
Other assets	37	74
Other current liabilities	(1)	(1)
Other liabilities	(281)	(155)
Net amount recognized	(245)	(82)
Amounts included in accumulated other comprehensive loss (pre-tax)
Net loss/(gain)	1,003	849
Prior service (credit)/cost	(7)	(6)
Total	996	843
Components of the increase/(decrease) in net loss/(gain) included in accumulated other comprehensive loss
Change in discount rate	636	(166)
Employee-related assumption changes	(112)	91
Liability-related experience different from assumptions	(12)	10
Actual asset return different from expected return	(225)	(108)
Amortization and settlement of losses	(61)	(68)
Other, including foreign currency adjustments	(72)	(6)
Total	154	(247)
Liability at end of year for service to date	2,721	2,369
Retiree Medical Plan
Change in projected benefit liability
Liability at beginning of year	1,384	1,511
Service cost	36	45	50
Interest cost	58	54	65
Plan amendments	(125)
Experience loss/(gain)	190	(128)
Benefit payments	(101)	(97)
Special termination benefits	3	2
Foreign currency adjustment	(6)	(3)
Liability at end of year	1,439	1,384	1,511
Change in fair value of plan assets
Fair value at beginning of year	406	365
Actual return on plan assets	46	76
Employer contributions/funding	64	62	251
Benefit payments	(101)	(97)
Fair value at end of year	415	406	$ 365
Funded status	(1,024)	(978)
Amounts recognized
Other current liabilities	(57)	(72)
Other liabilities	(967)	(906)
Net amount recognized	(1,024)	(978)
Amounts included in accumulated other comprehensive loss (pre-tax)
Net loss/(gain)	(49)	(222)
Prior service (credit)/cost	(166)	(69)
Total	(215)	(291)
Components of the increase/(decrease) in net loss/(gain) included in accumulated other comprehensive loss
Change in discount rate	98	(117)
Employee-related assumption changes	58	2
Liability-related experience different from assumptions	34	(13)
Actual asset return different from expected return	(19)	(49)
Amortization and settlement of losses	4	(1)
Other, including foreign currency adjustments	(2)
Total	$ 173	$ (178)

Pension, Retiree Medical and 64

Pension, Retiree Medical and Savings Plans (Components of Benefit Expense) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
United States Pension Plan of US Entity, Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Pre-tax non-cash settlement charge		$ 141		$ 195
Service cost		393	$ 467	407
Interest cost		580	527	534
Expected return on plan assets		(784)	(823)	(796)
Amortization of prior service cost/(credit)		21	18	17
Amortization of net loss/(gain)		175	289	259
Gross total		385	478	421
Settlement/curtailment loss/(gain)(a)	[1]	141	(4)	185
Special termination benefits		24	22	8
Total		550	496	614
International
Defined Benefit Plan Disclosure [Line Items]
Service cost		98	111	100
Interest cost		131	118	115
Expected return on plan assets		(176)	(157)	(146)
Amortization of prior service cost/(credit)			1	1
Amortization of net loss/(gain)		53	66	53
Gross total		106	139	123
Settlement/curtailment loss/(gain)(a)	[1]	7	7	4
Special termination benefits				1
Total		113	146	128
Retiree Medical Plan
Defined Benefit Plan Disclosure [Line Items]
Service cost		36	45	50
Interest cost		58	54	65
Expected return on plan assets		(27)	(27)	(22)
Amortization of prior service cost/(credit)		(28)	(23)	(26)
Amortization of net loss/(gain)		(4)	1
Gross total		35	50	67
Special termination benefits		3	2	5
Total		$ 38	$ 52	$ 72
[1]	U.S. includes pension lump sum settlement charge of $141 million in 2014 and $195 million in 2012. These charges are reflected in items affecting comparability (see additional unaudited information in “Items Affecting Comparability” in Management’s Discussion and Analysis of Financial Condition and Results of Operations).

Pension, Retiree Medical and 65

Pension, Retiree Medical and Savings Plans (Estimated Amounts to be Amortized from Accumulated Other Comprehensive Loss into Benefit Expense in 2012 for Pension and Retiree Medical Plans) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2014	Dec. 29, 2012
United States Pension Plan of US Entity, Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Payments for Defined Benefit Plan Settlement	$ 388	$ 405
Net loss	205
Prior service credit	(3)
Total	202
International
Defined Benefit Plan Disclosure [Line Items]
Net loss	74
Total	74
Retiree Medical Plan
Defined Benefit Plan Disclosure [Line Items]
Prior service credit	(38)
Total	$ (38)

Pension, Retiree Medical and 66

Pension, Retiree Medical and Savings Plans (Weighted-Average Assumptions to Determine Projected Benefit Liability and Benefit Expense for Pension and Retiree Medical Plans) (Details)	12 Months Ended
	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
United States Pension Plan of US Entity, Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Liability discount rate	4.20%	5.00%	4.20%
Expense discount rate	5.00%	4.20%	4.60%
Expected return on plan assets	7.50%	7.80%	7.80%
Liability rate of salary increases	3.50%	3.70%	3.70%
Expense rate of salary increases	3.70%	3.70%	3.70%
International
Defined Benefit Plan Disclosure [Line Items]
Liability discount rate	3.80%	4.70%	4.40%
Expense discount rate	4.70%	4.40%	4.80%
Expected return on plan assets	6.60%	6.60%	6.70%
Liability rate of salary increases	3.60%	3.90%	3.90%
Expense rate of salary increases	3.90%	3.90%	4.10%
Retiree Medical Plan
Defined Benefit Plan Disclosure [Line Items]
Liability discount rate	3.80%	4.60%	3.70%
Expense discount rate	4.30%	3.70%	4.40%
Expected return on plan assets	7.50%	7.80%	7.80%

Pension, Retiree Medical and 67

Pension, Retiree Medical and Savings Plans (Selected Information About Plans with Liability for Service to Date and Total Benefit Liability in Excess of Plan Assets) (Details) - USD ($) $ in Millions	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
United States Pension Plan of US Entity, Defined Benefit
Selected information for plans with liability for service to date in excess of plan assets
Liability for service to date	$ (661)	$ (577)
Fair value of plan assets	2	2
Selected information for plans with projected benefit liability in excess of plan assets
Benefit liability	(7,385)	(6,555)
Fair value of plan assets	6,103	5,589
Defined Benefit Plan, Fair Value of Plan Assets	12,224	11,462	$ 10,817
International
Selected information for plans with liability for service to date in excess of plan assets
Liability for service to date	(333)	(310)
Fair value of plan assets	288	259
Selected information for plans with projected benefit liability in excess of plan assets
Benefit liability	(2,865)	(2,291)
Fair value of plan assets	2,583	2,135
Defined Benefit Plan, Fair Value of Plan Assets	3,002	2,777	2,463
Retiree Medical Plan
Selected information for plans with projected benefit liability in excess of plan assets
Benefit liability	(1,439)	(1,384)
Fair value of plan assets		406
Defined Benefit Plan, Fair Value of Plan Assets	$ 415	$ 406	$ 365

Pension, Retiree Medical and 68

Pension, Retiree Medical and Savings Plans (Estimated Future Benefit Payments) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Pension Plans, Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Employer contributions/funding		$ 591	$ 200	$ 1,614
2,015		700
2,016		730
2,017		775
2,018		830
2,019		880
2020-24		5,160
Retiree Medical Plan
Defined Benefit Plan Disclosure [Line Items]
Employer contributions/funding		64	$ 62	251
2,015	[1]	120
2,016	[1]	125
2,017	[1]	125
2,018	[1]	125
2,019	[1]	125
2020-24	[1]	560
Years 2015 Through 2019
Defined Benefit Plan Disclosure [Line Items]
Subsidies expected to be received under the 2003 Medicare Act		3
Years 2020 Through 2024
Defined Benefit Plan Disclosure [Line Items]
Subsidies expected to be received under the 2003 Medicare Act		$ 13
Large Cap Funds In United States Commingled Funds [Member]
Defined Benefit Plan Disclosure [Line Items]
Representation As Percentage Of Total US Plan Assets		25.00%	25.00%
Discretionary [Member] | Pension Plans, Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Employer contributions/funding	[2]	$ 407	$ 23	1,375
Discretionary [Member] | Retiree Medical Plan
Defined Benefit Plan Disclosure [Line Items]
Employer contributions/funding	[2]	0	0	140
Nondiscretionary [Member] | Pension Plans, Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Employer contributions/funding		184	177	239
Nondiscretionary [Member] | Retiree Medical Plan
Defined Benefit Plan Disclosure [Line Items]
Employer contributions/funding		$ 64	$ 62	$ 111
[1]	Expected future benefit payments for our retiree medical plans do not reflect any estimated subsidies expected to be received under the 2003 Medicare Act. Subsidies are expected to be approximately $3 million for each of the years from 2015 through 2019 and approximately $13 million in total for 2020 through 2024.
[2]	Includes $388 million and $405 million in 2014 and 2012, respectively, pertaining to pension lump sum payments.

Pension, Retiree Medical and 69

Pension, Retiree Medical and Savings Plans Pension, Retiree Medical and Savings Plans (Target Asset Allocations) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Fixed Income
Target Asset Allocation [Line Items]
Target investment allocation percentage		40.00%
U.S. Equity
Target Asset Allocation [Line Items]
Target investment allocation percentage		33.00%
International Equity
Target Asset Allocation [Line Items]
Target investment allocation percentage		22.00%
Real Estate Funds [Member]
Target Asset Allocation [Line Items]
Target investment allocation percentage		5.00%
Scenario, Forecast | Fixed Income
Target Asset Allocation [Line Items]
Target investment allocation percentage	40.00%
Scenario, Forecast | U.S. Equity
Target Asset Allocation [Line Items]
Target investment allocation percentage	33.00%
Scenario, Forecast | International Equity
Target Asset Allocation [Line Items]
Target investment allocation percentage	22.00%
Scenario, Forecast | Real Estate Funds [Member]
Target Asset Allocation [Line Items]
Target investment allocation percentage	5.00%
United States Pension Plan of US Entity, Defined Benefit
Target Asset Allocation [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets		$ 12,224	$ 11,462	$ 10,817

Pension, Retiree Medical and 70

Pension, Retiree Medical and Savings Plans (Categorized Plan Assets Measured at Fair Value) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1]	$ 12,639	$ 11,868
International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets		3,002	2,777
Retiree Medical Plan
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets		415	406	$ 365
U.S. Savings Plan
Defined Benefit Plan Disclosure [Line Items]
Defined Contribution Plan, Cost Recognized		130	122	$ 109
U.S. Common Stock | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[2]	966	732
U.S. Common Stock | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[2]	5	4
U.S. Common Stock | Level 1 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[2]	966
U.S. Common Stock | Level 1 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[2]	5
U.S. Common Stock | Level 2 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[2]	0
U.S. Common Stock | Level 2 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[2]	0
U.S. Common Stock | Level 3 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[2]	0
U.S. Common Stock | Level 3 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[2]	0
U.S. Commingled Funds | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[3],[4]	3,437	3,334
U.S. Commingled Funds | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[3]	373	334
U.S. Commingled Funds | Level 1 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[3],[4]	0
U.S. Commingled Funds | Level 1 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[3]	0
U.S. Commingled Funds | Level 2 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[3],[4]	3,437
U.S. Commingled Funds | Level 2 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[3]	373
U.S. Commingled Funds | Level 3 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[3],[4]	0
U.S. Commingled Funds | Level 3 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[3]	0
International Common Stock [Member] | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[2]	1,488	1,669
International Common Stock [Member] | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[2]	171	176
International Common Stock [Member] | Level 1 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[2]	1,488
International Common Stock [Member] | Level 1 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[2]	171
International Common Stock [Member] | Level 2 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[2]	0
International Common Stock [Member] | Level 2 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[2]	0
International Common Stock [Member] | Level 3 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[2]	0
International Common Stock [Member] | Level 3 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[2]	0
International Commingled Fund | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[5]	876	902
International Commingled Fund | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[5]	918	914
International Commingled Fund | Level 1 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[5]	0
International Commingled Fund | Level 1 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[5]	0
International Commingled Fund | Level 2 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[5]	876
International Commingled Fund | Level 2 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[5]	918
International Commingled Fund | Level 3 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[5]	0
International Commingled Fund | Level 3 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[5]	0
Preferred Stock | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[6]	22	18
Preferred Stock | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[6]	1	1
Preferred Stock | Level 1 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[6]	0
Preferred Stock | Level 1 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[6]	0
Preferred Stock | Level 2 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[6]	22
Preferred Stock | Level 2 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[6]	1
Preferred Stock | Level 3 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[6]	0
Preferred Stock | Level 3 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[6]	0
Government Securities | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[6]	1,279	1,264
Government Securities | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[6]	454	$ 207
Government Securities | Level 1 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[6]	0
Government Securities | Level 1 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[6]	0
Government Securities | Level 2 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[6]	1,279
Government Securities | Level 2 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[6]	454
Government Securities | Level 3 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[6]	0
Government Securities | Level 3 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[6]	$ 0
Corporate Bonds
Defined Benefit Plan Disclosure [Line Items]
Representation of one fund in total U.S. plan assets		23.00%	21.00%
Corporate Bonds | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[6],[7]	$ 3,338	$ 2,958
Corporate Bonds | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[6]	320	261
Corporate Bonds | Level 1 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[6],[7]	0
Corporate Bonds | Level 1 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[6]	0
Corporate Bonds | Level 2 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[6],[7]	3,338
Corporate Bonds | Level 2 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[6]	320
Corporate Bonds | Level 3 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[6],[7]	0
Corporate Bonds | Level 3 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[6]	0
Mortgage-Backed Securities | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[6]	274	220
Mortgage-Backed Securities | Level 1 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[6]	0
Mortgage-Backed Securities | Level 2 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[6]	274
Mortgage-Backed Securities | Level 3 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[6]	0
Contracts With Insurance Companies | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[8]	6	6
Contracts With Insurance Companies | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[8]	36	34
Contracts With Insurance Companies | Level 1 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[8]	0
Contracts With Insurance Companies | Level 1 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[8]	0
Contracts With Insurance Companies | Level 2 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[8]	0
Contracts With Insurance Companies | Level 2 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[8]	0
Contracts With Insurance Companies | Level 3 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[8]	6
Contracts With Insurance Companies | Level 3 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[8]	36
Cash And Cash Equivalents | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1]	267	154
Cash And Cash Equivalents | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets		21	15
Cash And Cash Equivalents | Level 1 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1]	267
Cash And Cash Equivalents | Level 1 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets		21
Cash And Cash Equivalents | Level 2 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1]	0
Cash And Cash Equivalents | Level 2 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets		0
Cash And Cash Equivalents | Level 3 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1]	0
Cash And Cash Equivalents | Level 3 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets		0
Sub-Total U.S. Plan Assets | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1]	12,582	11,809
Sub-Total U.S. Plan Assets | Level 1 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1]	2,721
Sub-Total U.S. Plan Assets | Level 2 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1]	9,226
Sub-Total U.S. Plan Assets | Level 3 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1]	635
Fixed Income Commingled Funds | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[9]	517	650
Fixed Income Commingled Funds | Level 1 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[9]	0
Fixed Income Commingled Funds | Level 2 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[9]	517
Fixed Income Commingled Funds | Level 3 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[9]	0
Currency Commingled Funds | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[10]	87	91
Currency Commingled Funds | Level 1 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[10]	0
Currency Commingled Funds | Level 2 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[10]	87
Currency Commingled Funds | Level 3 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[10]	0
Real Estate Funds [Member] | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[11]	629	552
Real Estate Funds [Member] | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[11]	92	83
Real Estate Funds [Member] | Level 1 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[11]	0
Real Estate Funds [Member] | Level 1 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[11]	0
Real Estate Funds [Member] | Level 2 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[11]	0
Real Estate Funds [Member] | Level 2 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[11]	0
Real Estate Funds [Member] | Level 3 | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1],[11]	629
Real Estate Funds [Member] | Level 3 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[11]	92
Sub-Total International Plan Assets | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets		2,995	2,770
Sub-Total International Plan Assets | Level 1 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets		197
Sub-Total International Plan Assets | Level 2 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets		2,670
Sub-Total International Plan Assets | Level 3 | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets		128
Dividends And Interest Receivable | U.S. Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	[1]	57	59
Dividends And Interest Receivable | International Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets		$ 7	$ 7
Large-Cap Fund(s) In U.S. Commingled Funds
Defined Benefit Plan Disclosure [Line Items]
Representation of one fund in total U.S. plan assets		25.00%	25.00%
[1]	2014 and 2013 amounts include $415 million and $406 million, respectively, of retiree medical plan assets that are restricted for purposes of providing health benefits for U.S. retirees and their beneficiaries.
[2]	Based on quoted market prices in active markets.
[3]	Based on the fair value of the investments owned by these funds that track various U.S. large, mid-cap and small company indices.
[4]	Includes one large-cap fund that represents 25% of total U.S. plan assets for both 2014 and 2013.
[5]	Based on the fair value of the investments owned by these funds that track various non-U.S. equity indices.
[6]	Based on quoted bid prices for comparable securities in the marketplace and broker/dealer quotes in active markets.
[7]	Corporate bonds of U.S.-based companies represent 23% and 21%, respectively, of total U.S. plan assets for 2014 and 2013.
[8]	Based on the fair value of the contracts as determined by the insurance companies using inputs that are not observable.
[9]	Based on the fair value of the investments owned by these funds that track various government and corporate bond indices.
[10]	Based on the fair value of the investments owned by this fund that invests primarily in derivatives to hedge currency exposure.
[11]	Based on the appraised value of the investments owned by these funds as determined by independent third parties using inputs that are not observable.

Pension, Retiree Medical and 71

Pension, Retiree Medical and Savings Plans (Level 3 Assets) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Level 3
Defined Benefit Plan Disclosure [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	$ 763	$ 675	$ 453
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss)	70	55
Change in fair value of plan assets
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases, (Sales), Issuances, (Settlements)	$ 18	$ 167
Large Cap Funds In United States Commingled Funds [Member]
Defined Benefit Plan Disclosure [Line Items]
Representation As Percentage Of Total US Plan Assets	25.00%	25.00%
Real Estate Funds [Member] | Level 3
Defined Benefit Plan Disclosure [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	$ 721	$ 635	391
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss)	68	56
Change in fair value of plan assets
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases, (Sales), Issuances, (Settlements)	18	188
Contracts With Insurance Companies | Level 3
Defined Benefit Plan Disclosure [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	42	40	$ 62
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss)	2	(1)
Change in fair value of plan assets
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases, (Sales), Issuances, (Settlements)	$ 0	$ (21)

Pension, Retiree Medical and 72

Pension, Retiree Medical and Savings Plans (Effects of 1-Percentage-Point Change in the Assumed Health Care Trend Rate) (Details) $ in Millions	12 Months Ended
	Dec. 27, 2014USD ($)
General Discussion of Pension and Other Postretirement Benefits [Abstract]
One percent increase in 2013 service and interest cost components	$ 4
One percent decrease in 2013 service and interest cost components	(3)
One percent increase in 2013 benefit liability	46
One percent decrease in 2013 benefit liability	$ (40)

Debt Obligations and Commitme73

Debt Obligations and Commitments (Narrative) (Details) € in Millions, $ in Millions	12 Months Ended
	Dec. 27, 2014USD ($)	Jun. 14, 2014EUR (€)	Mar. 22, 2014USD ($)	Dec. 28, 2013USD ($)
Debt Instrument [Line Items]
Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range Not Possible	300
Long-term Debt, Current Maturities	$ 2,200
Commercial Paper	746			$ 2,924
Debt, Current	5,076			5,306
Long-term Debt	27,917			26,557
Long-term Debt Obligations	23,821			$ 24,333
International Divisions
Debt Instrument [Line Items]
Line of Credit Facility, Amount Outstanding	$ 228
Commercial Paper Zero Point One Percentage_ [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	0.10%			0.10%
Current Maturities Of Long Term Debt [Member]
Debt Instrument [Line Items]
Long-term Debt, Current Maturities	$ 4,096			$ 2,224
Other Debt Instruments due 2015 to 2019 [Member] [Domain] [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	4.40%			4.40%
Other Notes Payable	$ 40			$ 46
Other Borrowings Short-term [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	17.70%			12.40%
Other Short-term Borrowings	$ 234			$ 158
364 Day Unsecured Revolving Credit Agreement [Member] [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Amount Outstanding	$ 2,925
Notes Due 2017 [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	1.60%			2.00%
Senior Notes	$ 2,004			$ 1,258
Notes Due 2018 [Member] [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	4.40%			4.30%
Senior Notes	$ 3,410			$ 3,439
Notes Due 2019
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	3.70%			3.70%
Senior Notes	$ 1,631			$ 1,635
Notes Due 2020 to 2044 [Member] [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	3.90%			4.00%
Senior Notes	$ 13,640			$ 10,738
Notes Due 2016
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	2.60%			2.50%
Senior Notes	$ 3,099			$ 3,106
Notes Due 2015
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	1.40%			1.20%
Senior Notes	$ 4,093			$ 4,116
Notes Due 2014
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	0.00%			5.30%
Senior Notes	$ 0			$ 2,219
Five Year Unsecured Revolving Credit Agreement [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Current Borrowing Capacity	3,772.5
Line of Credit Facility, Maximum Borrowing Capacity	4,500
Line of Credit Facility, Amount Outstanding	2,925
Three Point Six Zero Percent Senior Notes Due 2024 [Member] | Notes Due 2024 [Member]
Debt Instrument [Line Items]
Fixed and floating rate notes issued			$ 1,250
Interest rate on debt			3.60%
Zero Point Nine Five Zero Percent Senior Notes Due 2017 [Domain] | Notes Due 2017 [Member]
Debt Instrument [Line Items]
Fixed and floating rate notes issued			$ 750
Interest rate on debt			0.95%
One Point Seven Five Zero Percent Senior Notes Due 2021 [Member] | Notes Due 2021 [Member]
Debt Instrument [Line Items]
Fixed and floating rate notes issued | €		€ 500
Interest rate on debt		1.75%
Two Point Six Two Five Percent Senior Notes Due 2026_ [Member] | Notes Due 2026 [Member]
Debt Instrument [Line Items]
Fixed and floating rate notes issued | €		€ 500
Interest rate on debt		2.625%
Four Point Two Five Zero Percent Senior Notes Due 2044 [Domain]
Debt Instrument [Line Items]
Fixed and floating rate notes issued	$ 500
Interest rate on debt	4.25%
364 Day Unsecured Revolving Credit Agreement [Member] [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Current Borrowing Capacity	$ 3,772.5
Line of Credit Facility, Maximum Borrowing Capacity	$ 4,500

Debt Obligations and Commitme74

Debt Obligations and Commitments (Schedule of Long and Short-Term Debt Contractual Commitments) (Details) - USD ($) $ in Millions		Dec. 27, 2014	Mar. 22, 2014	Dec. 28, 2013
Debt Instrument [Line Items]
Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months		$ 4,096
Long Term Debt Total Repayments Of Principal After One Year	[1],[2]	23,446
Long-term Debt, Maturing in One Year or Less	[3]	0
Long-term Debt, Current Maturities		2,200
Commercial paper (0.1% and 0.1%)		746		$ 2,924
Short-term debt obligations		(5,076)		(5,306)
Long-term debt obligations, gross		27,917		26,557
Less: current maturities of long-term debt obligations		(2,200)
Long-term Debt Obligations		23,821		24,333
Long-term Debt, Maturing in Years Two and Three	[1],[2]	5,108
Long-term Debt, Maturing in Years Four and Five	[1],[2]	4,863
Long-term Debt, Maturities, Repayments of Principal after Year Five	[1],[2]	13,475
Interest on Long-term Debt due	[1],[4]	8,839
Interest on Long-term Debt due in Twelve Months	[1],[4]	873
Interest on Long-term Debt due in Two and Three Years	[1],[4]	1,553
Interest on Long-term Debt due in Four and Five Years	[1],[4]	1,245
Interest on Long-term debt due after Five years	[1],[4]	5,168
Operating Leases, Future Minimum Payments Due	[1]	1,894
Operating Leases, Future Minimum Payments Due, Next Twelve Months	[1]	403
Operating Leases, Future Minimum Payments, Due in Two and Three Years	[1]	631
Operating Leases, Future Minimum Payments, Due in Four and Five Years	[1]	387
Operating Leases, Future Minimum Payments, Due Thereafter	[1]	473
Unrecorded Unconditional Purchase Obligation	[1],[5]	1,985
Unrecorded Unconditional Purchase Obligation, Due in Next Twelve Months	[1],[5]	693
Unrecorded unconditional purchase obligation, due in years two and three	[1],[5]	873
unrecorded unconditional purchase obligation, due in years four and five	[1],[5]	293
Unrecorded Unconditional Purchase Obligation, Due after Five Years	[1],[5]	126
Marketing Commitments	[1],[5]	2,178
Marketing Obligation, Due in Next Twelve Months	[1],[5]	391
Marketing Obligation, Due in Two and Three Years	[1],[5]	647
Marketing Obligation, Due in Four to Five Years	[1],[5]	525
Marketing obligation, due after five years	[1],[5]	615
Total Long Term Contractual Commitments	[1]	38,342
Total Long Term Contractual Commitments Due Current	[1]	2,360
Total Long Term Contractual Commitments Due in Two and Three Years	[1]	8,812
Total Long Term Contractual Commitments Due in Four and Five Years	[1]	7,313
Total Long Term Contractual Commitments Due after Five Years	[1]	19,857
Increase Decrease In Carrying Value Of Debt In Interest Rate Fair Value Hedge		179
Current Maturities Of Long-Term Debt
Debt Instrument [Line Items]
Long-term Debt, Current Maturities		4,096		2,224
Less: current maturities of long-term debt obligations		(4,096)		(2,224)
Other Borrowings (7.4% And 7.6%)
Debt Instrument [Line Items]
Other borrowings (7.4% and 7.6%)		$ 234		$ 158
Interest rate on debt		17.70%		12.40%
Notes Due 2014
Debt Instrument [Line Items]
Notes due		$ 0		$ 2,219
Interest rate on debt		0.00%		5.30%
Notes Due 2015 [Member]
Debt Instrument [Line Items]
Notes due		$ 4,093		$ 4,116
Interest rate on debt		1.40%		1.20%
Notes Due 2016
Debt Instrument [Line Items]
Notes due		$ 3,099		$ 3,106
Interest rate on debt		2.60%		2.50%
Notes Due 2017
Debt Instrument [Line Items]
Notes due		$ 2,004		$ 1,258
Interest rate on debt		1.60%		2.00%
Notes Due 2018
Debt Instrument [Line Items]
Notes due		$ 3,410		$ 3,439
Interest rate on debt		4.40%		4.30%
Notes Due 2019 [Member] [Member]
Debt Instrument [Line Items]
Notes due		$ 1,631		$ 1,635
Interest rate on debt		3.70%		3.70%
Notes Due 2020 to 2044 [Member] [Member]
Debt Instrument [Line Items]
Notes due		$ 13,640		$ 10,738
Interest rate on debt		3.90%		4.00%
Other Debt Instruments due 2015 to 2019 [Member] [Domain] [Member]
Debt Instrument [Line Items]
Other notes due		$ 40		$ 46
Interest rate on debt		4.40%		4.40%
Five Year Unsecured Revolving Credit Agreement [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Current Borrowing Capacity		$ 3,772.5
Line of Credit Facility, Maximum Borrowing Capacity		4,500
Long-term Line of Credit		2,925
364 Day Unsecured Revolving Credit Agreement [Member] [Member]
Debt Instrument [Line Items]
Long-term Line of Credit		2,925
Zero Point Nine Five Zero Percent Senior Notes Due 2017 [Domain] | Notes Due 2017
Debt Instrument [Line Items]
Debt Instrument, Face Amount			$ 750
Debt Instrument, Interest Rate, Stated Percentage			0.95%
Four Point Two Five Zero Percent Senior Notes Due 2044 [Domain]
Debt Instrument [Line Items]
Debt Instrument, Face Amount		$ 500
Debt Instrument, Interest Rate, Stated Percentage		4.25%
International [Member]
Debt Instrument [Line Items]
Long-term Line of Credit		$ 228
Pbg And Pas Acquisition [Member]
Debt Instrument [Line Items]
Fair Value Step Up Of Debt Acquired In Connection With Our Acquisitions		$ 196
[1]	Based on year-end foreign exchange rates. We expect to make net cash tax payments of approximately $300 million within the next 12 months, as discussed further in Note 5. Reserves for uncertain tax positions are excluded from the table above as we are unable to reasonably predict the ultimate amount or timing of any other settlements.
[2]	Excludes $4,096 million related to current maturities of long-term debt, $196 million related to the fair value step-up of debt acquired in connection with our acquisitions of PBG and PAS and $179 million related to the increase in carrying value of long-term debt representing the gains on our fair value interest rate swaps.
[3]	Based on quoted market prices in active markets.
[4]	Interest payments on floating-rate debt are estimated using interest rates effective as of December 27, 2014.
[5]	Primarily reflects non-cancelable commitments as of December 27, 2014.

Debt Obligations and Commitme75

Debt Obligations and Commitments (Long-Term Contractual Commitments) (Details) $ in Millions	Dec. 27, 2014USD ($)
Debt Instrument [Line Items]
Long-term debt obligations, total	$ 23,446	[1],[2]
Long-term Debt, Maturing in One Year	0	[3]
Long-term debt obligations, 2015-2016	5,108	[1],[2]
Long-term debt obligations, 2017-2018	4,863	[1],[2]
Long-term debt obligations, 2019 and beyond	13,475	[1],[2]
Interest on debt obligations, total	8,839	[1],[4]
Interest on debt obligations, 2013	873	[1],[4]
Interest on debt obligations, 2014-2015	1,553	[1],[4]
Interest on debt obligations, 2016-2017	1,245	[1],[4]
Interest on debt obligations, 2018 and beyond	5,168	[1],[4]
Operating leases, total	1,894	[1]
Operating leases, 2013	403	[1]
Operating Leases, 2014-2015	631	[1]
Operating Leases, 2016-2017	387	[1]
Operating Leases, 2018 and beyond	473	[1]
Purchasing commitments, total	1,985	[1],[5]
Purchasing commitments, 2013	693	[1],[5]
Purchasing commitments, 2014-2015	873	[1],[5]
Purchasing commitments, 2016-2017	293	[1],[5]
Purchasing commitments, 2018 and beyond	126	[1],[5]
Marketing commitments, total	2,178	[1],[5]
Marketing Obligation, 2013	391	[1],[5]
Marketing obligation, 2014-2015	647	[1],[5]
Marketing obligation, 2016-2017	525	[1],[5]
Marketing obligation, 2018 and beyond	615	[1],[5]
Total long-term contractual commitments	38,342	[1]
Total Long Term Contractual Commitments 2013	2,360	[1]
Total Long Term Contractual Commitments 2014-2015	8,812	[1]
Total Long Term Contractual Commitments 2016-2017	7,313	[1]
Total Long Term Contractual Commitments 2018 and beyond	19,857	[1]
Long-term debt obligations, 2013	4,096
Increase decrease in carrying value of debt in interest rate fair value hedge	179
PBG and PAS Acquisition
Debt Instrument [Line Items]
Fair value step-up of debt acquired in connection with our acquisitions of PBG and PAS	$ 196
[1]	Based on year-end foreign exchange rates. We expect to make net cash tax payments of approximately $300 million within the next 12 months, as discussed further in Note 5. Reserves for uncertain tax positions are excluded from the table above as we are unable to reasonably predict the ultimate amount or timing of any other settlements.
[2]	Excludes $4,096 million related to current maturities of long-term debt, $196 million related to the fair value step-up of debt acquired in connection with our acquisitions of PBG and PAS and $179 million related to the increase in carrying value of long-term debt representing the gains on our fair value interest rate swaps.
[3]	Based on quoted market prices in active markets.
[4]	Interest payments on floating-rate debt are estimated using interest rates effective as of December 27, 2014.
[5]	Primarily reflects non-cancelable commitments as of December 27, 2014.

Financial Instruments (Narrativ

Financial Instruments (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 27, 2014	Dec. 28, 2013
Derivatives, Fair Value [Line Items]
Available-for-sale Equity Securities, Accumulated Gross Unrealized Gain, before Tax	$ 111,000,000	$ 122,000,000
Debt instrument, fair value	$ 31,000,000,000	30,000,000,000
Foreign Exchange Contract
Derivatives, Fair Value [Line Items]
Derivative maturity term, maximum	2 years
Derivative, Notional Amount	$ 2,700,000,000	2,500,000,000
Interest Rate Contracts
Derivatives, Fair Value [Line Items]
Derivative, Notional Amount	$ 9,300,000,000	$ 7,900,000,000
Percentage of total debt, net of related interest rate derivatives, exposed to variable interest rates		31.00%
Commodity Contracts
Derivatives, Fair Value [Line Items]
Derivative maturity term, maximum	3 years
Expected reclassification of net losses related to hedge from accumulated OCI into net income within the next 12 months	$ 21,000,000
Designated as Hedging Instrument | Commodity Contracts
Derivatives, Fair Value [Line Items]
Derivative, Notional Amount	$ 1,200,000,000	$ 1,400,000,000
Interest Rate Contracts
Derivatives, Fair Value [Line Items]
Percentage of total debt, net of related interest rate derivatives, exposed to variable interest rates	25.00%
Revenue Outside U.S. [Domain]
Derivatives, Fair Value [Line Items]
Revenues	$ 0.49
Top Five International Countries [Domain]
Derivatives, Fair Value [Line Items]
Revenues	$ 0.23

Financial Instruments (Fair Val

Financial Instruments (Fair Values of Financial Assets and Liabilities) (Details) - USD ($) $ in Millions		Dec. 27, 2014	Dec. 28, 2013
Derivatives, Fair Value [Line Items]
Total asset derivatives at fair value	[1],[2]	$ 307	$ 326
Total liability derivatives at fair value	[1],[2]	393	243
Total Financial Assets at Fair Value	[2]	3,821	669
Total Financial Liabilities at Fair Value	[2]	897	747
Assets [Member]
Derivatives, Fair Value [Line Items]
Available-for-sale securities		3,291	135
Short-term investments - index funds, at fair value	[2],[3]	197	184
Prepaid forward contracts	[2],[4]	26	24
Deferred compensation	[2],[5]	0	0
Liability [Member]
Derivatives, Fair Value [Line Items]
Available-for-sale securities		0	0
Short-term investments - index funds, at fair value	[2],[3]	0	0
Prepaid forward contracts	[2],[4]	0	0
Deferred compensation	[2],[5]	504	504
Assets [Member] | Assets [Member]
Derivatives, Fair Value [Line Items]
Available-for-sale securities	[2],[6]	124	135
Liability [Member] | Liability [Member]
Derivatives, Fair Value [Line Items]
Available-for-sale securities	[2],[6]	0	0
Liability [Member] | Liability [Member]
Derivatives, Fair Value [Line Items]
Available-for-sale securities	[2],[7]	0	0
Assets [Member] | Assets [Member]
Derivatives, Fair Value [Line Items]
Available-for-sale securities	[2],[7]	3,167	0
Derivatives Not Designated As Hedging Instruments Liabilities [Member]
Derivatives, Fair Value [Line Items]
Forward exchange contracts	[2],[8]	13	8
Interest rate derivatives	[2],[9]	75	94
Commodity contracts - other	[2],[10]	166	89
Derivatives not designated as hedging instruments, Liabilities, Total	[2]	254	191
Derivatives Not Designated As Hedging Instruments Assets [Member]
Derivatives, Fair Value [Line Items]
Forward exchange contracts	[2],[8]	12	12
Interest rate derivatives	[2],[9]	57	71
Commodity contracts - other	[2],[10]	18	20
Derivatives not designated as hedging instruments, Assets, Total	[2]	87	103
Derivatives Designated As Cash Flow Hedging Instruments Liabilities [Member]
Derivatives, Fair Value [Line Items]
Forward exchange contracts	[2],[8]	12	13
Interest rate derivatives	[2],[8]	117	0
Commodity contracts - other	[2],[10]	10	29
Derivatives designated as hedging instruments, Liabilities, Total	[2]	139	42
Derivatives Designated As Cash Flow Hedging Instruments Assets [Member]
Derivatives, Fair Value [Line Items]
Forward exchange contracts	[2],[8]	76	22
Interest rate derivatives	[2],[8]	1	19
Commodity contracts - other	[2],[10]	3	6
Derivatives designated as hedging instruments, Assets, Total	[2]	80	47
Derivatives Designated As Fair Value Hedging Instruments Assets [Member]
Derivatives, Fair Value [Line Items]
Interest rate derivatives	[2],[9]	140	176
Derivatives Designated As Fair Value Hedging Instruments Liabilities [Member]
Derivatives, Fair Value [Line Items]
Interest rate derivatives	[2],[9]	0	$ 10
Cash and Cash Equivalents [Domain]
Derivatives, Fair Value [Line Items]
Available-for-sale securities		800
Short-term Investments [Member]
Derivatives, Fair Value [Line Items]
Available-for-sale securities		$ 2,400
[1]	Unless otherwise noted, derivative assets and liabilities are presented on a gross basis on our consolidated balance sheet. Amounts subject to enforceable master netting arrangements or similar agreements which are not offset on the consolidated balance sheet as of December 27, 2014 and December 28, 2013 were immaterial. Collateral received against any of our asset positions was immaterial.
[2]	Unless otherwise noted, financial assets are classified on our consolidated balance sheet within prepaid expenses and other current assets and other assets. Financial liabilities are classified on our consolidated balance sheet within accounts payable and other current liabilities and other liabilities. Unless specifically indicated, all financial assets and liabilities are categorized as Level 2 assets or liabilities.
[3]	Based on the price of index funds. Categorized as a Level 1 asset. These investments are classified as short-term investments and are used to manage a portion of market risk arising from our deferred compensation liability.
[4]	Based primarily on the price of our common stock.
[5]	Based on the fair value of investments corresponding to employees’ investment elections.
[6]	Based on the price of common stock. Categorized as a Level 1 asset. These equity securities are classified as investments in noncontrolled affiliates.
[7]	Based on quoted broker prices or other significant inputs derived from or corroborated by observable market data. As of December 27, 2014, $0.8 billion and $2.4 billion of debt securities were classified as cash equivalents and short-term investments, respectively. All of the Company’s available-for-sale debt securities have contractual maturities of one year or less.
[8]	Based on recently reported market transactions of spot and forward rates.
[9]	Based on LIBOR forward rates and recently reported market transactions of spot and forward rates. As of December 27, 2014 and December 28, 2013, amounts related to non-designated instruments are presented as a net liability on our consolidated balance sheet.
[10]	Based on recently reported market transactions, primarily swap arrangements.

Financial Instruments (Effectiv

Financial Instruments (Effective Portion of Pre-Tax (Gains)/Losses on Derivative Instruments) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 27, 2014	Dec. 28, 2013
Fair Value/Non-Designated Hedges
Derivatives, Fair Value [Line Items]
Losses/(Gains) Recognized in Income Statement(a)	[1]	$ 193	$ 216
Cash Flow Hedges
Derivatives, Fair Value [Line Items]
Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss		88	20
Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement(b)	[2]	249	45
Forward Exchange Contracts | Fair Value/Non-Designated Hedges
Derivatives, Fair Value [Line Items]
Losses/(Gains) Recognized in Income Statement(a)	[1]	2	(9)
Forward Exchange Contracts | Cash Flow Hedges
Derivatives, Fair Value [Line Items]
Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss		(70)	(24)
Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement(b)	[2]	(16)	0
Interest Rate Contracts | Fair Value/Non-Designated Hedges
Derivatives, Fair Value [Line Items]
Losses/(Gains) Recognized in Income Statement(a)	[1]	21	99
Interest Rate Contracts | Cash Flow Hedges
Derivatives, Fair Value [Line Items]
Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss		135	(13)
Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement(b)	[2]	233	3
Commodity Contracts | Fair Value/Non-Designated Hedges
Derivatives, Fair Value [Line Items]
Losses/(Gains) Recognized in Income Statement(a)	[1]	170	126
Commodity Contracts | Cash Flow Hedges
Derivatives, Fair Value [Line Items]
Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss		23	57
Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement(b)	[2]	$ 32	$ 42
[1]	Foreign exchange derivative gains/losses are primarily included in selling, general and administrative expenses. Interest rate derivative gains/losses are primarily from fair value hedges and are included in interest expense. These gains/losses are substantially offset by increases/decreases in the value of the underlying debt, which are also included in interest expense. Commodity derivative gains/losses are included in either cost of sales or selling, general and administrative expenses, depending on the underlying commodity.
[2]	Foreign exchange derivative gains/losses are primarily included in cost of sales. Interest rate derivative gains/losses are included in interest expense. Commodity derivative gains/losses are included in either cost of sales or selling, general and administrative expenses, depending on the underlying commodity.

Net Income Attributable to Pe79

Net Income Attributable to PepsiCo per Common Share (Narrative) (Details) - $ / shares shares in Millions	12 Months Ended
	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Earnings Per Share [Abstract]
Out-of-the-money options excluded from earnings per share		0.6	9.6
Out-of-the-money options average exercise price	$ 82.25	$ 75.69	$ 67.64

Net Income Attributable to Pe80

Net Income Attributable to PepsiCo per Common Share (Basic and Diluted Net Income Attributable to PepsiCo per Common Share) (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions		12 Months Ended
		Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Earnings Per Share [Abstract]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount			0.6	9.6
Net income		$ 6,513	$ 6,740	$ 6,178
Dividends		(1)	(1)	(1)
Redemption premium		(9)	(7)	(6)
Net income available for PepsiCo common shareholders - Value		$ 6,503	$ 6,732	$ 6,171
Net income available for PepsiCo common stockholders - Shares	[1]	1,509	1,541	1,557
Basic net income attributable to PepsiCo per common share		$ 4.31	$ 4.37	$ 3.96
Stock options and RSUs - Shares	[1]	17	18	17
Dilutive Securities, Effect on Basic Earnings Per Share, Options and Restrictive Stock Units		$ 0	$ 0	$ 0
ESOP convertible preferred stock - Value		$ 10	$ 8	$ 7
ESOP convertible preferred stock - Shares	[1]	1	1	1
Diluted shares - Value		$ 6,513	$ 6,740	$ 6,178
Diluted shares - Shares	[1]	1,527	1,560	1,575
Diluted net income attributable to PepsiCo per common share		$ 4.27	$ 4.32	$ 3.92
Out Of Money Options Average Exercise Price		$ 82.25	$ 75.69	$ 67.64
[1]	Weighted-average common shares outstanding (in millions).

Preferred Stock (Narrative) (De

Preferred Stock (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions		12 Months Ended
		Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Preferred Stock
Class of Stock [Line Items]
Preferred Stock, Shares Issued	[1]	800,000	800,000	800,000
Outstanding preferred shares, fair value		$ 41	$ 41	$ 41
Convertible Preferred Stock
Class of Stock [Line Items]
Preferred stock, authorized (in shares)		3,000,000	3,000,000
ESOP
Class of Stock [Line Items]
Preferred stock, dividends per share		$ 5.46
Preferred Stock, Shares Issued		803,953	803,953
Preferred shares, outstanding		145,453	167,053
Outstanding preferred shares, fair value		$ 70	$ 69
Preferred stock convertible at the option of the holder		4.9625
Preferred stock call price		$ 78
[1]	In millions.

Preferred Stock (Schedule of Pr

Preferred Stock (Schedule of Preferred Stock) (Details) - USD ($) shares in Millions, $ in Millions		12 Months Ended
		Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning of year		$ 24,389	$ 22,399
Balance, end of year		$ 17,548	$ 24,389	$ 22,399
Preferred Stock
Class of Stock [Line Items]
Preferred Stock, Shares Issued	[1]	0.8	0.8	0.8
Preferred stock, value		$ 41	$ 41	$ 41
Repurchased Preferred Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning of year (in shares)	[1]	0.6	0.6	0.6
Balance, beginning of year		$ 171	$ 164	$ 157
Redemptions (in shares)	[1]	0.1	0	0
Redemptions		$ 10	$ 7	$ 7
Balance, end of year (in shares)	[1]	0.7	0.6	0.6
Balance, end of year		$ 181	$ 171	$ 164
[1]	In millions.

Accumulated Other Comprehensi83

Accumulated Other Comprehensive Loss Attributable to Pepsico (Schedule of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Other comprehensive income/(loss) attributable to PepsiCo		$ (5,542)	$ 360	$ 742
Currency translation adjustment	[1]	(8,255)	(3,247)	(1,946)
Cash flow hedges, net of tax		34	(76)	(94)
Unamortized pension and retiree medical, net of tax (b)	[2]	(2,500)	(1,861)	(3,491)
Unrealized gain on securities, net of tax		87	93	64
Other		(35)	(36)	(20)
Accumulated other comprehensive loss attributable to PepsiCo		(10,669)	(5,127)	(5,487)
Net of taxes decrease to opening balance of accumulated other comprehensive loss attributable to Pepsico		$ 1,260	$ 945	$ 1,832
[1]	The change from 2013 to 2014 primarily reflects depreciation of the Russian ruble.
[2]	Net of taxes of $1,260 million in 2014, $945 million in 2013 and $1,832 million in 2012.

Accumulated Other Comprehensi84

Accumulated Other Comprehensive Loss Attributable to Pepsico Reclassification of Accumulated Other Comprehensive Loss to the Condensed Consolidated Statement of Income (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Derivatives Qualifying as Hedges, Net of Tax [Abstract]
Reclassification of net losses to net income, pre-tax amount		$ 249	$ 45	$ 90
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax		(95)	(17)	(32)
Net derivative losses		154	28	$ 58
Other Comprehensive (Income) Loss, Amortization Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Prior Service Cost (Credit), before Tax	[1]	(6)	(2)
Amortization of Net Actuarial Losses, OCI	[1]	226	357
Amortization and settlement of losses	[1]	149	(2)
Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, before Tax		369	353
Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, Tax		(122)	(123)
Remeasurement of net liabilities and translation		247	230
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax		401	258
Cash Flow Hedges
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	[2]	(249)	(45)
Forward Exchange Contracts | Cash Flow Hedges
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	[2]	16	0
Forward Exchange Contracts | Cost of Sales | Cash Flow Hedges
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net		(16)	0
Interest Rate Contracts | Cash Flow Hedges
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	[2]	(233)	(3)
Interest Rate Contracts | Interest Expense | Cash Flow Hedges
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net		233	3
Commodity Contracts | Cash Flow Hedges
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	[2]	(32)	(42)
Commodity Contracts | Cost of Sales | Cash Flow Hedges
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net		31	44
Commodity Contracts | Selling, General and Administrative Expenses | Cash Flow Hedges
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net		$ 1	$ (2)
[1]	(a)These items are included in the components of net periodic benefit cost for pension and retiree medical plans (see Note 7 for additional details).
[2]	Foreign exchange derivative gains/losses are primarily included in cost of sales. Interest rate derivative gains/losses are included in interest expense. Commodity derivative gains/losses are included in either cost of sales or selling, general and administrative expenses, depending on the underlying commodity.

Supplemental Financial Inform85

Supplemental Financial Information (Schedule of Supplemental Balance Sheet Information) (Details) - USD ($)		12 Months Ended
		Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Supplemental Financial Information [Abstract]
Inventory, LIFO Reserve		$ 0.03
Accounts and notes receivable
Trade receivables		5,817,000,000	$ 6,178,000,000
Other receivables		971,000,000	921,000,000
Total receivables		6,788,000,000	7,099,000,000
Analysis of valuation allowances
Allowance, beginning of year		145,000,000	157,000,000	$ 157,000,000
Net amounts charged to expense		38,000,000	29,000,000	28,000,000
Deductions	[1]	(27,000,000)	(34,000,000)	(27,000,000)
Other	[2]	(19,000,000)	(7,000,000)	(1,000,000)
Allowance, end of year		137,000,000	145,000,000	$ 157,000,000
Net receivables		6,651,000,000	6,954,000,000
Inventories (c)
Raw materials	[3]	1,593,000,000	1,732,000,000
Work-in-process	[3]	173,000,000	168,000,000
Finished goods	[3]	1,377,000,000	1,509,000,000
Inventories	[3]	3,143,000,000	$ 3,409,000,000
Percent of inventory cost calculated using the LIFO method			3.00%
Other assets
Noncurrent notes and accounts receivable		93,000,000	$ 105,000,000
Deferred marketplace spending		179,000,000	214,000,000
Pension plans	[4]	141,000,000	687,000,000
Other		447,000,000	419,000,000
Other Assets		860,000,000	1,425,000,000
Accounts payable and other current liabilities
Accounts payable		5,127,000,000	4,874,000,000
Accrued marketplace spending		2,222,000,000	2,245,000,000
Accrued compensation and benefits		1,746,000,000	1,789,000,000
Dividends payable		1,009,000,000	899,000,000
Other current liabilities		2,912,000,000	2,726,000,000
Accounts payable and other current liabilities		$ 13,016,000,000	$ 12,533,000,000
[1]	Includes accounts written off.
[2]	Includes adjustments related to acquisitions and divestitures, currency translation and other adjustments.
[3]	Approximately 3% of the inventory cost in both 2014 and 2013 was computed using the LIFO method. The differences between LIFO and FIFO methods of valuing these inventories were not material.
[4]	See Note 7 for additional information regarding our pension plans.

Supplemental Financial Inform86

Supplemental Financial Information (Schedule of Other Supplemental Information) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Supplemental Financial Information [Abstract]
Rent expense	$ 707	$ 639	$ 581
Interest paid	925	1,007	1,074
Income taxes paid, net of refunds	$ 1,847	$ 3,076	$ 1,840

Acquisitions (Narrative) (Detai

Acquisitions (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions	Mar. 31, 2012	Jun. 15, 2013	Jun. 16, 2012	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Business Acquisition [Line Items]
Merger and integration charges				$ 0	$ 10	$ 16
Tingyi
Business Acquisition [Line Items]
Indirect equity interest percentage	5.00%
Call option for indirect equity percentage, maximum percentage			20.00%
Merger and integration charges						150
Merger and integration charges, after tax						$ 176
Merger and integration charges, after-tax impact per share						$ 0.11
Subsidiary, Vietnam Bottling Operations
Business Acquisition [Line Items]
Gain (Loss) on Sale of Stock in Subsidiary, After-Tax		$ 137
Gain(loss) on sale of stock in subsidiary, after-tax per share		$ 0.09